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ABSTRACT OF DISSERTATION

DIFFERENTIAL ACTIVITY AND CONTENT OF HIGH-AFFINITY
GLUTAMATE TRANSPORTERS, CONTENT OF THEIR REGULATORY
PROTEINS, AND CAPACITY FOR GLUTAMINE AND GLUTATHIONE
SYNTHESIS IN TISSUES OF FINISHED VERSUS GROWING STEERS
Improvement of feeding regimens for production animals has been hindered
by a lack of fundamental knowledge about how the capacity to regulate nutrient
absorption across cell membranes affects the function of nutrient metabolizing
enzymes. The objective is to determine if the activities and protein content of system
X-AG glutamate transporter, its regulatory protein (GTRAP3-18 and ARL6IP1),
glutamine synthetase (GS) and glutathione (GSH) content, changes in liver
(Experiment 1), longissimus dorsi (LM) and subcutaneous adipose tissue (SF)
(Experiment 2) as beef steers transitioned from predominantly-lean (growing) to lipid (finished) tissue accretion phases. In liver (Experiment 1), system X-AG activity
in canalicular membranes was abolished as steers developed from growing to
finished stages but did not change in basolateral membranes. EAAC1 protein content
in liver homogenates decreased in finished vs. growing steers, whereas GTRAP3-18
and ARL6IP1 content increased and GLT-1 content did not change. Concomitantly,
hepatic GS activity decreased in finished steers whereas GS protein content did not
differ. Hepatic GSH content did not differ in finished vs. growing steers. These
results demonstrate a negative functional relationship between GTRAP3-18 and
system X-AG activity with glutamine synthesis capacity in livers of fattened cattle. In
addition to liver, skeletal muscle and adipose tissues play important roles in
maintaining whole-body glutamate and nitrogen homeostasis. In Experiment 2,
Western blot analysis of LM homogenates showed decreased EAAC1 and GS
content, whereas GTRAP3-18 and ARL6IP1 did not differ in finished vs. growing
steers. GSH content in LM was increased in finished vs. growing steers in
concomitance with increased mRNA expression of GSH-synthesizing enzymes. In
SF, GTRAP3-18 and ARL6IP1 content was increased, whereas EAAC1 and GS
content did not differ. Concomitantly, GSH content in SF was decreased in finished
vs. growing steers in parallel with decreased mRNA expression of GSHmetabolizing enzymes. These results demonstrate that the negative regulatory

relationship between GTRAP3-18 and ARL6IP1 with EAAC1 and GS expression,
which exists in liver, does not exist in LM and SF of fattened cattle; and antioxidant
capacity in LM and SF changes and differs as steer compositional gain shifts from
lean to lipid phenotype. To further explore the upstream regulatory machinery of
EAAC1, transcriptome analysis (Experiment 3) was conducted to gain a greater
understanding of hepatic metabolic shifts associated with the change in whole-body
compositional gain of growing vs. finished beef steers. The expression of upstream
regulators of EAAC1 was decreased in a manner consistent with the decreased
EAAC1 activity in Experiment 1. Bioinformatic analysis found that, for amino acid
metabolism, finished steers had increased capacities for ammonia, arginine, and urea
production, and shunting of amino acid carbons into pyruvate. For carbohydrate
metabolism, capacity for glycolysis was inhibited, whereas glycogen synthesis was
stimulated in finished steers. For lipid metabolism, finished steers showed decreased
capacity for fatty acid activation and desaturation, but increased capacity for fatty
acid β-oxidation and lipid storage. In addition, redox capacity and inflammatory
responses were decreased in finished steers. Collectively, these data describe novel
regulatory relationships of system X-AG in liver and peripheral tissues, and the
metabolic mechanisms that control nutrient use efficiency, as beef steers develop
from lean to lipid phenotypes.
Keywords: Finishing steers, Peripheral tissues, Glutamate transport, Glutathione,
Transcriptome
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Chapter 1. Introduction

L-glutamate (Glu) transport and metabolism are critical to support whole-animal
energy and N homeostasis (Heitmann and Bergman, 1981a; Wu, 1998; Burrin and Stoll,
2009). Glu can serve as a source of oxidizable fuel, precursor for amino acid synthesis,
carbon receptor for alpha-amino- and ammonia-nitrogen derived from the catabolism of
other amino acids, or substrate for de novo protein synthesis. The predominant metabolic
fate of Glu is tissue specific. For example, in the intestinal epithelia, dietary and enteric
Glu serve as important sources of carbons for oxidation-derived metabolic energy and
endogenous synthesis of alanine and other amino acids (Wu, 1998). In the liver, Glu is a
central substrate for ureagenesis, gluconeogenesis, glutathione (GSH) production, de
novo protein synthesis, and nitrogen shuttling via glutamine (Gln) (Meijer et al., 1990;
Brosnan, 2000; Watford, 2000). In skeletal muscle (Biolo et al., 1995; Vesali et al., 2002)
and subcutaneous fat (Kowalski and Watford, 1994), the production of Gln from plasma
Glu is thought to constitute an important route for whole-body ammonia recovery and
detoxification.
The principal source of circulating Glu is the liver where the Glu/Gln cycle
occurs. Under normal physiological conditions, Glu produced from the deamination of
Gln by liver-type glutaminase, and subsequently exported into sinusoidal blood by
periportal vein hepatocytes, is thought to be the principal source of Glu for peripheral
tissue use. In contrast to this net export of Glu by the liver, tissues that are net users of
Glu (including the subcutaneous adipose and skeletal muscle) also are net exporters of

1

Gln (Hediger and Welbourne, 1999a; Patterson et al., 2002). Given the central role of Glu
to support tissue and whole-body growth and maintenance, plus that plasma membrane
transport capacity is thought to limit Glu metabolism (Low et al., 1994; Nissim, 1999;
Gegelashvili et al., 2003), knowledge of how Glu transport capacity is regulated to
support peripheral tissue metabolism, including Gln synthesis and GSH metabolism, is
critical (Brosnan, 2000; Vandenberg and Ryan, 2013).
Growing and finishing phases are two important animal production stages, which
differ fundamentally in compositional growth. The growing stage reflects the acceleration
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase
reflects a time of greatest fat to lean deposition ratio with maximized meat yield and fat
cover (U.S market weight). Understanding the physiological mechanisms altered
concomitantly with the shift in whole-body compositional gain as cattle fatten (growing
vs. finished steers), should provide mechanistic knowledge that can be applied to
optimize tissue protein accretion. Accordingly, the goals of this dissertation were:
1. To determine whether the hepatic activities and protein content of system X-AG
transporters (EAAC1, GLT-1), system X-AG regulatory proteins (GTRAP3-18,
ARL6IP1), and glutamine synthetase (GS) change as beef steers developed from
predominantly lean to predominantly lipid deposition growth phases (Chapter 4).
2. To determine whether the content of system X-AG transporters, their regulatory
proteins, glutamine synthetase (GS), glutathione (GSH), and mRNA expression of GSHsynthesizing and metabolizing enzymes change in longissimus dorsi (LM) and
subcutaneous adipose (SA) tissues of the same steers developing from predominantly
lean into predominantly lipid growth phases (Chapter 5).
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3. To identify shifts in hepatic transcriptome profiling and the upstream regulatory
mechanisms of EAAC1 as beef steers develop from lean to lipid phenotype (Chapter 6).
For convenience, the L-isomer form of amino acids is implied unless indicated
otherwise.
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Chapter 2. Literature Review

Molecular and Functional Characterization of Proteins Capable of Glu Transport
In mammals, mediated absorption of Glu occurs by Na+-dependent and Na+independent biochemical activities. System X-AG is a high affinity Glu transport system
(K = 4-40 μM) that mediates Na+-dependent uptake of L-Glu, D-, L-aspartate and Lcysteine with an obligatory counter-exchange of K+ across cell membranes (Guidotti and
Gazzola, 1992; Ganapathy et al., 1994; Danbolt, 2001). In addition to system X-AG,
systems ASC and B0 also mediate Na+-dependent transport of L-Glu and L-aspartate, but
only in acidic (pH < 5.5) environments. In contrast to Na+-dependent biochemical
activities, Na+-independent uptake of Glu is mediated by system x-c. System x-c transport
is an obligate exchange activity that typically mediates the exchange of intracellular LGlu for extracellular L-cystine (Sato et al., 1999; Matthews, 2005). The molecular
identification and functional properties of these transporters have been characterized in
mammals (see below) (Matthews, 2005).
System X-AG Transporters. Five mammalian proteins capable of system X-AG
have been cloned, with the nonhuman system X-AG orthologs known as excitatory amino
acid carrier 1 (EAAC1) (Kanai and Hediger, 1992), Glu transporter 1 (GLT1) (Pines et
al., 1992), Glu-aspartate transporter 1 (GLAST1) (Storck et al., 1992) and excitatory
amino acid transporter 4 (EAAT4) (Fairman et al., 1995b) and excitatory amino acid
transporter 5 (EAAT5) (Kanai and Hediger, 2003; Beart and O'shea, 2007). The
expression and function of these high- affinity Glu transporters has been extensively
studied in the brain to understand how their presence facilitates the use of Glu as a
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neurotransmitter (Danbolt, 2001). Except for EAAT5, all the system X-AG transporters are
highly expressed by brain tissue, but with distinct distribution patterns. GLAST1 and
GLT-1 represent glial-specific Glu transporters that are involved in the neurotransmission
(Torp et al., 1994; Berger and Hediger, 1998), whereas EAAC1 and EAAT4 are the
predominant transporters in neurons to support metabolic functions of brain tissues (Torp
et al., 1997; Berger and Hediger, 1998).
In addition to being the predominant transporter in the brain tissues, EAAC1 is
the most widely distributed of the Glu transporters in peripheral tissues. For example, in
the rabbit, EAACl mRNA is expressed by the duodenum, jejunum, ileum, heart, liver,
and placenta, but not the colon, lung, or spleen (Kanai and Hediger, 1992). In ruminants,
EAAC1 and GLT-1 are expressed by the intestinal epithelia, liver, kidney, and skeletal
muscle tissues, whereas only EAAC1 protein is consistently detectable in adipose tissues
(Howell et al., 2001; Howell et al., 2003; Xue et al., 2010; Miles et al., 2015; Matthews et
al., 2016). In humans, GLAST1 mRNA is expressed in heart, lung, skeletal muscle and
placenta tissues (Nakayama et al., 1996). However, in cattle and sheep, GLAST1 protein
is not detectable by immunoblot analysis in non-neuronal tissues that express EAAC1
and GLT-1, except for the pancreas (Howell et al., 2001). In contrast to the wide
distribution of EAAC1 and GLT-1, the expression of EAAT4 and EAAT5 is restricted in
the brain (Fairman et al., 1995a; Nagao et al., 1997) and in the retina (Arriza et al., 1997),
respectively.
System ASC/B0 Transporters. Na+-dependent system ASC transports alanine,
serine, cysteine, and other neutral α-amino acids. ASCTl cDNA, originally cloned from
human brain tissue, encodes for system ASC-like activity and shares nearly 40% amino
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acid sequence identity with the anionic EAAT transporters (Arriza et al., 1993;
Utsunomiya Tate et al., 1996). Although ASCT1 also transports Glu and Asp at pH of 5.5
or lower, system ASC accounts for the majority uptake of neutral amino acids above pH
6 (Palacín et al., 1998). ASCTl mRNA is highly expressed in the brain, skeletal muscle,
and pancreas, and also detectable in liver, heart, lung, placenta, and kidney human tissues
(Arriza et al., 1993; Hofmann et al., 1994; Weiss et al., 2001).
Similar to system ASC transporter, system B0 mediates Na+-coupled uptake of
neutral amino acids, including alanine, serine and cysteine (Stevens et al., 1982). In
acidic (pH < 5.5) environments, system B0 also transports L-Glu and L-aspartate. The
cDNAs of ATB0 and ASCT2 that encode for the system B0 activity have been isolated in
mammals (Kekuda et al., 1996; Kekuda et al., 1997; Pollard et al., 2002). ATB0 is
localized to the brush border membrane in proximal tubule cells and enterocytes (Avissar
et al., 2001; Bröer et al., 2004), which is consistent with previously characterized pattern
of biochemically defined system B0 activity (Stevens et al., 1982; Lynch and McGivan,
1987). In mice, expression of ASCT2 mRNA has been identified in various tissues, such
as adipose, skeletal muscle, placenta, kidney, large intestine, lung, pancreas, and testes
(Liao and Lane, 1995; Utsunomiya Tate et al., 1996).
System x-C Transporters. System x-C is the most widely expressed Na+independent transport activity for anionic amino acids. Although system x-C activity is
typically low, this activity mediates the highly specific counter-exchange of intracellular
L-Glu for extracellular L-cystine (Bannai and Kitamura, 1980), which finally yields two
cysteine molecules as cystine is rapidly reduced in the cytosol. Because cysteine is
thought to be the limiting substrate for glutathione synthesis (Sato et al., 1999; Matthews,

6

2005), it follows that system x-C is important in regulating GSH synthesis and cellular
redox balance. Indeed, system x-C activity is upregulated in response to oxidative stress
(Sato et al., 2005).
The protein capable of system x-C activity has been identified in human and
mouse, is designated as xCT (Sato et al., 1999). Human xCT (Bassi et al., 2001) displays
Km values of 43 and 93 µM for L-cystine and L-Glu, respectively. Knockout of xCT
leads to alterations of redox balance (Sato et al., 2005), further suggesting system x-C
activity influences the redox potential of a cell by transporting cystine for glutathione
synthesis (Kilberg, 1982; Takada and Bannai, 1984; Bannai and Tateishi, 1986).
Glu transport in support of tissue-specific metabolism
Liver. A primary function of the mammalian liver is to coordinate whole-body
energy and N metabolism. Hepatic transport and intermediary metabolism of Glu are
critical to these processes as Glu is a central substrate for hepatic ureagenesis,
gluconeogenesis, glutathione production, de novo protein synthesis, and nitrogen
shuttling via Gln (Meijer et al., 1990; Nissim, 1999; Watford, 2000) (Figure 2.1; Figure
2.2). Hepatocytes are highly polarized cells containing three functionally distinct surface
domains: sinusoidal, lateral and canalicular (Boyer, 1980; Evans, 1980). Because the
sinusoidal and lateral membranes are in physical continuity and highly specialized for the
exchange of metabolites with the blood, these two plasma membrane surface areas are
designated as the basolateral domain. In contrast, the bile canalicular domain participates
in the primary secretion of bile constituents, including bile acids, and other detoxified
substances (Boyer, 1980).
Glu/Gln Metabolism in the liver. An important aspect of Glu metabolism in the

7

liver is the heterogeneity of Gln/Glu metabolism. Specifically, Gln, arriving from the
peripheral tissues via the portal vein, is efficiently absorbed by periportal hepatocytes and
deaminated by glutaminase (liver-type) to release ammonia and Glu. Alanine
transaminase (glutamic-pyruvic transaminase, GPT), also primarily expressed by
periportal vs. pericentral hepatocytes, supports ammonia production by transaminating
Ala to pyruvate (Welsh, 1972), producing Glu from α-KG. Glu, in turn, can be
deaminated by Glu dehydrogenase to produce ammonia and α-KG. Ammonia from
peripheral Gln and Ala now can be incorporated into carbamoyl phosphate for
ureagenesis. Moreover, aspartate transaminase (GOT) expressed in the periportal
hepatocytes (Boon et al., 1999; Braeuning et al., 2006) converts oxaloacetate and Glu
into aspartate and oxoglutarate, that also feeds into urea cycle, whereas the remaining Glu
is available for conversion to α-KG (as an anapleurotic reaction to replenish the citric
acid cycle), used for gluconeogenesis, used for protein synthesis, or transported into the
sinusoids.
In contrast to the periportal zone, when released into the sinusoidal blood, Glu is
available for absorption by “down-acinus” pericentral hepatocytes, which express the
high-affinity system X-AG activity (Häussinger and Gerok, 1983; Braeuning et al., 2006;
Brosnan and Brosnan, 2009) (Figure 2.3). If absorbed by pericentral hepatocytes, Glu and
the “scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990;
Wagenaar et al., 1994). Besides supporting Gln synthesis by GS, pericentral hepatocytelocalized system X-AG uptake of Glu complements pericentral hepatocyte-specific

8

synthesis of glutathione by glutamylcysteine ligase and glutathione synthetase
(Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic carbons
and for de novo protein synthesis (Watford, 2000).
To gain an insight into the molecular mechanisms of the metabolic function of
bovine hepatocytes, it is essential to determine if Glu transport capacities are localized in
basolateral (sinusoidal) and canalicular (apical) membranes of hepatocytes. Using
isolated membrane vesicles from rat liver, system X-AG activity has been detected in
canalicular-enriched fractions and a Na+-independent activity in the sinusoidal membrane
domain (Ballatori et al., 1986; Cariappa and Kilberg, 2006). In contrast, other studies
have shown both system X-AG activity and Na+-independent (exchanger) Glu transport
activities exist in sinusoidal membranes of rat hepatocytes (Low et al., 1992).
Furthermore, the system X-AG activity was upregulated in response to catabolic hormones
(corticosteroid, glucagon), whereas the Na+-independent, Glu exchanger activity (system
x-c-like) was insensitive to alteration of whole-body catabolic status. These results
suggest that system X-AG activity on the sinusoidal membrane facilitates adaptation of
hepatocytes to handle the increase in sinusoidal ammonia loads that accompany catabolic
stress. That is, possession of an increased concentrative Glu transport capacity would
supply more Glu to serve as an acceptor of ammonia through the activities of glutamine
synthetase.
However, it has been argued that Na+-dependent Glu uptake does not limit
pericentral hepatocyte GS activity and that GS activity is relatively insensitive to change
in various metabolic states for nonruminants (Watford, 2000). For example, during
acidosis and long-term starvation in nonruminants, the liver switches from a net
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consumer to net producer of Gln (Heitmann and Bergman, 1980) by decreasing
glutaminase activity and the rate of urea synthesis to conserve nitrogen, with the absolute
rate of Gln synthesis unchanged. In contrast, in ruminants, hepatic GS activity and
protein content do not change during metabolic acidosis (Lobley et al., 2001; Xue et al.,
2010). Thus, these findings may represent differences in hepatic Glu/Gln metabolism
between ruminants and nonruminats.
Glutathione synthesis and metabolism. In addition to supporting Gln synthesis,
Glu is also the substrate for glutathione synthesis. The tripeptide glutathione (γ-Lglutamyl-L-cysteinylglycine) is present in mammalian tissues at 1-10 mM concentrations
with highest concentrations in liver (Lu, 2013) (Table 2.1). GSH functions as the major
antioxidant and serves as a transport reservoir of cysteine to maintain the celluar thiol
reduction potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen,
2012). Of the total cellular glutathione pool, 80-85% of GSH is found in the cytosol
versus 10-15% in the mitochondria, and a small amount in the endoplasmic reticulum
(Meredith and Reed, 1982; Hwang et al., 1992; Yuan and Kaplowitz, 2009; Lu, 2013).
Glutathione modulates diverse cellular processes. For example, GSH is involved in redox
signaling, detoxification of xenobiotics and regulates cell proliferation, apoptosis and
immunity (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et al., 2009;
Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010).
Biosynthesis and whole-body utilization of GSH occurs in a tightly regulated
manner. Cellular GSH synthesis strongly depends on the availability of Cys and Glu
(Sato et al., 1999; Flaring et al., 2003; Matthews, 2005). Cys can be derived from the
diet, protein breakdown by liver, and other sulfur amino acid GSH precursor such as
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methionine via the transsulfuration pathway (Lu, 2013). Cys is oxidized to disulfide
cystine extracellularly, but cystine can be rapidly reduced to Cys once taken up by cells
(Bannai and Tateishi, 1986). In hepatocytes, the uptake of Cys is mediated by Na+
dependent system X-AG transporters and the ASC system, whereas cystine (the oxidized
form of cysteine) is absorbed by the Na+ -independent x-C system (Kilberg, 1982; Takada
and Bannai, 1984; Matthews, 2005). In addition to cysteine uptake mediated by
transporters, Glu plays an important role in GSH synthesis. GSH synthesis is enhanced
with high intracellular Glu concentration in canine erythrocytes (Griffith, 1999).
However, in patients with cancer or brain injury with high extracellular Glu
concentration, Cys uptake is competitively inhibited by Glu, resulting in reduced GSH
synthesis (Tapiero et al., 2002). Glu also prevents the feedback inhibitory effect of GSH
on GSH-synthesizing enzymes (e.g., glutamate-cysteine ligase) by competing with GSH
for binding to the enzyme (Griffith, 1999).
The main site for GSH production is the liver with system X-AG transporters, with
GSH and bile acid synthesizing enzymes being co-localized to pericentral hepatocytes
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). Because GSH
exported from the liver to the blood is utilized by organs such as muscle and kidney,
depletion of liver GSH under oxidative stress may also deplete GSH in these tissues.
Thus, factors that regulate hepatic GSH production and secretion play a critical role in
whole animal GSH homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989;
Ookhtens and Kaplowitz, 1998).
Antioxidant function of GSH
Glutathione is the most abundant cellular thiol present in mammalian tissues.
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Several GSH related enzymes guard cells against oxidative injury by scavenging reactive
oxygen species and nitrogen radicals. In the cytosol and mitochondria, superoxide
dismutase (SOD) catalyzes the dismutation of superoxide radical (O2-) into H2O2, which
is subsequently reduced into water and oxygen by catalase in the peroxisome (Salvi et al.,
2007). However, in mitochondria and cytosol, GSH is especially important in defending
against oxidative stress (Fernandez Checa et al., 1997; Garcia Ruiz and Fernandez Checa,
2006; Lu, 2013). The antioxidant function of GSH is catalyzed by GSH peroxidase,
which reduces lipid peroxide and hydrogen peroxide into corresponding alcohols and
water to prevent the organism from the oxidative damage. Glutathione can also conjugate
with xenobiotics via glutathione-S-transferases (GST) for the purpose of detoxification
(Schmidt and Dringen, 2012). At the same time, GSH (reduced form of glutathione) is
oxidized to GSSG (disulfide-oxidized form) that can be subsequently reduced back into 2
GSH by GSSG reductase, forming a redox cycle. In the cell, the ratio of GSH to GSSG
mainly determines the intracellular redox potential (Forman et al., 2009). However,
severe oxidative injury may compromise the ability of the cell to reduce GSSG into 2
GSH molecules, leading to GSSG accumulation (Lu, 2009). To maintain the redox
equilibrium, GSSG is either exported out of the cell or reacts with a protein sulfhydryl
group to form a mixed disulfide (Figure 2.4) (Schmidt and Dringen, 2012; Lu, 2013).
Glutathione synthesis
Glutathione synthesis involves two consecutive ATP-requiring enzymatic
reactions: formation of γ-glutamylcysteine from Glu and Cys by γ-glutamylcysteine
ligase (GCL) and formation of glutathione from γ-glutamylcysteine and glycine by
glutathione synthase. The rate-limiting enzyme GCL is composed of a catalytic subunit
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(GCLC) and a modifier subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC
catalyzes γ-glutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering
the Km for Glu and increasing the Ki for the feedback inhibition of GCL by glutathione
(Richman and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al.,
2005). Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione
synthase (GSS). Although glutathione synthase is usually not considered to be rate
limiting, increased glutathione synthase expression can further promote GSH production
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004).
Extracellular metabolism of glutathione
Glutathione is transported out of the cell by GSH transporters such as the
multidrug resistance protein Mrp family (Schmidt and Dringen, 2012; Bachhawat et al.,
2013). The unique structure of GSH is that Cys is linked with γ-carboxyl group of Glu
instead of α-carboxyl group, which makes glutathione resistant to intracellular
degradation (Lu, 2013). The only enzyme to hydrolyze the γ-carboxyl-amine bound of
glutathione is γ-glutamyltranspeptidase (GGT), expressed on the surface of certain cell
types (Meister and Anderson, 1983). GGT is highly expressed in epithelium of lung,
kidney and intestine (Deneke and Fanburg, 1989). However, importantly, GGT is lowly
expressed in hepatocytes, which is consistent with the role of liver as a net exporter of
GSH (see below) (Lauterburg et al., 1984). GGT transfers the γ-glutamyl motif to an
acceptor amino acid, forming γ-glutamyl amino acid and cysteinylglycine. The γglutamyl amino acid can be transported back into the cell to release 5-oxoproline, which
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is finally converted to Glu as the substrate for GSH synthesis. On the other hand,
cysteinylglycine is broken down by dipeptidase to yield cysteine and glycine, which are
also transported back into the cell to be reincorporated into GSH. Once inside the cell,
most of the cysteine is used for GSH synthesis while the rest is broken down into sulfate
and taurine or is incorporated into new protein. Therefore, the γ-glutamyl cycle is
important to maintain GSH homeostasis by breaking down extracelluar glutathione
through GGT and recycling back into the rate-limiting cysteine for intracellular GSH
synthesis (Figure 2.5) (Lu, 2013).
Inter-organ flux of GSH
The main site for the GSH production is the liver with system X-AG transporters
and glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After GSH
synthesized by the liver is exported into blood and bile, the kidney can either directly take
up GSH from the plasma into cells or salvage plasma GSH through the GGT reaction.
Plasma GSH can also be utilized by other organs such as lung and intestinal epithelium
with high levels of GGT activity (Deneke and Fanburg, 1989). The portal vein brings
blood from the intestine to the liver where xenobiotics are neutralized by hepatocytes if
not detoxified in the intestine (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012).
Because the liver has low GGT activity and is a net exporter of GSH, depletion of liver
GSH under oxidative stress or xenobiotics metabolism may also deplete GSH in other
tissues. Therefore, hepatic GSH production and secretion play a critical role in the whole
animal glutathione homeostasis (Figure 2.6) (Lauterburg et al., 1984; Deneke and
Fanburg, 1989; Ookhtens and Kaplowitz, 1998).
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GSH mediated oxidative capacity in the liver in response to physiological challenges in
animal models
The oxidative capacity in liver changes in response to physiological challenges.
Selenoproteins, such as glutathione peroxidase and selenoprotein W (SEPW1), bind to
GSH and target reactive oxygen species such as hydrogen peroxide and lipid peroxide
(Jeong et al., 2002). Administration of selenium protects rats from the arsenic-induced
oxidative damage in liver (Messarah et al., 2012). In maturing beef heifers,
supplementation of different forms of selenium (inorganic, organic and mixed form)
changes the hepatic transcriptome profiles (Matthews et al., 2014). The seleneoprotein W
(SEPW1) mRNA was upregulated in all forms of selenium supplementation, suggesting a
greater antioxidant capacity (Matthews et al., 2014). Moreover, GSH content and
expression of enzymes responsible for GSH synthesis change under disease conditions. In
chronic liver disease, the cellular glutathione content and GPx expression are increased
upon activation of rat hepatic stellate cells to protect against the ROS induced toxicity
(Dunning et al., 2013). Similarly, the increased transcription rate of GCLC and
glutathione synthase results in elevated GSH levels for liver regeneration in human
hepatocellular carcinoma (Huang et al., 2001).
In summary, much still remains to be determined about how the submembrane
localization of Glu transport activities supports Gln and GSH synthesis and metabolism.
Moreover, improvement of feeding regimens for production animals has been hindered
by a lack of fundamental knowledge about how the capacity to regulate nutrient
absorption across cell membranes affects the function of nutrient metabolizing enzymes.
Although plasma membrane transport capacity is thought to limit Glu metabolism (Low
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et al., 1994; Nissim, 1999; Gegelashvili et al., 2003), knowledge of how hepatic Glu
transport capacity may be regulated to support changes in metabolic capacity associated
with different phases of growth (e.g., predominately-lean to predominately-lipid tissue
accretion) is limited.
Skeletal Muscle Tissues. The uptake of plasma Glu, its intracellular conversion to
Gln, and subsequent export of Gln to the plasma by skeletal muscle is critical to the
proper functioning of intestinal epithelia and immune system (Newsholme and ParryBillings, 1990; Hack et al., 1996). In addition to having important roles in other tissues of
the body, Glu is central to many metabolic processes in skeletal muscle. For example,
Glu is required for transamination of branch-chain amino acids, pivotal to the formation
of ammonia, Asp, Ala, and Gln, and is the primary AA taken up by resting and active
muscles (Mourtzakis and Graham, 2002). A reduction in the capacity for plasma Glu
uptake by skeletal muscle is thought to cause intracellular deficiencies of Glu, Gln,
glutathione, and citric acid cycle intermediates (Hack et al., 1996; Ushmorov et al.,
1999).
In skeletal muscle (Biolo et al., 1995; Vesali et al., 2002), the production of Gln
from plasma Glu is thought to constitute an important route for whole-body ammonia
recovery and detoxification. However, information on the molecular identity of Glu
transporters expressed in muscle tissue is limited. System X-AG activity has been reported
in skeletal myocytes (Low et al., 1994), as has EAAC1 mRNA and protein expression by
rat and human skeletal muscle (Kanai and Hediger, 1992). Recently, we have identified
the presence of both mRNA and protein for two system X-AG transporters (EAAC1 and
GLT-1) in the Longissimus dorsi (LM) of fattening cattle (Matthews et al., 2016),
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whereas GLT-1, GLAST-1 or EAAT4 protein was not detected. These results suggest
EAAC1 and GLT-1 play an important role in supporting carbon and N metabolism in this
skeletal muscle. Moreover, although GS mRNA was identified in LM, GS protein was
not detected in LM, indicating a relatively low GS content in LM. This low GS content in
steer LM is consistent with the general understanding that although GS activity is low in
mammalian skeletal muscle, the total amount of skeletal muscle- expressed GS activity is
very high, as a consequence of the large total skeletal muscle mass (Kuhn et al., 1999).
From a developmental perspective, an important observation was that the protein
expression of both EAAC1 and GLT-1 was inversely proportional to developmental age.
That is, the content of both EAAC1 and GLT-1 in the Longissimus dorsi of suckling
animals (30 days old) was greater than in weanling age (184 days old), which was greater
than that by backgrounding (284 days) or finishing (423 days old) cattle. These results
suggest longissimus dorsi of steers developing through typical production stages have
different capacities for Glu uptake. Whether this reduction in Glu transport capacity in
skeletal muscle reflects a shift in nitrogen and glutathione metabolism remains to be
determined.
GSH mediated oxidative capacity in the skeletal muscle in response to physiological
challenges in animal models
In addition to supporting nitrogen metabolism, Glu transporters contribute to the
cellular redox potential by delivering substrates to support intracellular GSH synthesis in
LM. However, under oxidative stress conditions, Glu transporter proteins and enzymes
supporting the sodium and Glu gradients (e.g., Na, K-ATPase, Gln synthetase) can be
oxidized in presence of higher concentrations of reactive oxygen radicals, leading to

17

inhibition of metabolic functions (Volterra et al., 1994; Gegelashvili and Schousboe,
1997). In a human trauma model, glutathione concentration decreases in skeletal muscle,
indicating oxidative stress caused by tissue injury (Flaring et al., 2003). However,
glutathione depletion in muscle can be attenuated by Gln supplementation via a supply of
Glu for glutathione synthesis (Flaring et al., 2003). Thus, dietary amino acid
supplementation seems to be a good therapeutic strategy to modulate GSH synthesis. On
the contrary, a deficient sulfur amino acids diet decreases growth and glycolysis of
longissimus muscle in piglets (Conde-Aguilera et al., 2015), suggesting the inadequate
nutrition supply impairs GSH homeostasis.
Adipose tissues. Adipose tissues play a significant role in whole body amino acid
metabolism (Frayn et al., 1991; Kowalski et al., 1997; Patterson et al., 2002).
Subcutaneous adipose has been proven to be a net user of Glu and net producer of Gln
(Frayn et al., 1991) with the metabolic capacity to be an important site for Gln synthesis
in the body (Ritchie et al., 2001). The inguinal adipose pad/adipocyte tissue of fed rats
also appears to be a net user of Glu and ammonia, and a producer of Gln (Kowalski and
Watford, 1994). Accordingly, these studies gave rise to the concept that the adipose
tissues of normally-nourished mammals absorb Glu to synthesize Gln and, therefore,
contribute to whole-body nitrogen metabolism through the production of Gln and
removal of ammonia from the blood. Thus, it seems reasonable to suggest that the
relative contribution of adipose-synthesized Gln to whole-body N metabolism is strongly
influenced by the relative activity of Glu transporters and GS (Ritchie et al., 2001).
However, information characterizing amino acid uptake in adipose tissue in vivo
is very limited. EAAC1 was the only system X-AG transporter expressed in subcutaneous
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and kidney adipose tissues (Matthews et al., 2016), suggesting EAAC1 function may be
critical for Glu-based adipose metabolism, including the synthesis of Gln from plasma
Glu. Another important finding of Matthews et al. (2016) was that expression of GS
paralleled the increase in EAAC1 content from the weanling to backgrounding stage, but
not during the finished stage, when GS content, but not EAAC1, was decreased
(Matthews et al., 2016). Thus, Gln formation in the younger steer is important to steer
development, but by the finishing stage, assuming that increased EAAC1 content is
equivalent to increased Glu uptake, the increased Glu is used for some function other
than Gln formation. For example, Glu carbons could enter the TCA cycle as αketoglutarate to be used for fatty acid synthesis. Although speculative, the metabolic
significance of this finding may be that glucose molecules are spared from oxidation to
be available for glycerol synthesis to support triglyceride synthesis by oxidizing Glu
instead of glucose or lactate (Smith and Prior, 1982; Smith, 1995). When combined with
the higher GS content in subcutaneous and kidney adipose tissues at backgrounding vs.
finishing, although speculative, the aggregate findings demonstrate the capacity to handle
increase ammonia production as steers develop is concomitant with an increased capacity
of the disproportionately accreting adipose tissue – up to the finishing phase.
In addition to subcutaneous and kidney adipose tissues, EAAC1 protein was
expressed by subcutaneous, kidney, omental, mesenchymal, and intramuscular adipose
tissues in finishing steers. These depots displayed differential expression of EAAC1,
suggesting that EAAC1 function may be linked to the metabolic differences known to
exist among bovine adipose depots (Eguinoa et al., 2003; Baldwin et al., 2007). Among
these adipose depots, intramuscular adipose tissues had higher EAAC1 content than
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kidney and subcutaneous adipose tissues, suggesting a greater ability to absorb Glu to
support ammonia capture and/or glucose-sparing in these tissues (Matthews et al., 2016).
In addition to maintaining whole-body Glu and nitrogen homeostasis, adipose
tissues also contribute to the redox potential and energy homeostasis in the whole animal
body. Increased oxidative stress in obesity has been shown in human, mice, and pig
models: increased reactive species production and oxidative damage were observed in
subcutaneous adipose tissue in obese and type 2 diabetes (Chattopadhyay et al., 2015);
dysregulation of adipose glutathione peroxidase 3 results in systemic oxidative stress in
obese mice (Lee et al., 2008); moreover, selenoprotein gene profiles change in different
tissues such as liver and subcutaneous fat in pigs fed on a high fat diet (Zhao et al., 2015),
suggesting a potential change of redox potential. In addition to obesity, adipogenesis can
be inhibited by oxidative stress accumulation in adipose tissue in aging mice (Findeisen
et al., 2011).
Regulation of Glu transport capacity
Posttranscriptional Regulation of Glu Transporter Content and Capacity. An
important question of gene and protein expression is at what level the regulation occurs.
The mRNA expression of system X-AG transporters by liver, skeletal muscle, adipose
tissues, kidney, small intestine epithelia and placenta, does not always correlate with the
protein expression levels (Matthews et al., 1998; Howell et al., 2001; Howell et al., 2003;
Matthews et al., 2016). Other studies also reported that increased content of EAAC1 by
AA-deprived NBL-1 cells is accompanied by a decrease in EAAC1 mRNA levels
(Plakidou-Dymock and McGivan, 1993). These findings indicate that posttranscriptional
regulation is an important form of regulating the expression of system X-AG transporters
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(Vogel and Marcotte, 2012).
MicroRNAs (miRNAs) are small, non-coding RNAs (approximately 22
nucleotides) that regulate gene expression primarily through mRNA degradation or
inhibition of protein translation in a sequence-specific manner, although some miRNAs
are reported to enhance translation (Bartel, 2004). In mouse dopaminergic neurons, miR96-5p has been identified to target EAAC1, resulting in degradation of EAAC1 mRNA
(Kinoshita et al., 2014). Intracerebroventricular administration of miR-96-5p inhibitor
increases the mRNA and protein level of EAAC1 as well as that of GSH and
consequently, exhibits a neuroprotective effect in the mouse brain (Kinoshita et al.,
2014).
Posttranslational Regulation of Glu Transporter Content and Capacity. At the
post-translational level, platelet-derived growth factor (PDGF) stimulates EAAC1
expression and transport activities through the phosphatidylinositol 3-kinase (PI3K)
pathway in mouse neuronal cells (Sims et al., 2000). PI3K activates serum- and
glucocorticoid- inducible kinase 1 (SGK1) and protein kinase B (Akt/PKB) through
phosphoinositide-dependent kinase 1(PDK1) activation (Aoyama and Nakaki, 2013).
Consequently, the constitutively active SGK1 and Akt/PKB stimulate Glu uptake by
EAAC1(Schniepp et al., 2004) (Figure 2.7). Another upstream regulator of EAAC1 is
protein kinase C (PKC). PKCa activation increases the transport activity and the cell
surface expression of EAAC1, whereas PKCe activation stimulates Glu transport activity
of EAAC1 without changing the protein abundance on the plasma membrane (González
et al., 2002; Huang et al., 2006). EAAC1 is also up-regulated by the serine/threonine
kinase mammalian target of rapamycin (mTOR) (Almilaji et al., 2012), which plays a
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critical role in protein synthesis, cell growth and proliferation (Hay and Sonenberg,
2004). Conversely, EAAC1 activity and expression were decreased by expression of the
constitutively active AMP-activated protein kinase (AMPK) in Xenopus oocytes (Sopjani
et al., 2010).
In addition to various signal transduction pathways in which EAAC1 is involved,
EAAC1 is also regulated by protein-protein interactions (Figure 2.8). The activity of
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18
(Glu transporter-associated protein 3-18, a.k.a. addicsin and ADP-ribosylation factor-like
6 interacting protein 5/ARL6IP5, or PRAF3) and ARL6IP1 (ADP-ribosylation factor-like
6 interacting protein 1). GTRAP3-18 forms homodimers to bind to EAAC1, thus
decreasing EAAC1 trafficking from ER to the Golgi and, subsequently, cell surface
localization of EAAC1 (Ruggiero et al., 2008). Once the [GTRAP3-18]2-EAAC1
complex reaches the cell surface, GTRAP3-18 negatively regulates EAAC1 transport
activity by decreasing its substrate affinity (Lin et al., 2001). Accordingly, inhibition of
GTRAP3-18 leads to an increase in EAAC1 activity and GSH production, at least in mice
neurons (Watabe et al., 2007, 2008; Aoyama et al., 2012). However, an ER-localized
protein ARL6IP1 serves as a positive regulator of EAAC1 by interacting with GTRAP318 to decrease the GTRAP3-18/EAAC1 interaction. If ARL6IP1 abundance is relative
high to GTRAP3-18, ARL6IP1 interacts with GTRAP3-18 to prevent formation of
[GTRAP3-18]2-EAAC1 complexes and therefore, indirectly promotes EAAC1 transport
activity and GSH synthesis in neurons (Figure 2.8) (Akiduki and Ikemoto, 2008).
Collectively, above findings indicate that regulation of system X-AG proteins is
complex and likely involves transcriptional, posttranscriptional, and posttranslational
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regulation, depending on the particular effects. Much research has been performed
regarding the regulation of system X-AG transporters in neuronal tissues. However,
despite the central role of system X-AG in supporting carbon and nitrogen metabolism,
little is known about the regulatory mechanisms of system X-AG transporters in peripheral
tissues of production animal species. Moreover, even less is known regarding the
relationship between system X-AG activities and expression of system X-AG proteins, and
their possible role in GS activity and GSH content.
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Table 2. 1 Glutathione levels in liver, muscle and adipose tissues in animal models
Tissues
Liver

Liver
Liver
Liver

Liver
Liver

Liver
Liver

Liver

Liver
Liver
Liver

Liver

Soleus muscle

Species Glutathione levels
Rat
GSH:
96.5nmol/mg
protein
Rat
GSH: 59
nmol/mg protein
Rat
GSH/GSSG ratio:
44
Rat
Total glutathione:
3.2 µmol/g liver;
GSH/GSSG ratio:
8.6
Rat
120 nmol/mg
protein
Rat
GSH: 117.8
nmol/mg protein;
GSSG: 1.0
nmol/mg protein;
GSH/GSSG ratio:
122.3
Rat
GSH: 9.8 µmol/g
liver
Rat
Cytosolic
fraction: 32
nmol/mg protein
Rat
GSH: 45
nmol/mg protein;
GSSG: 1.23
nmol/mg protein
Rat
16.3 µg/mg
protein
Rat
GSH: 6 mM;
GSSG:0.1mM
Rat
Total glutathione:
3.27 µmol/g wet
wt
Rat
Total glutathione:
6.4 µmol/g fresh
tissue
Rat
GSH: 2.64
µmol/g wet
tissue; GSSG:
0.10 µmol/g wet
tissue;
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Assay method
DTNB (Ellman’s
method)

Reference
(Moron et al.,
1979)

Ellman’s method
(Ellman, 1959)
Oxis GSH/GSSG-412
assay kit
Enzymatic method
(Tietze, 1969)

(Sadi et al.,
2014)
(Zhang et al.,
2003)
(Perez et al.,
2005)

DTNB (Ellman’s
method)
DTNB method

(Messarah et
al., 2012)
(Picklo et al.,
2013)

Bioxytech GSH 400 kit

(Bagchi et al.,
1996)
(Vendemiale et
al., 1998)

HPLC

HPLC

(Ercal et al.,
2001)

Enzymatic method
(Anderson, 1985)
M4VP+DTNB

(Lacroix et al.,
2004)
(Shaik and
Mehvar, 2006)
(Sen et al.,
1992)

(Tietze, 1969)

Enzymatic method

(Mosoni et al.,
2004)

HPLC

(Leeuwenburgh
et al., 1994)

Table 2.1 (continued)
Gastrocnemius Rat
muscle
Longissimus
dorsi

Rat

Skeletal
muscle

Rat

Visceral
adipose

Rat

Inguinal white
adipose

Rat

Liver

Mouse

Liver

Mouse

Liver

Mouse

Skeletal
muscle

Mouse

Skeletal
muscle

Mouse

Gastrocnemius Mouse
muscle

Total glutathione:
0.8 µmol/g fresh
tissue
Total glutathione:
0.29 µmol/g wet
wt
GSH: 1.4
nmol/mg wet
weight; GSSG:
0.08 nmol/mg wet
weight;
GSH/GSSG ratio:
17.15
GSH: 26.6
nmol/mg protein;
GSSG: 2.6
nmol/mg protein;
GSH/GSSG ratio:
11.4
Total glutathione:
4nmol/mg protein

Enzymatic method

(Mosoni et al.,
2004)

(Tietze, 1969)

(Sen et al.,
1992)

HPLC

(Dam et al.,
2012)

DTNB method

(Picklo et al.,
2013)

HPLC

(Galinier et al.,
2006)

Total glutathione:
2.5 nmol/mg
liver; GSSG: 0.17
nmol/mg liver
GSH: 53
nmol/mg protein;
GSSG: 3.7
nmol/mg protein
GSH: 37
nmol/mg protein
GSH: 4.0 µmol/g
protein; GSSG:
0.42 µmol/g
protein; GSSG:
GSH ratio: 0.1
Total glutathione
in mitochondria:
19 nmol/mg
protein
GSH: 38.75
nmol/mg protein;
GSSG/GSH ratio:
0.13

M2VP+DTNB

(Eriksson et al.,
2015)

HPLC-MS/MS

(Bouligand et
al., 2006)

Fluorogenic assay

(Riehle et al.,
2013)
(Ham et al.,
2014)
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BIOXYTECH
GSH/GSSG-412 kit,
OxisResearch

HPLC

(Adjeitey et al.,
2013)

Spectrophotometric
recycling assay

(Cruzat et al.,
2014)

Table 2.1 (continued)
Mouse
epididymal
adipose tissue

GSH/GSSG ratio:
52

Bioxytech GSH/GSSG412 kit (Oxis Research)

(Findeisen et
al., 2011)

GSH: 42
nmol/mg protein;
GSH/GSSG ratio:
50
GSH: 22.4
nmol/mg protein
Total glutathione:
1.47 mmol/kg
w.w.
Total glutathione:
1.74-1.90
mmol/kg w.w. ;
GSH: 1.45-1.65
mmol/kg w.w.
GSH: 4.9 µmol/g
liver
GSH: 40
nmol/mg protein

Bioxytech GSH/GSSG412 kit (Oxis Research,
Portland, OR)

(Kobayashi et
al., 2009)

Enzymatic assay

(Huang et al.,
2001)
(Hellsten et al.,
2001)

White adipose

Mice

Liver

Human

Skeletal
muscle

Human

Skeletal
muscle

Human

Liver

Pig

Liver

Pig

Liver

Pig

Liver

Pig

Longissimus
Dorsi

Pig

GSH: 3.23 mg/g
protein

GSH kit (Nanjing
Jiancheng
Bioengineering
Institute)

(Li et al., 2015)

longissimus

Pig

Total
glutathione: 117
pmol/g fresh
tissue; GSH: 94.6
pmol/g fresh
tissue; GSSG:
43.9 pmol/g fresh
tissue;

HT Glutathione Assay
Kit (7511-100-K;
Trevigen)

(CondeAguilera et al.,
2015)

GSH/GSSG ratio:
49
GSH: 11.12 mg/g
protein
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HPLC

HPLC

(Flaring et al.,
2003)

Enzymatic assay

(Kannan et al.,
1997)
(Cadenas et al.,
1995)

Spectrophotometric
recycling assay (Tietze,
1969)
HPLC
GSH kit (Nanjing
Jiancheng
Bioengineering
Institute)

(Podszun et al.,
2014)
(Li et al., 2015)

Table 2.1 (continued)
Liver
Cow

Liver

Cow

Liver

Bull

Muscle psoas
major

Steers

Longissimus
Lumborum

Beef
steers

Total glutathione:
12.64 µmol/g
protein
Total glutathione:
42-78 µmol/g
protein; GSH: 4075 µmol/g protein

Bioxytech® GSH-420
assay

(Abd et al.,
2008)

(cat. no. NWK-GSH01;
Northwest Life Science
Specialties LLC,
Vancouver, WA)

(Osorio et al.,
2014)

GSSG: 0.09
µmol/g liver;
GSH: 2.5 µmol/g
liver; GSH/GSSG
ratio: 27
GSH: 0.2780.514 mM;
GSSG: 0.03380.0629 mM;
GSH/GSSG: 8.5
GSH: 14.5
mg/100g raw
muscle

Spectrophotometric
recycling assay

(Netto et al.,
2014)

(Tietze, 1969)

(Descalzo et
al., 2007)

SIGMA Glutathione
Assay Kit, Catalog
Number CS0260

(Rakowska et
al., 2017)
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Figure 2. 1 Illustration of glutamate metabolism and its link to the TCA cycle, urea cycle,
and glutamine and glutathione synthesis (Nissim, 1999).
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Figure 2. 2 Diagrammatic representation of the net utilization (-, +) of plasma glutamate
(Glu) by gut and peripheral tissues in relationship to glutamine (Gln) and alanine (Ala)
use and/or production (Matthews, 2005).
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Figure 2. 3 Diagrammatic representation of hepatic acinus. See text for justification for
the distribution of X-AG (X) and x-C (xc) transport activities in periportal and/or pericentral
hepatocytes, and within a hepatocyte population, assignment to canalicular (bile-facing)
or basal (sinusoidal blood-facing) membrane subdomains (Matthews, 2005).
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Figure 2. 4 Antioxidant function of glutathione (GSH) (Lu, 2013). Hydrogen peroxide is
metabolized by GSH peroxidase in the cytosol and mitochondria. The oxidized form of
GSH (GSSG) is reduced back to GSH by GSSG reductase forming a redox cycle. During
oxidative stress, protein thiols are protected by glutathionylation forming Prot-SSG,
which can be subsequently reduced back to Prot-SH. To maintain cellular redox
equilibrium, GSSG can be transported out of the cell via glutathione transporters.
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Figure 2. 5 Extracelluar metabolism of glutathione (GSH) via γ-glutamyl cycle and
intracellular synthesis (Lu, 2013). γ-glutamyltranspeptidase (GGT) cleaves extracellular
GSH into γ-glutamyl amino acid and cysteinylglycine. The γ-glutamyl amino acid can be
transported back into the cell and finally converted into Glu to incorporate into GSH. The
cysteinylglycine is broken down into cysteine and glycine, which can also be utilized as
the substrate for intracellular GSH synthesis.
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Figure 2. 6 Inter-organ flux of glutathione (GSH) (Deneke and Fanburg, 1989). Liver
exports GSH into blood and bile and the plasma GSH can be utilized by kidney, lung and
intestine.
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Figure 2. 7 Signaling pathways with stimulatory (right arrow) and inhibitory (-|)
modifications for EAAC1 activity (Aoyama and Nakaki, 2013). The abbreviations are as
follows: platelet-derived growth factor (PDGF), phosphatidyl-inositol 3-kinase (PI3K),
Janus-activated tyrosine kinase-2 (JAK-2), phosphoinositide-dependent kinase 1 (PDK1),
serum- and glucocorticoid-inducible kinase 1 (SGK1), Akt/protein kinase B (Akt/PKB),
protein kinase C (PKC), mammalian target of rapamycin (mTOR), AMP-activated
protein kinase (AMPK), excitatory amino acid carrier 1 (EAAC1).
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Figure 2. 8 ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) positively
regulates the metabolic function of EAAC1 (excitatory amino acid carrier 1) by
decreasing EAAC1/GTRAP3-18 (Glu transporter-associated protein 3-18, a.k.a. addicsin
and ADP-ribosylation factor-like 6 interacting protein 5/ARL6IP5, or PRAF3) interaction
in the ER. After exiting from the ER to the trans-Golgi, EAAC1 is subject to the
internalization in endosome and then recycled back to the plasma membrane. After
trafficking to the plasma membrane, EAAC1 transports Glu and cysteine for GSH
synthesis (Aoyama and Nakaki, 2012).
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Chapter 3. Dissertation Objectives

Growing and finishing phases are two important animal production stages, which
differ fundamentally in compositional growth. The growing stage reflects the acceleration
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase
reflects a time of greatest fat to lean deposition ratio with maximized meat yield and fat
cover (U.S market weight). Understanding the physiological mechanisms altered
concomitantly with the shift in whole-body compositional gain as cattle fatten (growing
vs. finished steers), should provide mechanistic knowledge that can be applied to
optimize tissue protein accretion. Accordingly, the overall goal of the dissertation was to
answer the following questions:
1) Where is system X-AG activity localized in hepatocytes, canalicular or
basolateral membrane? Do the activities and protein content of system X-AG and GS
change in the liver of finished vs. growing steers? Are the regulatory proteins of system
X-AG expressed in the cattle liver, and how does the hepatic content of regulatory proteins
change in finished vs. growing steers? (Experiment 1; Chapter 4)
2) Does the content of GSH, system X-AG and GS change in Longissimus dorsi
and subcutaneous adipose tissues of finished vs. growing steers? Are the regulatory
proteins of system X-AG expressed in LM and SF, and how does the content of regulatory
proteins change in LM and SF of finished vs. growing steers? How is the GSH-mediated
antioxidant capacity achieved in LM and SF when beef steers develop from growing to
finished stage? (Experiment 3; Chapter 5)
3) What are the upstream regulatory mechanisms of EAAC1 and the metabolic
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pathways altered in the liver, as beef steers develop from lean to lipid phenotype
(Experiment 2; Chapter 6)?
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Chapter 4. Hepatic glutamate transport and glutamine synthesis capacities are
decreased in finished vs. growing beef steers, concomitant with increased GTRAP318 content

ABSTRACT
The liver plays important roles in maintaining whole-body glutamate and nitrogen
homeostasis via glutamate transporters and the glutamine-glutamate cycle. The objective
of this study was to determine if hepatic activities and protein content of system X-AG
transporter (EAAC1, GLT-1) and system X-AG regulatory proteins (GTRAP3-18,
ARL6IP1), and glutamine synthetase (GS) activity and content, differed as beef steers
transitioned from predominantly-lean (growing) to –lipid (finished) tissue accretion
phases. Sixteen weaned Angus steers were randomly assigned (n = 8) to growing or
finished treatment and fed a cotton seed hull-based diet to achieve a final body weight of
301 ± 7.36 or 576 ± 36.9 kg, respectively, at a constant rate of growth. Liver tissues were
collected at slaughter and glutamate uptake assays determined that X-AG activity in
canalicular membranes was abolished (P = 0.07) as steers developed from growing (n =
6) to finished stages (n = 4) but did not change in basolateral membranes. EAAC1 protein
content in liver homogenates (n = 8, Western blot analysis) decreased (P = 0.02) in
finished vs. growing steers, whereas GTRAP3-18 and ARL6IP1 content increased (P ≤
0.05) and GLT-1 content did not change. Concomitantly, hepatic GS activity decreased
(P = 0.01) whereas GS protein content did not differ as steers fattened. We conclude that
hepatic Glu transport and GS synthesis capacities are reduced in livers of fattened cattle.
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These are the first data to describe a negative functional relationship between GTRAP318 and system X-AG activity outside of neuronal tissue.
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INTRODUCTION

Improvement of feeding regimens for production animals has been hindered by a
lack of fundamental knowledge about how the capacity to regulate nutrient absorption
across cell membranes affects the function of nutrient metabolizing enzymes. Hepatic Lglutamate (Glu) transport and metabolism are critical to support whole-animal energy and
N homeostasis (Heitmann and Bergman, 1981b; Wu, 1998; Burrin and Stoll, 2009). In
the liver, Glu is a central substrate for ureagenesis, gluconeogenesis, glutathione
production, de novo protein synthesis, and nitrogen shuttling via glutamine (Meijer et al.,
1990; Brosnan, 2000; Watford, 2000). Although plasma membrane transport capacity is
thought to limit Glu metabolism (Low et al., 1994; Nissim, 1999; Gegelashvili et al.,
2003), knowledge of how hepatic Glu transport capacity may be regulated to support
changes in metabolic capacity associated with different phases of growth (e.g.,
predominately-lean to predominately-lipid tissue accretion) is limited.
Two high-affinity (µM), concentrative, Glu transporters (GLT-1 and EAAC1) that
demonstrate system X-AG activity (Na+-dependent L-Glu and L-Asp uptake that is
inhibited by D-Asp) are expressed by the intestinal epithelia, liver, and kidney of sheep
(Howell et al., 2001; Howell et al., 2003; Xue et al., 2010) and cattle (Howell et al., 2001;
Miles et al., 2015). In mouse neuronal cells, the function of EAAC1 (solute carrier
1A1/SLC1A1) and GLT-1 (SLC1A2) is inhibited by endoplasmic reticulum-localized
GTRAP3-18 (glutamate transporter-associated protein 3-18; a.k.a. addicsin, ADPribosylation factor-like 6 interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al., 2008;
Watabe et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is
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proportional to GTRAP3-18 content (Lin et al., 2001). However, ADP-ribosylation
factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits GTRAP3-18, and
indirectly promotes EAAC1 activity (Akiduki and Ikemoto, 2008; Aoyama and Nakaki,
2012). The ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver (Akiduki
and Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and GTRAP3-18
(Miles et al., 2015). The objective of this study was to determine whether the hepatic
activities and protein content of system X-AG transporters (EAAC1, GLT-1), system X-AG
regulatory proteins (GTRAP3-18, ARL6IP1), and GS changed as beef steers developed
from predominantly lean to predominantly lipid deposition growth phases.

MATERIALS AND METHODS

Animal Model
All procedures involving animals were approved by the University of Kentucky
Institutional Animal Care and Use Committee. The steers were raised, and trial
conducted, at the University of Kentucky Research and Education Center in Princeton,
KY.
Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and
water for 14 h) BW were randomly assigned (n = 8) to either growing (BW = 215 ± 28.6
kg) or finished (BW = 202 ± 30.2 kg) treatment groups. Steers then were randomly
assigned to one of 4 feedlot pens that contained Calan gates in a dry-lot barn. Four steers
were assigned per pen. Steers were individually fed enough of a diet that contained (%
as-fed) cracked corn (60), cottonseed hulls (20), soybean meal (7), soybean hulls (5),
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dried distiller’s grain (2), alfalfa meal (2), glycerin (2), limestone (1.5), and urea (0.5) to
support 1.51 kg gain/d (NRC, 1996) throughout the trial. Steers had ad libitum access to
fresh water and a vitamin-mineral mix (UK IRM Beef Cattle Vitamin-mineral Mix,
Burkmann Mill, Inc., Danville, KY). Full BW were determined every 14 d and amount of
diet adjusted to achieve target rate of gain. Steer ADG was calculated as the difference
between shrunk BW at trial initiation and 1 d before slaughter.

Slaughter, Tissue Collection, and Carcass Evaluation
One steer per day was slaughtered. Steers were stunned by captive bolt pistol and
then exsanguinated to allow recovery of carcasses for consumption. Fresh liver tissue was
collected from the middle of the right lobe and used for (a) preparation of plasma
membrane vesicles and determination of glutamine synthesis activity and (b) placed in
foil packs, snap-frozen in liquid nitrogen, and stored at -80°C until assayed for RNA and
protein expression.
After 24 h postmortem, carcass evaluations were conducted on the right side of
the carcass according to USDA standards (USDA, 1997).

Isolation of Enriched Canalicular (cLPM) and Basolateral (bLPM) Liver Plasma
Membrane (LPM) Vesicles
Isolation of cLPM- and bLPM-enriched vesicles from liver homogenates was
performed as described by Meier and Boyer (1990) with minor modifications. Ten grams
of fresh liver tissue was cut into small pieces, washed three times in 80 mL ice-cold 1
mM NaHCO3, and homogenized in 80 mL 1 mM NaHCO3 with a Dounce homogenizer
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(nine to eleven up-and-down strokes). The homogenate was centrifuged (SA-600 rotor,
Sorvall Instruments Inc.) at 1,500 x g for 15 min. The pellet was resuspended in 2.2
volumes of 70% (w/w) sucrose. After stirring for 15 min to disrupt membrane aggregates,
12 mL of suspension was filled into SW32 rotor (Beckman Instruments) tubes and
overlayed with 10 mL of 44% and then 10 mL 36.5% (w/w) of sucrose. The tubes were
filled to the top with 8.1% sucrose and the gradient system centrifuged at 89,300 x g for
90 min. After slow deceleration to a complete stop, a mixed liver plasma membrane
fraction was carefully collected from the 44/36.5% sucrose interface with a plastic
Pasteur pipet and diluted with 8.1% sucrose to a total volume of 9.1 mL. The mixed liver
membrane fraction was then homogenized in a glass-glass Dounce homogenizer using 50
strokes (1 stroke equals up and down) and loaded on top of a three-step sucrose gradient
consisting of 10.5 mL 38%, 6.5 mL 34%, and 6.5 mL 31% sucrose. The tubes were
centrifuged at 195,700 x g for 3 h in a Beckman SW41 rotor (Beckman Coulter Inc.,
Brea, CA). This resulted in three distinct bands and a pellet. The fractions at the 31/34%
(cLPM-enriched) and the 34/38% (bLPM-enriched) interfaces were recovered, diluted in
8.1% sucrose and sedimented at 105,000 x g (Ti 70 rotor, Beckman Coulter Inc., Brea,
CA) for 60 min. The resulting cLPM and bLPM pellets were resuspended in the preload
buffer (250 mM sucrose, 100 mM KCl, 0.2 mM CaCl2, 50 mM Hepes/Tris, pH 7.5) by
repeated (20 times in and out) aspiration through a 25-gauge needle. The protein content
of cLPM and bLPM was quantified at 280 nm using a NANODROP ND-1000
spectophotometer (NanoDrop Technologies Inc., Wilmington, DE). The vesiculated
membranes were stored in liquid nitrogen for Glu uptake assays, and at -80°C for enzyme
activity and immunoblot analyses.
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Na+K+-ATPase and γ-Glutamyltransferase Activity Assays
The Na+K+-ATPase activity in liver homogenate and cLPM and bLPM vesicles
was determined using an ATPase assay kit (Sigma, St. Louis, MO) in 96-well plates, as
per manufacturer instructions. The reaction was initiated by combining 30 µL of preincubated (37°C for 30 min) sample solution (40 mM Tris, 80 mM NaCl, 8 mM MgAc2,
1 mM EDTA, pH 7.5) containing 0.35 µg of homogenate or vesicle protein (in the
absence or presence of 1 mM ouabain) with 10 µL of 4 mM ATP. After a 30 min
incubation period at room temperature, the reaction was terminated by the addition of 200
µL malachite green reagent. The plate was further incubated at room temperature in the
dark for 30 min. The amount of inorganic phosphate (Pi) released from ATP was
quantified colorimetrically at 620 nm (SpectraMax 250, Molecular Devices, Sunnyvale,
CA). Samples were assayed in triplicate and Na+K+-ATPase-specific activity (μmol Pi ∙
min-1 ∙ μg-1 protein) was calculated by subtracting the ouabain-insensitive activity from
the overall activity (in the absence of ouabain). The inter- and intra-assay CV were 8.5
and 1.8%, respectively.
γ-Glutamyltransferase activity in liver homogenate and cLPM and bLPM vesicles
was determined using a high-sensitivity colorimetric assay kit (Sigma, St. Louis, MO)
following the manufacturer’s instructions. Ten microliters of sample solution (40 mM
Tris, 80 mM NaCl, 8 mM MgAc2, 1 mM EDTA, pH 7.5) that contained 35 µg of
homogenate or vesicle protein was incubated with 90 µL substrate L-γ-glutamyl-pnitroanilide solution at 37°C in the dark for 18 min. The amount of chromogen pnitroanilide released was quantified colorimetrically at 418 nm (SpectraMax 250), as
described (Meister, 1981). Samples were assayed in triplicate, and the activity of γ-
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glutamyltransferase is reported as μmol p-nitroanilide liberated from L-γ-Glutamyl-pnitroanilide per min by 1 μg of protein (μmol p-nitroanilide ∙ min-1 ∙ μg-1 protein). The
inter- and intra-assay CV were 13.3 and 3.8%, respectively.

LPM Vesicle Transport Assays
Uptake of Glu by isolated cLPM and bLPM vesicles was conducted using a rapid
filtration technique (Ballatori et al., 1986). The previously frozen and preloaded
membrane vesicles (see above) were quickly thawed, diluted in preload buffer to the
desired protein concentration (50-100 μg of protein in 20 μL), and aspirated 10 times
through a 25-gauge needle. Membrane vesicles and appropriate Glu uptake buffers (22.5
µM unlabeled Glu, 195 mM sucrose, 0.2mM CaCl2, 50 mM HEPES, 5 mM MgCl2, and
100 mM of either NaCl or choline chloride, at pH 7.5) were separately pre-incubated at
25°C for 10 min. Uptake assays were initiated by addition of 20 µL of membrane vesicles
and 10 µCi of L- [3,4-3H]Glu ([3H]Glu, PerkinElmer, Waltham, MA; specific activity:
47.5 Ci/mmol) to 80 µL of the appropriate Glu uptake buffer. Uptake reactions were
performed at 25°C for 10 min. Preliminary experiments determined that Glu uptake was
linear and optimal under these conditions (data not shown).
Uptake reactions were terminated by addition of 2 mL of ice-cold stop solution
(175 mM sucrose, 0.2 mM CaCl2, 5 mM MgCl2, 150 mM NaCl, 10mM HEPES/Tris, pH
7.5), followed by immediate filtration of the uptake reaction/stop solution mix through
Millipore HAWP filters (25 mm, 0.45 µm; Millipore Corp., Bedford, MA), using a 1225
sampling vacuum manifold (Millipore Corp.). The uptake tubes were rinsed 2 times with
2 mL of stop solution, filtering the resulting uptake reaction/stop solution mix through the
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filter after each rinse. Filters were then washed 3 times more with 2 mL stop
solution/wash, and dissolved in 6 mL of liquid scintillation cocktail (SX 25, Fisher
Scientific). The radioactivity per filter was measured by liquid scintillation counting
(TRI-CARB 2900TR spectrometer, PerkinElmer, Downers Grove, IL). Nonspecific
binding of [3H]Glu to filters or vesicles was determined by adding 1 mL 4°C stop
solution to the [3H]Glu uptake mixture before addition to LPM vesicles. The resulting
“background” values were subtracted from each experimental Glu uptake observation.
Sodium-dependent Glu uptake activity was calculated as the difference between Glu
uptake in the presence of NaCl vs. choline chloride. System X-AG activity was calculated
as the difference between Na+-dependent Glu uptake and Na+-dependent Glu uptake in
the presence of 500 µM of D-aspartate. Samples were assayed in triplicate and all uptake
activities are reported as pmol Glu ∙ 10 min-1 ∙ μg-1 protein per steer liver preparation.

Hepatic Glutamine Synthetase Activity Analysis
About 400 mg of liver tissue was homogenized (30,000 rpm for 15 s, twice) in 5
volumes of ice-cold extraction buffer (pH 7.9) containing 50 mM Tris and 2mM EDTA,
using a PowerGen 125 homogenizer (Thermo Fisher Scientific, Waltham, MA). The
homogenate was centrifuged at 2000 x g and 4ºC for 10 min. The derived supernatant
was assayed for glutamine synthetase activity (EC 6.3.1.2) using a radiochemical method
modified from that of (James et al., 1998). A 50 µL aliquot of the supernatant was mixed
with 200 µL of reaction medium which consisted of 0.25 µCi L-[1-14C]Glu (ARC, Saint
Louis, MO; specific activity: 50-60 mCi/mmol), 25 mM unlabeled glutamate, 25 mM
MgCl2, 25 mM NH4Cl, 18.75 mM ATP, 12.5 mM phosphocreatine, 4 units creatine

46

kinase, and 62.5 mM imidazole-HCl buffer, at pH 7.6. The mixture was incubated at
37ºC for 20 min, and the reaction was then terminated by adding 1 mL of ice-cold 20 mM
imidazole-HCl buffer, at pH 7.5. An aliquot of the incubate (1 mL) was loaded into a 4
mL prefilled (formate resin) ion-exchange column (Bio-Rad, Hercules, CA) previously
rinsed by distilled water. The column was washed with 4 mL of distilled water, and the
effluent was collected. An aliquot of the effluent (1 mL) was mixed with 4 mL of
ScintiSafe Plus 50% cocktail (Thermo Fisher Scientific, Waltham, MA), and the
radioactivity was determined by liquid scintillation counting using a TRI-CARB 2900TR
spectrometer (PerkinElmer). Assays were conducted in triplicate. Positive control
contained 2.5 units of glutamine synthetase from Escherichia coli (Sigma, Saint Louis,
MO) instead of supernatant from liver tissue. Negative control contained neither
supernatant nor glutamine synthetase. Samples were assayed in triplicate and glutamine
synthetase activity is expressed as nmol ∙ min-1 ∙mg-1 wet mass. The intra- and inter assay
CV were 8.5% and 8.8%, respectively.

Western Blot Analysis
In general, Western blot analyses of liver tissue and LPM vesicles was performed
as previously described by this research group (Howell et al., 2001; Miles et al., 2015).
For liver homogenates, 1 g of liver tissue was homogenized on ice for 30 s (setting 11,
POLYTRON, Model PT10/35; Kinematic, Inc., Neuchâtel) in 7.5 mL of 4°C sample
extraction buffer solution (0.25 mM sucrose, 10 mM HEPES-KOH pH 7.5, 1 mM EDTA,
and 50 µL of protease inhibitor (Sigma, St. Louis, MO). Protein was quantified by a
modified Lowry assay, using bovine serum albumin as a standard (Kilberg, 1989). For
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liver homogenates (30 μg/lane) and LPM (15 μg/lane, protein quantified during
preparation), proteins were separated by 12% SDS-PAGE, followed by electrotransfer to
a 0.45 µm nitrocellulose membrane (Bio-Rad, Hercules, CA). Blots were stained with
Fast-Green (Fisher, Pittsburgh, PA) and the relative amount of stained protein per
lane/sample determined by densitometric analyses and recorded as arbitrary units
(Howell et al., 2001; Miles et al., 2015).
The relative protein content of EAAC1, GLT-1, GTRAP3-18, GS, and β-catenin
in liver homogenates was detected using antibodies as described previously (Brown et al.,
2009; Miles et al., 2015; Miles et al., 2016). For ARL6IP1, an antibody raised against the
human ortholog (see below) was validated for detection of cattle ARL6IP1 using a
standard pre-hybridization regimen (Xue et al., 2011; data not shown). More specifically,
blots were hybridized with 1 μg of IgG antihuman EAAC1 polyclonal anti-body (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), 1 μg of IgG anti-rabbit GLT-1 polyclonal
antibody (Abcam Inc., Cambridge, MA), 4 μg of IgG anti-human GTRAP3-18 (Abcam
Inc., Cambridge, MA), and 5 μg of IgG antihuman ARL6IP1 (Abgent Inc., San Diego,
CA), respectively, per mL of blocking solution (1% nonfat dry milk (w, v) in 30 mM
Tris-Cl, 200 mM NaCl, 0.1% Tween 20 (v, v), pH 7.5) for 1.5 h at room temperature with
gentle rocking. For β-catenin detection, blots were hybridized with 14.5 μg of IgG antichicken beta-catenin (Abcam Inc., Cambridge, MA) per mL of blocking solution (1.5%
nonfat dry milk [wt/vol] in 30 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.1% Tween-20) for
1.5 h at room temperature with gentle rocking, whereas GS was detected using 1.25 μg of
IgG anti-sheep polyclonal antibody (BD Biosciences, San Jose, CA) per mL of blocking
solution (5% nonfat dry milk [wt/vol], 10 mM Tris-Cl [pH 7.5], 100 mM NaCl, 0.1%
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Tween 20 [vol/vol]) for 1 h at 37°C with gentle rocking.
All protein-primary antibody binding reactions were visualized with a
chemiluminescence kit (Pierce, Rockford, IL) after hybridization of primary antibodies
with horseradish peroxidase-conjugated donkey anti-rabbit IgG (Amersham, Arlington
Heights, IL; GLT-1, EAAC1 and ARL6IP1, 1:5,000); horseradish peroxidase-conjugated
goat anti-mouse IgG (BD Biosciences, San Jose, CA; GS, 1:5,000, and beta-catenin,
1:10,000); and horseradish peroxidase-conjugated donkey anti-goat IgG (Santa Cruz
Biotechnology; GTRAP3–18, 1:5,000).
Densitometric analysis of immunoreactive products was performed as described
previously (Howell et al., 2003; Fan et al., 2004; Xue et al., 2011). Briefly, after exposure
to autoradiographic film (Amersham, Arlington Heights, IL), a digital image of the
radiographic bands was recorded and quantified as described (Swanson et al., 2000).
Apparent migration weights (Mr) were calculated by regression of the distance migrated
against the Mr of a 16 to 185 kDa standard (Gibco BRL, Grand Island, NY) using the
Versadoc imaging system (BioRad) and Quantity One software (BioRad). Band
intensities of all observed immunoreactive species (one for GTRAP3-18, ARL6IP1, GS,
and β-catenin; two for EAAC1 and GLT-1) within a sample were quantified by
densitometry (as described above for Fast-Green stained proteins) and reported as
arbitrary units. Densitometric data then were corrected for unequal (≤ 12%) loading,
transfer, or both, and amount of detected protein normalized to relative amounts of FastGreen-stained proteins common to all immunoblot lanes/samples (Miles et al., 2015).
Digital images were prepared using PowerPoint software (Microsoft, PowerPoint 2003,
Bellvue, MA).
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Statistical Analysis
Individual steers were the observational units. Data were analyzed as a completely
randomized design by ANOVA using the GLM procedures of SAS (SAS Inst. Inc., Cary,
NC). Except for the enzymatic and immunological characterization of bovine cLPM and
bLPM vesicles, all data were analyzed in a 1-way ANOVA model to test for finished vs.
growing treatment effects. For Glu transport data, significance was declared when P <
0.10, and for all other data, treatment differences were considered significant at the α =
0.05 level. For the enzymatic characterization of cLPM and bLPM fractionation data,
enzyme activities among homogenates, cLPM, and bLPM were compared by ANOVA,
followed by Fisher’s protected LSD test. For the immunological characterization of
cLPM and bLPM fractionation, the relative amount of beta-catenin in cLPM and bLPM
vesicles was compared by ANOVA, both within and between growing and finished
steers. Unequal experimental treatment observations resulted from loss of sample
integrity during collection or storage.

RESULTS

Animal Model
The growth and carcass characteristics of growing and finished steers are
presented in Table 4.1. The growing treatment steers required 57 ± 7 d to reach target
weights and 261 ± 12 d were required for finished treatment steers to reach their target
weight. As planned, ADG (1.51 vs. 1.46 kg/d), initial BW (215 vs. 202 kg) and frame
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scores (4.73 vs. 4.61) did not differ (P ≥ 0.42) between growing and finished steers. As
expected, finished steers had greater (P < 0.01) final BW (91%), HCW (107%), ribeye
area (44%), 12th rib adipose (220%), marbling score (126%), yield grade (71%) and
whole liver wet weight (44%), while KPH tended (P = 0.06) to be greater. In contrast,
whole liver wet weight/100 kg of final BW was 25% less (P < 0.01) in finished vs.
growing steers.

Enzymatic and Immunological Characterization of cLPM and bLPM Vesicles
The enrichment of cLPM and bLPM from liver tissue homogenate was evaluated
by comparing the enzyme activity (μmol ∙ min-1 ∙ μg-1 protein) of marker proteins in
growing steers (Table 4.2). The bLPM vesicles had 24 times more (P < 0.01) Na+K+
ATPase activity than liver homogenates (1.655 vs. 0.070) and 60% more (P < 0.01) than
cLPM vesicles, whereas cLPM had 15 times more (P < 0.01) Na+K+ ATPase activity than
liver homogenates (1.039 vs. 0.070). In contrast, the cLPM vesicles had 27 times more (P
< 0.01) GGT activity than liver homogenates (0.054 vs. 0.002) and 93% more (P < 0.01)
than bLPM, whereas bLPM had 14 times more (P < 0.01) GGT activity than liver
homogenates.
To further characterize the membrane composition of cLPM and bLPM vesicles,
the relative content of the basolateral marker protein β-catenin (Lutz and Burk, 2006;
Decaens et al., 2008) was determined by Western blot analysis (Fig. 4.1) in both growing
and finished steers. For growing steers, the β-catenin content of bLPM-enriched vesicles
was 158% greater (P = 0.003) than for cLPM. Similarly, the β-catenin content of bLPMenriched vesicles from finished steers was 78.0% greater (P = 0.009) than for cLPM.
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Between growing and finished steers, the amount of β-catenin in cLPM (P = 0.75) or
bLPM (P = 0.88) vesicles did not differ. Consistently, the bLPM:cLPM ratio of β-catenin
did not differ (P = 0.60) between growing and finished steers.

Decreased Glu Transport Activity in Hepatic Vesicles Isolated from Finished vs.
Growing Steers
Glu uptake (pmols ∙ 10 min-1 uptake ∙ µg protein-1) assays were conducted using
canalicular- and basolateral-enriched liver plasma membrane vesicles isolated from livers
of growing (n = 6) and finished (n = 4) steers. In hepatic canalicular plasma membrane
vesicles (Table 4.3), total L-Glu uptake and Na+-dependent Glu uptake decreased (P ≤
0.03) 75% and 90%, respectively, whereas Na+-independent Glu uptake did not change
(P = 0.80). Concomitantly, X-AG activity (0 ± 0 vs. 2.78 ± 2.57) in canalicular membranes
was abolished (P = 0.07) and non- X-AG activity tended to decrease (P = 0.10) in finished
vs. growing steers.
In hepatic bLPM vesicles (Table 4.4), total L-Glu uptake (56%), Na+-dependent
Glu uptake (60%) and Na+-independent Glu uptake (56%) also decreased (P ≤ 0.08) in
finished vs. growing steers. However, in contrast to decreased X-AG activity in cLPM, XAG

activity in bLPM did not change (P = 0.55) whereas non- X-AG activity decreased

(73%, P = 0.08) in finished vs. growing steers.

Decreased EAAC1 Protein Content Concomitant with Increased GTRAP3-18 and
ARL6IP1 Content in Liver Tissue of Finished vs. Growing Steers
Canalicular LPM- and bLPM-enriched vesicles were subjected to Western blot
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analysis to determine the relative content of system X-AG activity transporter proteins
(Fig. 4.2). Both EAAC1 and GLT-1 were detected in both membrane fractions and
development phases. Densitometric analyses (Table 4.5) found that the amount of
EAAC1 decreased (P ≤ 0.09) 47% and 19%, respectively, in both canalicular and
basolateral liver plasma membrane fractions of finished vs. growing steers, whereas
GLT-1 content did not change (P = 0.58).
Liver tissue homogenates were subjected to Western blot analysis to determine
the relationship among the relative contents of system X-AG activity transporters and their
regulatory proteins (Fig. 4.3). All proteins were detected in liver tissue from both
development phases. Densitometric analysis found that the relative abundance in liver
homogenates of EAAC1 was 24% less (P = 0.02) in finished vs. growing steers, whereas
GLT-1 content did not differ (P = 0.66) (Table 4.6). Concomitantly, hepatic GTRAP3-18
and ARL6IP1 content increased (P ≤ 0.05) 63% and 23%, respectively, in finished vs.
growing steers.

Decreased GS activity but not GS protein Content in Liver Homogenate of Finished vs.
Growing Steers
Glutamine synthetase activity was determined in liver homogenates. Paralleling
the decreased system X-AG-specific and total Glu uptake in cLPM vesicles, GS activity
decreased (P = 0.01) 32% (Table 4.7) as steers developed from growing to finished
production states. In contrast, GS protein content did not differ (P = 0.72) between
growing and finished steers (Table 4.7).
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DISCUSSION

A primary function of the mammalian liver is to coordinate whole-body energy
and N metabolism. Hepatic transport and intermediary metabolism of glutamate is critical
to these processes as glutamate is a central substrate for hepatic ureagenesis,
gluconeogenesis, glutathione production, de novo protein synthesis, and nitrogen
shuttling via glutamine (Meijer et al., 1990; Watford, 2000). An important aspect of
glutamate metabolism in the liver is the heterogeneity of Gln/Glu metabolism.
Specifically, Gln arriving from the peripheral tissues via the portal vein, is efficiently
absorbed by periportal hepatocytes and deaminated by glutaminase (liver-type) to release
ammonia and Glu. The released ammonia can be incorporated into carbamoyl phosphate
for ureagenesis, whereas the remaining Glu is available for conversion to α-KG (as an
anapleurotic reaction to replenish the citric acid cycle), used for gluconeogenesis, used
for protein synthesis, or transported into the sinusoids.
Sinusoidal blood Glu is available for absorption by “down-acinus” pericentral
hepatocytes, which express the high-affinity system X−AG Glu transporters, as well as
Glu-using enzymes for the synthesis of Gln and glutathione (Häussinger and Gerok,
1983; Braeuning et al., 2006; Brosnan and Brosnan, 2009). If absorbed by pericentral
hepatocytes, Glu and the “scavenged” sinusoidal ammonia that escapes incorporation into
urea by periportal hepatocytes are incorporated into Gln by pericentral hepatocytespecific GS activity, thus completing the hepatic Gln-Glu cycle (Moorman et al., 1989;
Moorman et al., 1990; Wagenaar et al., 1994). Besides supporting Gln synthesis by GS,
pericentral hepatocyte-localized system X−AG uptake of Glu complements pericentral
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hepatocyte-specific synthesis of glutathione by glutamylcysteine ligase and glutathione
synthetase (Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic
carbons and for de novo protein synthesis (Watford, 2000).
Na+-dependent, high-affinity glutamate transporters are members of the solute
carrier family 1A (SLC1A) and function to mediate the Na+-dependent, concentrative
uptake of glutamate, aspartate, and cysteine across cell membranes. The functional
capacities of these system X-AG transporters are critical to support cell- and tissue-level
nitrogen and carbon metabolism (Heitmann and Bergman, 1981b; Häussinger et al.,
1989; Hediger and Welbourne, 1999b; Nissim, 1999; Hundal and Taylor, 2009). In
bovine liver, EAAC1 and GLT-1 are the only known system X−AG transporters (Howell et
al., 2001). In rodents, it has been shown that endoplasmic reticulum-localized GTRAP318 binds and inhibits the function of EAAC1 and GLT-1 (Ruggiero et al., 2008; Watabe
et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is proportional to
GTRAP3-18 content (Lin et al., 2001). GTRAP3-18 also is expressed by bovine liver
tissue, and the content of GTRAP3-18 is greater in liver tissue of aged vs. mature cattle,
concomitant with decreased GS content (Miles et al., 2015).
Understanding how the expression and function of system X-AG transporters, its
regulatory proteins, and GS are coordinated could yield important insight into the
importance of Glu use and metabolism as production animals grow, especially as they
transition from predominantly low to high lipid accretion phases. Accordingly, the
objective of this study was to determine if hepatic activities and protein content of
EAAC1, GLT-1, GTRAP3-18, and ARL6IP1, and GS activity and protein content in liver
changes as steers developed from growing through finished stages, using a commercially-
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relevant development regimen. To obviate potential metabolic changes as a result of
ruminants growing at different rates (Howell et al., 2003), diets for the growing and
finished treatment groups were formulated to support the same average rate of growth. As
planned, ADG did not differ in finished vs. growing steers and lipid accretion clearly
differed among development stages (Table 4.1). That is, the transition from
predominantly lean phenotypes of growing steers, to predominantly lipid phenotype of
finished steers was demonstrated by higher final BW, HCW, ribeye area, adjusted 12th
rib adipose, marbling scores, and yield grade in finished vs. growing steers. Thus, the
steers of each treatment group in this study were typical of growing and finished beef
cattle phenotypes.

Characterization of Enriched cLPM and bLPM
Hepatocytes are highly polarized cells containing three functionally distinct
surface domains: sinusoidal, lateral and canalicular (Boyer, 1980; Evans, 1980). Because
the sinusoidal and lateral membranes are in physical continuity and highly specialized for
the exchange of metabolites with the blood, these two plasma membrane surface areas are
designated as the basolateral domain. In contrast, the bile canalicular domain participates
in the primary secretion of bile constituents, including bile acids, and other detoxified
substances (Boyer, 1980). To gain an insight into the molecular mechanisms of the
metabolic function of bovine hepatocytes, it is essential to isolate liver plasma
membranes enriched in canalicular and basolateral fractions in sufficient yield to permit
functional studies of membrane solute transport processes. Thus, we used a wellestablished hepatic membrane isolation regimen (Meier and Boyer, 1990) to
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simultaneously isolate canalicular (cLPM)- and basolateral (bLPM)-enriched plasma
membranes from bovine liver.
The enrichment of hepatic canalicular- and basolateral-enriched liver plasma
membrane separation was evaluated by determining the relative amount of marker
enzyme activities in cLPM and bLPM vesicles vs. the homogenates of liver tissue from
which they were isolated (Table 4.2). Na+K+-ATPase activity was enriched 22-fold in
bLPM and 15-fold in cLPM over homogenates, consistent with the known enrichment of
Na+K+-ATPase activity in both bLPM and cLPM isolated from human and rat
hepatocytes (Wannagat et al., 1978; Boyer et al., 1983; Schenk and Leffert, 1983; Leffert
et al., 1985; Sutherland et al., 1988; Benkoël et al., 1995), and the higher enrichment of
Na+K+-ATPase activity in bLPM than cLPM vesicles (Poupon and Evans, 1979; Boyer et
al., 1983; Sutherland et al., 1988; Ali et al., 1990). The determination of Na+K+-ATPase
activity in our cLPM vesicles is incompatible with that of Meier et al. (1984), in which
the cLPM sub-fraction isolated from rat hepatocytes was reported as lacking Na+K+ATPase activity, but is consistent with many other rat studies (Toda et al., 1975;
Wannagat et al., 1978; Boyer et al., 1983; Inoue et al., 1983; Sutherland et al., 1988).
These data suggest that, in addition to the highly enriched Na+K+ -ATPase activities in
basolateral membrane, Na+K+ -ATPase also localizes to the canalicular membrane of the
bovine hepatocytes, perhaps to support the secretion of bile constituents and other
functions (Wheeler, 1972; Reichen and Paumgartner, 1977; Simon et al., 1977).
The degree of enrichment of isolated cLPM and bLPM vesicles from bovine liver
tissue was further demonstrated by the 29-fold greater GGT activity in cLPM vesicles vs.
homogenates (Table 4.2), consistent with previous findings that GGT is highly enriched
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in canalicular membranes isolated from rat and human liver (Poupon and Evans, 1979;
Inoue et al., 1983; Meier et al., 1984). γ-Glutamyltransferase activity also was enriched
(16-fold) in bovine bLPM vesicles, consistent with previous studies showing a 4- to 19fold enrichment of the canalicular markers in bLPM isolated from rat liver (Meier et al.,
1984). The demonstration of GGT activity in both cLPM and bLPM vesicles isolated
from bovine liver is consistent with histochemical studies showing that GGT is
distributed in both canalicular and basolateral membrane of rat and pig liver (Lanca and
Israel, 1991; Carrion et al., 1993; Videla and Fernández, 1995).
In summary, we successfully isolated enriched cLPM and bLPM vesicles from
bovine liver homogenates. This conclusion is demonstrated by the 22-fold enrichment
over homogenate in Na+K+ -ATPase activity in bLPM and the 29-fold enrichment in
GGT activity in cLPM. The additional finding that the ratio of β-catenin in bLPM:cLPM
did not differ between growing and finished steers (Figure 4.1) indicates that the
preparation of vesicles was not affected by steer phenotype.

Glu Uptake and Gln Synthesis Capacity of Finished Beef Steers
To test whether hepatic Glu transport capacity changed as steers develop from
growing to finished stages, Glu uptake assays by cLPM- and bLPM-enriched vesicles
from growing and finished steers were performed. Total Glu uptake decreased in
canalicular and basolateral plasma membranes as steers developed from growing to
finished production stages. This finding may be indicative of a decreased requirement for
sinusoidal blood/bile-derived Glu as the steers developed from a predominately-lean to
predominately-lipid tissue accretion phases, due to either (a) an increased supply of intra-
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cellular Glu from increased glutamate dehydrogenase or ornithine transaminase activity,
or (b) a reduced need to capture sinusoidal Glu and ammonia.
Although the activities of glutamate dehydrogenase or ornithine transaminase
were not determined, we did measure GS activity in liver homogenates and found that GS
activity was decreased 33% in finished vs. growing steers (Table 4.7), paralleling the
reduced total Glu uptake by both cLPM and bLPM, and system X-AG-mediated Glu
uptake by cLPM. This finding suggests that the ability of liver tissue to use sinusoidal
ammonia decreased from growing to finished steers or that the load of sinusoidal
ammonia decreased. With regard to the possibility of decreased use of sinusoidal
ammonia, detoxification of ammonia by GS may have been limited due to a shortage of
intracellular glutamate (Boon et al., 1999). If so, the above findings suggest that the
observed decreased Glu uptake capacity and concomitant decreased GS activity, was
paralleled by a decreased ability to produce intracellular Glu. With regard to the second
possibility of decreased sinusoidal levels of ammonia, ammonia concentrations may have
been decreased due to an elevated capacity to synthesize urea by periportal hepatocytes.
Regardless of the cause, our findings indicate that the hepatic capacity for plasma
membrane glutamate uptake and glutamine synthesis was less in liver tissue of finished
vs. growing steers. Both of these findings appear incongruent with accepted
understandings for nonruminants. That is, for nonruminants, it has been argued that Na+dependent Glu uptake does not limit pericentral hepatocyte GS activity and that GS
activity is relatively insensitive to change in various metabolic states (Watford, 2000).
Thus, our findings may represent another difference in hepatic Gln metabolism between
ruminants and nonruminats. For example, during acidosis in nonruminants, the liver
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switches from a net consumer to net producer of Gln (Heitmann and Bergman, 1980),
whereas hepatic GS activity and protein content do not change in ruminants (Lobley et
al., 2001; Xue et al., 2010).

Regulation of EAAC1 Transporter in Livers of Growing and Finished Steers
As mentioned earlier, EAAC1 is a high-affinity glutamate transporter that
mediates “system X-AG” transporter activity. In mouse neuronal cells, the activity of
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18
and ARL6IP1. GTRAP3-18, the negative regulator of EAAC1, decreases EAAC1mediated Glu uptake by interacting and retaining EAAC1 in the ER, thus delaying
EAAC1 trafficking to the trans-Golgi and plasma membrane, increasing its rate of
degradation, or both (Lin et al., 2001; Ruggiero et al., 2008). However, an ER localized
protein ARL6IP1 serves as a positive regulator of EAAC1 by interacting with GTRAP318 to decrease GTRAP3-18/EAAC1 binding. Consequently, high ARL6IP1 expression
indirectly promotes the transport activity of EAAC1, at least in mouse neurons (Akiduki
and Ikemoto, 2008; Aoyama and Nakaki, 2012).
In contrast, little is known about the potential regulation of EAAC1 by GTRAP318/ARL6IP1 in peripheral tissues. In beef cows, hepatic GTRAP3-18 protein content is
greater in aged vs. young cows, whereas EAAC1 and GLT1 contents did not differ (Miles
et al., 2015). In the present study with growing vs. finished beef steers, EAAC1 content
was less in finished vs. growing steers, concomitant with increased content of GTRAP318 and ARL6IP1. Taken together, the decreased system X-AG -mediated Glu uptake and
the reduced EAAC1 protein expression in cLPM in finished vs. growing steers indicate
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that system X-AG -mediated glutamate transport activity was inversely proportional to
GTRAP3-18 content in finished beef steers. Because GS activity in liver homogenates
also was decreased in finished vs. growing steers, we conclude that a negative functional
relationship exists between GTRAP3-18 content and EAAC1-mediated system X-AG and
GS activities in bovine liver, as originally identified in rodent neuronal cells (Lin et al.,
2001). However, in contrast to ARL6IP1 paralleling EAAC1 content as reported for rat
neurons (Akiduki and Ikemoto, 2008), ARL6IP1 content was up-regulated 25% in the
liver of finished steers, suggesting that either (a) ARL6IP1 content was being stimulated
by elevated GTRAP3-18 content, (b) novel regulators might exist in the EAAC1
regulatory network for cattle liver vs. rat brain, or (c) that ARL6IP1 transcription and
translation are controlled by discordant regulatory pathways in cattle liver. Overall,
additional research is needed using cattle to further investigate pre-translational
regulators, including the potential role of microRNAs to regulate expression of EAAC1,
GTRAP3-18, and ARL6IP1, as is thought to occur for rodents (Kinoshita et al., 2014).
The present study found that system X-AG activity in cLPM was abolished in
finished vs. growing steers in concomitance with reduced GS activity. In contrast, system
X-AG activity did not differ in bLPM of finished vs. growing steers. In addition to Glu and
Aspartate uptake, system X-AG also transports cysteine, the rate-limiting substrate for
GSH synthesis (Kilberg, 1982; Takada and Bannai, 1984; Sato et al., 1999; Matthews,
2005). Therefore, although speculative, the metabolic significance of this finding may be
that system X-AG transporters in canalicular liver plasma membrane function to deliver
glutamate substrates for Gln synthesis, whereas the role of system X-AG in the basolateral
liver plasma membrane is to transport amino acid (Glu, Aspartate, Cysteine) precursors
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for other metabolites (e.g., glutathione synthesis).
In summary, to our knowledge, this is the first report to describe (a) a shift in
glutamate transport capacity in the liver as cattle develop from lean to finished
phenotypes and, more globally, the relationship of (b) system X-AG activity and
transporter content to GTRAP3-18 and ARP6IP1 content outside of brain tissue/cultured
cells, and (c) decreased content of EAAC1 and system X-AG activity in hepatic apical
membranes concomitant with decreased hepatic GS activity.
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Table 4. 1 Growth and carcass characteristics of growing vs. finished Angus steers1
Treatment
Item
Growing
Finished
SEM2
Growth
Initial BW, kg
215
202
23.5
Final BW, kg
301
576
28.7
ADG, kg
1.51
1.45
0.16
Frame Score
4.73
4.61
0.25
Carcass
HCW, kg
164
339
14.0
2
Ribeye area, cm
53.2
76.8
0.80
12th rib adipose, cm2
0.54
1.73
0.06
Marbling score
296
668
67.8
KPH, %
1.79
2.10
0.10
Yield grade
2.13
3.65
0.22
Liver, g
4031
5786
243
Liver, g/100kg of BW
1341
1005
0.29
1
Values are means (n = 8) and SEM from growing and finished Angus steers
2
Most conservative error of the mean
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P-value
0.42
<0.01
0.55
0.76
<0.01
<0.01
<0.01
<0.01
0.06
<0.01
<0.01
<0.01

Table 4. 2 Enzymatic characterization of bovine canalicular (cLPM) and basolateral
(bLPM) liver plasma membrane vesicles1
Enzyme
Homogenate
cLPM
bLPM
SEM3
P-value
2
activity
Na+K+-ATPase4
0.070a
1.039b
1.655c
0.049
<0.01
4
a
b
GGT
0.002
0.054
0.028c
0.054
<0.01
1
Values are means (n = 3) and SEM of marker enzyme activities in canalicular- and
basolateral-enriched liver plasma membrane isolated from growing (BW = 301 kg)
Angus steers
2
Values are specific activities expressed as μmol product ∙min-1 ∙ μg-1 protein
3
Most conservative error of the mean
4
Means within a row that lack a common letter differ (P < 0.01).
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Table 4. 3 Glutamate uptake in canalicular liver plasma membrane vesicles of growing
vs. finished Angus steers1
Uptake activity2
Growing
Finished
SEM3
P-Value
4
Total uptake
8.78
2.23
1.82
0.02
Na+- dependent5
6.99
0.67
1.89
0.03
+
6
Na -dependent, %
73.2
25.6
11.8
0.01
Na+ -independent7
1.79
1.56
0.65
0.80
+
8
Na -independent, %
26.8
74.4
11.8
0.01
Non-X-AG9
4.21
1.29
1.19
0.10
10
Non-X AG, %
50.0
100
8.92
<0.01
X-AG11
2.78
0
1.05
0.07
12
X AG, %
50.1
0
8.92
<0.01
1
Values are means (n = 4 to 6) and SEM from growing (BW = 301 kg) and finished (BW =
576 kg) Angus steers
2
Specific uptake activities are expressed as pmols Glu ∙ 10 min-1 uptake ∙ μg-1 protein in
uptake buffer that contained 25 µM L-Glu
3
Most conservative error of the mean
4
Glu uptake measured in presence of 100 mM NaCl-containing uptake buffer
5
Na+-dependent Glu uptake is calculated as the difference between total and Na+independent uptake
6
Percentage of Na+-dependent Glu uptake is calculated as the amount of Na+-dependent Glu
uptake divided by the amount of total Glu uptake
7
Glu uptake measured in presence of 100 mM choline chloride-containing uptake buffer
8
Percentage of Na+-independent Glu uptake is calculated as one minus percentage of Na+dependent Glu uptake
9
Glu uptake measured in the presence of 500 µM D-Asp and Na+-containing uptake buffer
10
Percentage of Non-X-AG activity is calculated as one minus percentage of X-AG activity
11 X AG uptake is calculated as the amount of Na+-dependent uptake that was inhibited by
500 µM D-Asp
12
The percentage of X-AG activity is calculated as the amount of X-AG uptake divided by the
amount of Na+-dependent Glu uptake

65

Table 4. 4 Glutamate uptake in basolateral liver plasma membrane vesicles of growing
vs. finished Angus steers1
Uptake activity2
Growing
Finished
SEM3
P-Value
4
Total uptake
5.91
2.39
1.21
0.05
Na+- dependent5
5.06
2.02
1.22
0.08
+
6
Na -dependent, %
79.8
86.6
6.41
0.47
Na+ -independent7
0.85
0.37
0.17
0.08
+
8
Na -independent, %
20.2
13.5
6.47
0.47
Non-X-AG9
3.21
0.87
0.93
0.08
10
Non-X AG, %
79.0
37.0
13.0
<0.01
X-AG11
1.85
1.15
0.90
0.55
12
X AG, %
21.0
63.0
13.0
<0.01
1
Values are means (n = 4 to 6) and SEM from growing (BW = 301 kg) and finished (BW =
576 kg) Angus steers
2
Specific uptake activities are expressed as pmols Glu ∙ 10 min-1 uptake ∙ μg-1 protein in
uptake buffer that contained 25 µM L-Glu
3
Most conservative error of the mean
4
Glu uptake measured in presence of 100 mM NaCl-containing uptake buffer
5
Na+-dependent Glu uptake is calculated as the difference between total and Na+independent uptake
6
Percentage of Na+-dependent Glu uptake is calculated as the amount of Na+-dependent Glu
uptake divided by the amount of total Glu uptake
7
Glu uptake measured in presence of 100 mM choline chloride-containing uptake buffer
8
Percentage of Na+-independent Glu uptake is calculated as one minus percentage of Na+dependent Glu uptake
9
Glu uptake measured in the presence of 500 µM D-Asp and Na+-containing uptake buffer
10
Percentage of Non-X-AG activity is calculated as one minus percentage of X-AG activity
11
X-AG uptake is calculated as the amount of Na+-dependent uptake that was inhibited by
500 µM D-Asp
12
The percentage of X-AG activity is calculated as the amount of X-AG uptake divided by the
amount of Na+-dependent Glu uptake
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Table 4. 5 EAAC1 and GLT-1 content in canalicular (cLPM) and basolateral liver plasma
membrane (bLPM) of growing vs. finished Angus steers1
Growing

Finished

SEM2

P-Value

cLPM
EAAC1
7453
3950
1742
0.09
GLT-1
1732
1397
438
0.58
bLPM
EAAC1
6920
5162
610
0.05
GLT-1
2228
3144
1201
0.50
1
Values (arbitrary densitometric units) are means (n = 4) and SEM of relative EAAC1
and GLT-1 content in canalicular and basolateral liver plasma membranes prepared from
growing (BW = 301 kg), and finished (BW = 576 kg) Angus steers. Densitometric
quantification was of immunoreactive species identified by Western blot analysis (Fig. 2)
2
Most conservative error of the mean
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Table 4. 6 Densitometric analysis of EAAC1, GLT-1, GTRAP3-18 and ARL6IP1 content
of liver homogenates from growing vs. finished Angus steers1
Growing
Finished
SEM2
P-Value
EAAC1
10607
8065
789
0.02
GLT-1
1975
1771
345
0.66
GTRAP3-18
1086
1775
228
0.03
ARL6IP1
3416
4217
275
0.05
1
Values (arbitrary densitometric units) are means (n = 8) and SEM from liver
homogenates of growing (BW = 301 kg) and finished (BW = 576 kg) Angus steers
2
Most conservative error of the mean
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Table 4. 7 Glutamine synthetase (GS) activity and protein content in liver homogenates
of growing vs. finished Angus steers
Growing
Finished
SEM3
P-Value
1
GS activity
0.99
0.67
0.09
0.01
GS protein2
8787
8385
1035
0.72
1
-1
-1
Values are nmol ∙ min ∙ mg wet tissue (n = 8)
2
Values (arbitrary densitometric units) are means (n = 8) and SEM from liver
homogenates of growing (BW = 301 kg) and finished (BW = 576 kg) Angus steers
3
Most conservative error of the mean
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Figure 4. 1 Western blot analysis of β-catenin protein in enriched canalicular- (cLPM)
and basolateral- (bLPM) liver plasma membrane vesicles (15µg per lane) of growing (G)
and finished (F) steers. The apparent migration weight was ~ 94 kDa. Data are
representative of 4 growing and 4 finished steers
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Figure 4. 2 Western blot analysis of EAAC1 and GLT-1 in enriched canalicular- (cLPM)
and basolateral- (bLPM) liver plasma membrane vesicles (15µg per lane) of growing (G,
n = 4) and finished (F, n = 4) steers. The apparent migration weights (kDa) of the lower
and upper immunoreactants for EAAC1 were 70 and 89, and 75 and 92 for GLT-1,
respectively
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Figure 4. 3 Western blot analysis of EAAC1, GLT-1, GTRAP3-18, ARLI6P1, and
glutamine synthetase (GS) in homogenates (15µg per lane) of growing (G) and finished
(F) steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower,
and 89 kDa for the higher, predominant immunoreactants for EAAC1; 75 kDa for GLT1; 42 for GTRAP3-18; 21 for ARL6IP1; and 43 for GS; respectively. Data are
representative of 8 growing and 8 finished steers
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Chapter 5. The content of glutathione, glutamine synthetase, and EAAC1 glutamate
transporter and controllers, differs in tissues of finished vs. growing beef steers

ABSTRACT
Skeletal muscle and adipose tissues play important roles in maintaining wholebody Glu and N homeostasis via Glu transporters and Glu-utilizing enzymes. The goal of
this study was to determine if the content of high affinity Glu transporter EAAC1,
GTRAP3-18 (an inhibitor of EAAC1), ARL6IP1 (an inhibitor of GTRAP3-18),
glutamine synthase (GS), glutathione (GSH), and mRNA expression of GSHsynthesizing and metabolizing enzymes, changes in longissimus dorsi (LM) and
subcutaneous adipose tissue (SF), as it does in the liver, when steers develop from
predominately lean to lipid growth phases. Weaned Angus steers (BW = 209 ± 29.4 kg)
were randomly assigned (n = 8) to develop through lean (GROW, final BW = 301 ± 7.06
kg) vs. lipid (FINISH, final BW = 576 ± 36.9 kg) growth phases and individually fed
enough of a cotton seed hull-based diet to achieve a constant ADG (1.5 kg/d) throughout
the trial. The effect of development on experimental parameters was assessed by 1-way
ANOVA using the GLM procedure of SAS. Marbling score (668, 296) and yield grade
(3.65, 2.13) were greater (P < 0.01) for FINISH vs. GROW steers. Western blot analysis
of LM homogenates showed less EAAC1 (30%, P = 0.02) and GS (28%, P = 0.02)
content, whereas GTRAP3-18 (P = 0.80) and ARL6IP1 (P = 0.57) did not differ in
FINISH vs. GROW steers. GSH content (mg/g wet tissue) in LM was increased (42%, P
< 0.01) in FINISH vs. GROW steers in concomitance with increased mRNA expression
of GSH-synthesizing enzymes (GCLC, GCLM). For SF, Western blot analysis found
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greater GTRAP3-18 (123%, P = 0.03) and ARL6IP1 (43%, P = 0.01) content in FINISH
vs. GROW steers, whereas EAAC1 (P = 0.11) and GS content (P = 0.37) did not differ.
Concomitantly, the content of GSH in SF was decreased (38%, P = 0.04) in FINISH
steers in parallel with decreased mRNA expression of GSH-metabolizing enzymes
(GPX4, GGT1). We conclude that the negative regulatory relationship between
GTRAP3-18 and ARL6IP1 with EAAC1 and GS expression, which exists in liver, does
not exist in LM and SF of fattened cattle. Thus, novel regulators may contribute to the
differential expression of EAAC1, GS and GSH content in LM and SF; and antioxidant
capacity in LM and SF changes and differs as steer compositional gain shifts from lean to
lipid phenotype. Our results provide mechanistic knowledge of how the antioxidant
capacity is achieved in tissues of economic and metabolic importance to fattened cattle.
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INTRODUCTION

Glutathione (γ-L-glutamyl-L-cysteinylglycine, GSH) modulates diverse cellular
processes. For example, GSH is involved in detoxification of xenobiotics and regulates
cell proliferation, apoptosis and immunity, and redox signaling (Meister and Anderson,
1983; Suthanthiran et al., 1990; Ballatori et al., 2009; Lu, 2009; Pallardó et al., 2009; Liu
and Pravia, 2010). Aberrant redox signaling is induced by excessive production of
reactive oxygen species (ROS) that can lead to sub-optimal growth by disrupting tissue
metabolism. Glutathione functions as the major antioxidant (through oxidation of GSH to
GSH disulfide (GSSG)) to protect against oxidative damage and to maintain the cellular
redox potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen, 2012).
Of the total cellular GSH pool, 80-85% is found in the cytosol versus 10-15% in the
mitochondria and a small amount in the endoplasmic reticulum (Meredith and Reed,
1982; Hwang et al., 1992; Yuan and Kaplowitz, 2009; Lu, 2013).
Biosynthesis and whole-body utilization of GSH occurs in a tightly regulated
manner in the animal body. Cellular GSH synthesis strongly depends on the availability
of Glu and Cys (Sato et al., 1999; Flaring et al., 2003; Matthews, 2005), which are
substrates of two high-affinity (µM), concentrative, Glu transporters (GLT-1 and
EAAC1) that demonstrate system X-AG activity (Na+-dependent L-Glu, L-cysteine and LAsp uptake that is inhibited by D-Asp). EAAC1 and GLT-1 are expressed by the
intestinal epithelia, liver, kidney, and skeletal muscle tissues of ruminants, whereas only
EAAC1 protein is consistently detectable in ruminant adipose tissue (Howell et al. 2001;
Howell et al. 2003; Xue et al. 2010; Miles et al. 2015; Matthews et al., 2016). In mouse
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neuronal cells, the function of EAAC1 (solute carrier 1A1/SLC1A1) and GLT-1
(SLC1A2) is inhibited by endoplasmic reticulum-localized GTRAP3-18 (glutamate
transporter-associated protein 3-18; a.k.a. addicsin, ADP-ribosylation factor-like 6
interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al. 2008; Watabe et al. 2008) and
that the effect of GTRAP3-18 on EAAC1 activity is proportional to GTRAP3-18 content
(Lin et al. 2001). Accordingly, inhibition of GTRAP3-18 leads to an increase in GSH
production in mice neurons (Watabe et al., 2007, 2008; Aoyama et al., 2012). However,
ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits
GTRAP3-18, and indirectly promotes EAAC1 activity and cellular GSH levels (Aoyama
and Nakaki 2012; Akiduki and Ikemoto 2008; Aoyama and Nakaki 2013). The
ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver (Akiduki and
Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and GTRAP3-18 (Miles et
al. 2015).
To assess whether hepatic expression and activity of system X-AG transporters and
regulatory proteins, and glutamine synthetase activity, is altered concomitantly with the
shifts in whole-body compositional gain as cattle fatten, we conducted a study to compare
these parameters as beef steers developed from predominantly-lean to predominantlylipid phenotypes (Chapter 4). However, knowledge about the expression of these proteins
in skeletal muscle and adipose tissues is limited, despite evidence of the metabolic
importance of their joint function to antioxidant capacity and whole-body N metabolism
(Kowalski and Watford, 1994; Patterson et al., 2002; Vesali et al., 2002; Matthews et al.,
2016). The goal of the current research was to determine whether the content of system
X-AG transporters, their regulatory proteins, glutamine synthetase (GS), GSH, and mRNA
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expression of GSH-synthesizing and metabolizing enzymes, changed in longissimus dorsi
(LM) and subcutaneous adipose (SA) tissues of the same steers developing from
predominantly-lean into predominantly lipid growth phases.

MATERIALS AND METHODS
Animal Model
All procedures involving animals were approved by the University of Kentucky
Institutional Animal Care and Use Committee. The steers were raised, and trial
conducted, at the University of Kentucky Research and Education Center in Princeton,
KY.
Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and
water for 14 h) body weight (BW = 209 ± 29.4 kg) were randomly assigned (n = 8) to
either growing (final BW = 301 ± 7.06 kg) or finished (final BW = 576 ± 36.9 kg)
treatment groups. Steers then were randomly assigned to one of 4 feedlot pens that
contained Calan gates in a dry-lot barn. Four steers were assigned per pen. Steers were
individually fed enough of a diet that contained (% as-fed) cracked corn (60), cottonseed
hulls (20), soybean meal (7), soybean hulls (5), dried distiller’s grain (2), alfalfa meal (2),
glycerin (2), limestone (1.5), and urea (0.5) to support 1.51 kg gain/d (NRC 1996)
throughout the trial. Steers had ad libitum access to fresh water and a vitamin-mineral
mix (UK IRM Beef Cattle Vitamin-mineral Mix, Burkmann Mill, Inc., Danville, KY).
Full BW were determined every 14 d and amount of diet adjusted to achieve target rate of
gain. Steer average daily gain (ADG) was calculated as the difference between shrunk
BW at trial initiation and 1 d before slaughter.
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Slaughter, Tissue Collection, and Carcass Evaluation
One steer per day was slaughtered. Steers were stunned by captive bolt pistol and
then exsanguinated to allow recovery of carcasses for consumption. After the HCW was
recorded, liver, Longissimus dorsi (between 12th and 13th rib) muscle and its adjacent
subcutaneous adipose tissue were collected as described (Brown et al., 2009). For GSH
content, fresh tissues were homogenized in 5% ice-cold metaphosphoric acid solution
followed by centrifugation at 3000 x g, 4°C for 10 min. The supernatant was collected
and stored at -80°C overnight for next day assay (see below). For all other analyses,
tissue samples were placed in foil packs, snap-frozen in liquid nitrogen, and stored at 80°C until assayed for RNA and protein expression.
After 24 h postmortem, carcass evaluations were conducted on the right side of
the carcass according to USDA standards (USDA, 1997).

Western Blot Analysis
In general, liver tissues were processed for immunoblot analysis of relative
protein content as previously described by this research group (Howell et al., 2001; Miles
et al., 2015). For liver homogenates, 1 g of liver tissue was homogenized on ice for 30 s
(setting 11, POLYTRON, Model PT10/35; Kinematic, Inc., Neuchâtel) in 7.5 mL of 4°C
sample extraction buffer solution (0.25 mM sucrose, 10 mM HEPES-KOH pH 7.5, 1 mM
EDTA, and 50 µL of protease inhibitor (Sigma, St. Louis, MO). Protein was quantified
by a modified Lowry assay, using bovine serum albumin as a standard (Kilberg, 1989).
For liver homogenates and cLPM and blpm (protein quantified during preparation),
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proteins were separated by 12% SDS-PAGE, followed by electrotransfer to a 0.45 µm
nitrocellulose membrane (Bio-Rad, Hercules, CA). Blots were stained with Fast-Green
(Fisher, Pittsburgh, PA) and the relative amount of stained protein per lane/sample
determined by densitometric analyses and recorded as arbitrary units (Howell et al., 2001;
Miles et al., 2015).
The relative protein content of EAAC1, GLT-1, GTRAP3-18, GS, and betacatenin in liver homogenates was evaluated by immunoblot analyses as described (Brown
et al., 2009; Miles et al., 2015), whereas for ARL6IP1, an antibody raised against the
human ortholog (see below) was validated for detection of cattle ARL6IP1 using a
standard pre-hybridization regimen (Xue et al., 2011; data not shown). Briefly, blots were
hybridized with 1 μg of IgG antihuman EAAC1 polyclonal anti-body (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), 1 μg of IgG anti-rabbit GLT-1 polyclonal antibody
(Abcam Inc., Cambridge, MA), 4 μg of IgG antihuman GTRAP3-18 (Abcam Inc.,
Cambridge, MA), and 5 μg of IgG antihuman ARL6IP1 (Abgent Inc., San Diego, CA),
respectively, per mL of blocking solution (1% nonfat dry milk (w, v) in 30 mM Tris-Cl,
200 mM NaCl, 0.1% Tween 20 (v, v), pH 7.5) for 1.5 h at room temperature with gentle
rocking. For β-catenin detection, blots were hybridized with 14.5 μg of IgG anti-chicken
beta-catenin (Abcam Inc., Cambridge, MA) per mL of blocking solution (1.5% nonfat
dry milk [wt/vol] in 30 mM Tris-Cl [pH 7.5], 200 mM NaCl, 0.1% Tween-20) for 1.5 h at
room temperature with gentle rocking, whereas GS was detected using 1.25 μg of IgG
anti-sheep polyclonal antibody (BD Biosciences, San Jose, CA) per mL of blocking
solution (5% nonfat dry milk [wt/vol], 10 mM Tris-Cl [pH 7.5], 100 mM NaCl, 0.1%
Tween 20 [vol/vol]) for 1 h at 37°C with gentle rocking.
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All protein-primary antibody binding reactions were visualized with a
chemiluminescence kit (Pierce, Rockford, IL) after hybridization of primary antibodies
with horseradish peroxidase-conjugated donkey antirabbit IgG (Amersham, Arlington
Heights, IL; GLT-1, EAAC1 and ARL6IP1, 1:5,000); horseradish peroxidase-conjugated
goat antimouse IgG (BD Biosciences, San Jose, CA; GS, 1:5,000, and beta-catenin,
1:10,000); and horseradish peroxidase-conjugated donkey antigoat IgG (Santa Cruz
Biotechnology; GTRAP3–18, 1:5,000).
Densitometric analysis of immunoreactive products was performed as described
previously (Howell et al., 2003; Fan et al., 2004; Xue et al., 2011). Briefly, after exposure
to autoradiographic film (Amersham, Arlington Heights, IL), a digital image of the
radiographic bands was recorded and quantified as described (Swanson et al., 2000).
Apparent migration weights (Mr) were calculated by regression of the distance migrated
against the Mr of a 16 to 185 kDa standard (Gibco BRL, Grand Island, NY) using the
Versadoc imaging system (BioRad) and Quantity One software (BioRad). Band
intensities of all observed immunoreactive species (one for GTRAP3-18, ARL6IP1, GS,
and β-catenin; two for EAAC1 and GLT-1) within a sample were quantified by
densitometry (as described above for Fast-Green stained proteins) and reported as
arbitrary units. Densitometric data then were corrected for unequal (≤ 12%) loading,
transfer, or both, and amount of detected protein normalized to relative amounts of FastGreen-stained proteins common to all immunoblot lanes/samples (Miles et al., 2015).
Digital images were prepared using PowerPoint software (Microsoft, PowerPoint 2003,
Bellvue, MA).
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GSH Content in Liver, longissimus dorsi (LM) and subcutaneous fat (SF) tissues
Upon collection, liver, longissimus dorsi (LM) and subcutaneous fat (SF) tissues
(0.30 g to 0.35 g) were rinsed in 0.9% (w,v) NaCl solution and homogenized in 2.5 mL
5% (w,v) ice-cold metaphosphoric acid solution. The homogenates were then centrifuged
at 3000 x g, 4°C for 10 min. After centrifugation, 100 μL to 200 μL of supernatant was
collected and stored at -80°C overnight for use the next day.
The reduced glutathione (GSH) concentrations in liver, LM and SF were
determined using the GSH-400 kit (Oxis International Inc., Beverly Hills, CA), following
the manufacturer’s instructions. For liver and LM, a standard curve was prepared using 0,
20, 40, 60, and 80 μmol/L GSH. For SF, the standard curve was prepared with 0, 4, 8, 12,
16, 20 µmol/L GSH.The final absorbance at 400 nm was measured using a Genesys 20
spectrometer (Thermo Electron Corp., Waltham, MA). Samples were assayed in triplicate
and values are reported as mg GSH/g wet tissue.

RNA Extraction and Analysis
For each animal, total RNA was extracted from frozen LM and SF tissue using
TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the manufacturer’s
instructions. The purity and concentration of total RNA samples was analyzed by a
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE),
which revealed that all samples were of high purity with 260:280 nm absorbance ratios of
2.0 to 2.1 and 260:230 nm absorbance ratios ranging from 1.5 to 1.9. The integrity of
total RNA was examined by gel electrophoresis using an Agilent 2100 Bioanalyzer
System (Agilent Technologies, Santa Clara, CA) at the University of Kentucky
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Microarray Core Facility (Lexington, KY). Visualization of gel images and
electropherograms showed that all RNA samples had high quality with RNA integrity
numbers being greater than 8.5 and 28S: 18S rRNA absorbance ratios greater than 1.8.

Real-Time Reverse-Transcribed (RT) PCR Analysis
Real-time RT-PCR was performed using RNA samples from LM and SF tissue to
determine the expression of mRNA for glutathione-synthesizing and metabolizing
proteins using an Eppendorf Mastercycler ep realplex2 system (Eppendorf, Hamburg,
Germany) with iQ SYBR Green Supermix (Bio-RAD, Hercules, CA). Briefly, cDNA
was synthesized using the SuperScript III 1st Strand Synthesis System (Invitrogen), with
0.5 μg of RNA used for each reverse transcription reaction. Real-time RT-PCR was
performed with a total volume of 25 μL per reaction, with each reaction containing 5 μL
of cDNA, 1 μL of a 10 μM stock of each primer (forward and reverse), 12.5 μL of 2×
SYBR Green PCR Master Mix, and 5.5 μL of nuclease-free water. The resulting realtime PCR products were purified using a PureLink Quick Gel Extraction Kit (Invitrogen)
and sequenced at Eurofins Scientific (Eurofins, Louisville, KY). Sequences were
compared with the corresponding RefSeq mRNA sequences used as templates for primer
set design. The sequences of the primers and the resulting sequence-validated real time
PCR reaction amplicons are presented in Figure 5.3. Beta-actin (ACTB), glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and ubiquitin C (UBC) were used as the
housekeeping genes in the LM, and beta-actin (ACTB), glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA) were used as the
housekeeping genes in the SF. RT-PCR reactions were run in triplicate and gene
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expression was analyzed by the 2ΔΔCT method (Livak and Schmittgen, 2001).

Statistical Analysis
Individual steers were the observational units. Data were analyzed as a completely
randomized design by ANOVA using the GLM procedures of SAS (SAS Inst. Inc., Cary,
NC). All data were analyzed in a 1-way ANOVA model to test for finishing vs. growing
treatment effects. Treatment differences were considered significant at the α = 0.05 level.
Unequal experimental treatment observations resulted from loss of sample integrity
during collection or storage.

RESULTS

Expression of System X-AG Transporters, the Regulatory Proteins and GS in LM and
SF in Developing Steers
EAAC1 (Mr = 70 kDa for the lower, and 89 kDa for the higher, predominant
immunoreactants), GTRAP3-18 (Mr = 42 kDa), ARL6IP1 (Mr = 21 kDa) and GS (Mr =
43 kDa) proteins were detected by Western blot analysis in LM (Figure 5.1) and SF
(Figure 5.2) of growing and finished steers (Table 5.2). In contrast, GLT-1 was not
detected in LM and SF (data not shown).

Decreased EAAC1 and GS Content in LM, concomitant with Increased GSH Content,
of Fattening Beef Steers
Densitometry analysis of western blot data of LM homogenates (Table 5.1)
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showed less EAAC1 (30%, P = 0.02) and GS (28%, P = 0.02) content in FINISH vs.
GROW steers, whereas GTRAP3-18 (P = 0.80) and ARL6IP1 (P = 0.57) did not differ.
GSH content (mg/g wet tissue) in LM was greater (42%, P < 0.01) in FINISH vs. GROW
steers (Table 5.1).

Increased GTRAP3-18 and ARL6IP1 Content in SF, concomitant with Decreased GSH
Content, of Fattening Beef Steers
For SF, densitometric analysis of western blot data (Table 5.2) found increased
GTRAP3-18 (123%, P = 0.03) and ARL6IP1 (43%, P = 0.01) content in FINISH vs.
GROW steers, whereas EAAC1 (P = 0.11) and GS content (P = 0.37) did not differ.
Concomitantly, the content of GSH in SF was decreased (38%, P = 0.04) in FINISH vs.
GROW steers.

GSH content does not differ but mRNA Expression of Glutathione Synthesizing,
Metabolizing, and Exporter Proteins Differed in LV of Fattening Steers
The liver content of GSH did not differ between FINISH (1.08) and GROW
(1.07) steers. For glutathione-synthesizing proteins in LV (Table 5.3), real time RT-PCR
analysis found less GCLC (39%, P = 0.024) and GSS (29%, P = 0.009) mRNA
expression, whereas GCLM (P = 0.683) and GSR expression (P = 0.354) did not differ
in FINISH vs. GROW steers. For glutathione-metabolizing protein in LV, real time RTPCR assays showed less GPX1 (30%, P = 0.001) but more GSTM1 (113%, P = 0.001)
mRNA expression, whereas GGT1 expression tended to be greater (P = 0.077) and
mGST3 expression did not differ (P = 0.254) in FINISH vs. GROW steers. For
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glutathione exporters in LV, mRNA abundance was less for ABCC1 (39%, P = 0.001),
SLCO2B1 (61%, P = 0.025), and SLCO1B3 (32%, P = 0.001) in FINISH vs. GROW
steers.

mRNA Content of Glutathione-Synthesizing and Metabolizing Proteins Differed in LM
of Fattening Steers
For glutathione-synthesizing proteins in LM, the relative abundance of mRNA
was greater for GCLC (61%, P = 0.004) and GCLM (29%, P = 0.001) in FINISH vs.
GROW steers, but did not differ for GSS (P = 0.146) and GSR (P = 0.837) (Table 5.4).
For glutathione-metabolizing protein in LM, GPX1 (61%, P = 0.004), GPX3 (29%, P =
0.001) and GGT1 (56%, P = 0.045) mRNA abundance was greater in FINISH vs.
GROW steers, whereas GPX2 (46%, P < 0.001) expression was less and GPX4
expression tended to be less (P = 0.093).

mRNA Content of Glutathione-Synthesizing and Metabolizing Protein in SF of
Fattening Steers
For glutathione-synthesizing proteins in SF, the relative abundance of GCLC,
GCLM, GSS and GSR mRNA did not differ (P ≥ 0.261) in FINISH vs. GROW steers
(Table 5.5). For glutathione-metabolizing proteins in SF, the relative content was less for
GPX4 (52%, P = 0.013) and GGT1 (71%, P = 0.001) mRNA, whereas GPX1 (P =
0.319) and GPX3 mRNA abundance did not differ (P = 0.101) in FINISH vs. GROW
steers.
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DISCUSSION

Understanding the relationship between expression of system X-AG transporters,
their regulatory proteins, GS, and proteins responsible for GSH content, could yield
important insight into the importance of Glu use and metabolism. Importantly, these
relationships likely reflect changes in tissues that support (e.g. liver) or account for
(skeletal muscle, adipose) changes in compositional change as production animals
transition from predominantly low to high lipid accretion phases. To assess whether
hepatic expression and activity of system X-AG transporters and regulatory proteins, and
glutamine synthetase activity, is altered concomitantly with the shifts in whole-body
compositional gain as cattle fatten, we conducted a study that compared these parameters
as beef steers developed from predominantly-lean to predominantly-lipid phenotypes
(Chapter 4). However, knowledge about the expression of these proteins in skeletal
muscle and adipose tissues is limited, despite evidence of the metabolic importance of
their joint function to antioxidant capacity and whole-body N metabolism (Kowalski and
Watford, 1994; Patterson et al., 2002; Vesali et al., 2002; Matthews et al., 2016). The
goal of the current research was to determine whether the content of system X-AG
transporters, their regulatory proteins, GS, GSH, and mRNA expression of GSHsynthesizing and metabolizing enzymes, changed in longissimus dorsi (LM) and
subcutaneous adipose (SA) tissues of the same steers developing from predominantlylean into predominantly lipid growth phases.

86

Decreased EAAC1 and GS Content but Increased GSH Content in LM of Fattening
Beef Steers
Because of its integral physiological role and economic importance in carcass
evaluation, and its presumed relationship with intramuscular adipose content, LM was
studied as the model for skeletal muscle tissue. In addition to having important roles in
other tissues of the body, Glu is central to many metabolic processes in skeletal muscle.
For example, Glu is required for transamination of branch-chain amino acids, pivotal to
the formation of ammonia, Asp, Ala, and Gln, and is the primary AA taken up by resting
and active muscles (Mourtzakis and Graham, 2002). A reduction in the capacity for
plasma Glu uptake by skeletal muscle is thought to cause intracellular deficiencies of
Glu, Gln, GSH, and citric acid cycle intermediates (Hack et al., 1996; Ushmorov et al.,
1999). Reports on the identity of glutamate transporters in muscle tissue are limited.
However, system XAG- activity has been reported in skeletal myocytes (Low et al., 1994),
as has EAAC1 mRNA and protein expression by rat and human skeletal muscle (Kanai
and Hediger, 1992; Hediger and Welbourne, 1999). Similarly, we found both EAAC1
mRNA and protein in fattening steer LM. In contrast, we did not detect GLT-1, GLAST1 or EAAT4 protein in LM, using the same amount of homogenate as for EAAC1
(Matthews et al., 2016). Thus, EAAC1 plays an important role in supporting carbon and
N metabolism in this skeletal muscle.
The present study found that the protein content of EAAC1 in LM decreased as
steers developed from growing to finishing phases, in contrast to a previous report that
EAAC1 content in LM did not differ between backgrounding and finishing production
stages (Matthews et al., 2016). Because about half of the Gln released from muscle
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originates from Glu taken up from the blood (Wagenmakers, 1998), this current finding
may be indicative of a decreased requirement for blood-derived Glu as the steers
developed from a predominately-lean to predominately-lipid tissue accretion phases, due
to either (a) an increased supply of intra-cellular Glu from increased glutamate
dehydrogenase or ornithine transaminase activity, or (b) a reduced need to capture
sinusoidal Glu and ammonia.
The uptake of plasma Glu, its intracellular conversion to Gln, and subsequent
export of Gln to the plasma by skeletal muscle is critical to the proper functioning of
intestinal epithelia and immune system (Newsholme et al., 1990; Hack et al., 1996).
Although the activities of glutamate dehydrogenase or ornithine transaminase were not
determined, we did measure GS content in LM homogenates and found that GS content
was decreased 33% in finished vs. growing steers, paralleling the reduced EAAC1
content in LM. This finding suggests that the ability of LM to use blood ammonia
decreased from growing to finished steers or that the load of blood ammonia decreased.
With regard to the possibility of decreased use of blood ammonia, detoxification of
ammonia by GS may have been limited due to a shortage of intracellular glutamate (Boon
et al., 1999). If so, the above findings suggest that the observed decreased EAAC1 and
GS content, was paralleled by a decreased ability to produce intracellular Glu. With
regard to the second possibility of decreased blood levels of ammonia, ammonia
concentrations in the blood may have been decreased due to an elevated capacity to
scavenge ammonia for urea synthesis in the liver of finished vs. growing steers.
Oxidative stress results in changes in metabolic balance and nutrient use
efficiency (Elsasser et al., 2008). Glu transporter proteins and enzymes supporting the
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Na+ and Glu gradients (e.g., Na, K-ATPase, glutamine synthetase) can be oxidized in
presence of higher concentrations of reactive oxygen radicals, leading to inhibition of
metabolic functions (Volterra et al., 1994; Gegelashvili and Schousboe, 1997). To protect
against oxidative damage, GSH serves as the major antioxidant to maintain the celluar
thiol reduction potential (Aoyama et al., 2008; Forman et al., 2009; Schmidt and Dringen,
2012). In a human trauma model, GSH concentration decreases in skeletal muscle,
indicating oxidative stress caused by tissue injury (Flaring et al., 2003). However,
glutathione depletion in muscle can be attenuated by glutamine supplementation via a
supply of glutamate for glutathione synthesis (Flaring et al., 2003). Thus, dietary amino
acid supplementation seems to be a good therapeutic strategy to modulate GSH synthesis.
On the contrary, a deficient sulfur amino acids diet decreases growth and glycolysis of
longissimus muscle in piglets (Conde-Aguilera et al., 2015), suggesting the inadequate
nutrition supply impairs GSH homeostasis.
To characterize the role of LM metabolism of Glu to support GSH-mediated
antioxidant capacity in LM of fattening cattle, GSH content was determined in LM
homogenates. Opposite with decreased EAAC1 and GS content, GSH content in LM was
increased in finished vs. growing steers. This finding suggests that GS and the enzymes
responsible for GSH synthesis may compete for Glu as a substrate, when the
compositional gain of steers shifts from lean to lipid phenotypes. Concomitantly, the
increased GSH content in LM is indicative of a decreased oxidative stress in LM
(Aoyama et al., 2006; Findeisen et al., 2011; Aoyama and Nakaki, 2012) and/or the
increased intracellular capacity for GSH synthesis in LM of finished vs. growing steers,
either by increase of γ-glutamylcysteine ligase catalytic and modifier units (GCLC,
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GCLM) or glutathione synthase activity (Lu, 2013). Consistent with this possibility was
the increased expression of both GCLC and GCLM in LM tissue of FINISH vs. GROW
steers (Table 5.4). Another possible explanation for the increased GSH content is that
finished steers may have an increased capacity to import plasma GSH released from the
liver into the LM (Lew et al., 1985; Ji and Fu, 1992).
Expression of EAAC1 and GS in SF, Concomitant with Decreased GSH Content of
Fattening Beef Steers
Adipose tissues play a significant role in whole body amino acid metabolism
(Fryan et al., 1991; Kowalski et al., 1997; Patterson et al., 2002). Subcutaneous adipose
has been proven to be a net user of Glu and net producer of Gln (Frayn et al., 1991) with
the metabolic capacity to be an important site for Gln synthesis in the body (Ritchie et al.,
2001). The inguinal adipose pad/adipocyte tissue of fed rats also appears to be a net user
of Glu and ammonia, and a producer of Gln (Kowalski and Watford, 1994). Accordingly,
these studies gave rise to the concept that the adipose tissues of normally-nourished
mammals absorb Glu to synthesize Gln and, therefore, contribute to whole-body nitrogen
metabolism through the production of Gln and removal of ammonia from the blood.
Thus, it seems reasonable to suggest that the relative contribution of adipose-synthesized
Gln to whole-body N metabolism is strongly influenced by the relative activity of Glu
transporters and GS (Ritchie et al., 2001).
In addition to supporting nitrogen metabolism, adipose tissues also contribute to
the redox potential and energy homeostasis in the whole animal body. Increased
oxidative stress in obesity has been shown in human, mice and pig model: increased
reactive species production and oxidative damage were observed in subcutaneous adipose
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tissue in obese and type 2 diabetes (Chattopadhyay et al., 2015); dysregulation of adipose
glutathione peroxidase 3 results in systemic oxidative stress in obese mice (Lee et al.,
2008); moreover, selenoprotein gene profiles change in different tissues such as liver and
subcutaneous fat in pigs fed on a high fat diet (Zhao et al., 2015), suggesting a potential
change of redox potential. In addition to obesity, adipogenesis can be inhibited by
oxidative stress accumulation in adipose tissue in aging mice (Findeisen et al., 2011).
However, knowledge on the role of adipose tissue metabolism of Glu in wholebody N scavenging and antioxidant capacity in fattening cattle is very limited. Therefore,
in terms of adipose tissue utilization of blood Glu, an important finding from this study
was that EAAC1 was the only system XAG- transporter detected by SF in fattening cattle.
Thus, EAAC1 function likely is critical for Glu-based adipose metabolism, including the
synthesis of Gln and GSH from plasma Glu. That GLT-1 protein was not detected in
these tissues, but that GLT-1 mRNA was, indicates that either GLT-1 was expressed in
levels too low for immunoblot detection or that GLT-1 transcription and translation are
controlled by discordant regulatory pathways. Alternatively, the sensitivity of GLT-1
Western blot reagents were insufficient to detect GLT-1.
To determine whether the expression of EAAC1 was associated with Gln and
GSH production in SF, the relative expression of EAAC1 and GS, and GSH content were
characterized in SF. The content of EAAC1 and GS did not differ in SF of finished vs.
growing steers. For GS, this result is incompatible with that of Matthews et al. (2016), in
which GS content decreased when steers developed from backgrounding to finishing
production stages, but is consistent with the finding that EAAC1 content did not differ in
SF between backgrounding and finishing phases. However, we found a decreased GSH
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content in SF of finished vs. growing steers, suggesting an increased oxidative stress in
SF or that GSH was quickly oxidized in the presence of high concentrations of reactive
species (Aoyama et al., 2006; Findeisen et al., 2011; Aoyama and Nakaki, 2012).
Alternatively, the intracellular capacity for GSH synthesis in SF may have decreased in
finished vs. growing steers.

Regulation of GSH Levels through Alteration of EAAC1 Expression and Function in
LV, LM, and SF of Growing and Finishing Steers
The main site for the GSH production is liver with amino acid transporters and
glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After exported
into blood and bile, GSH can be utilized by other organs such as kidney, brain, muscle
and intestine (Deneke and Fanburg, 1989). Because the liver is a net exporter of GSH,
depletion of liver GSH under oxidative stress or xenobiotics metabolism may also deplete
GSH in other tissues (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012).
Therefore, hepatic GSH production and use vs. secretion play a critical role in the whole
animal glutathione homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989;
Ookhtens and Kaplowitz, 1998).
As noted earlier, EAAC1 delivers substrates (Glu, Cys) to support GSH synthesis
(Aoyama et al., 2005). However, EAAC1 expression and function are tightly regulated at
the post-transcriptional and post-translational levels (Aoyama et al., 2005). At the posttranscription level, miR-96-5p has been identified to target EAAC1 in mouse
dopaminergic neurons (Kinoshita et al., 2014). Intracerebroventricular administration of
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miR-96-5p inhibitor increases the level of EAAC1 as well as that of GSH and exhibits a
neuroprotective effect in the mouse brain. At the post-translational level, the activity of
EAAC1 is regulated by two endoplasmic reticulum (ER)-localized proteins, GTRAP3-18
(glutamate transporter-associated protein 3-18, a.k.a. addicsin and ADP-ribosylation
factor-like 6 interacting protein 5/ARL6IP5, or PRAF3) and ARL6IP1 (ADP-ribosylation
factor-like 6 interacting protein 1). The negative regulator of EAAC1, GTRAP3-18
decreases EAAC1-mediated transport activities by interacting with EAAC1 and retaining
EAAC1 in the ER and consequently delays EAAC1 trafficking to the trans-Golgi and
plasma membrane (Lin et al., 2001; Ruggiero et al., 2008). Inhibition of GTRAP3-18
leads to an increase in GSH production in mice neurons (Watabe et al., 2007, 2008;
Aoyama et al., 2012). However, an ER-localized protein ARL6IP1 serves as a positive
regulator of EAAC1 by interacting with GTRAP3-18 to decrease the GTRAP318/EAAC1 interaction. Consequently, high ARL6IP1 expression promotes the transport
activity of EAAC1 and glutathione synthesis in mouse neurons (Akiduki and Ikemoto,
2008; Aoyama and Nakaki, 2012).
Although GTRAP3-18 regulation of EAAC1 is well known in the brain,
knowledge on regulation of EAAC1 in peripheral tissues is very limited. However,
hepatic GTRAP3-18 protein content was shown to increase in aged vs. young cows,
whereas GS decreased and EAAC1, GLT1 contents did not differ (Miles et al., 2015).
Our previous research (Chapter 4) found that in the liver of finished vs. growing steers,
hepatic Glu transport and Gln synthesis capacities were decreased, concomitant with
increased GTRAP3-18 and ARL6IP1 content. We also measured GSH content in the
liver, however, GSH content did not change (1.08 vs. 1.07) in liver of finishing vs.
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growing steers. This result may suggest that increased hepatic GSH synthesis parallels
the increased potential for GSH export from hepatocytes into blood and bile (Table 5.3),
and vice versa, resulting in no change of GSH content in liver of finishing vs. growing
steers. However, assuming the intracellular GSH synthesis capacity in finishing steers
was the same as in growing steers, this finding indicates that hepatic GSH synthesis
likely is not limited by EAAC1-mediated cysteine uptake, as evidenced by decreased
EAAC1 protein content in liver homogenate, canalicular and basolateral plasma
membrane and reduced system X-AG activity in canalicular liver plasma membrane in
finishing vs. growing steers (Chapter 4). When combined with the higher hepatic
GTRAP3-18 content in finishing vs. growing steers, this finding is inconsistent with
previous finding that GTRAP3-18 negatively regulates cellular GSH content via
interaction with EAAC1 in human embryonic kidney 293 cells (Watabe et al., 2007) and
that suppression of GTRAP3-18 increases neuronal GSH content in GTRAP3-18–/– mice
(Aoyama and Nakaki, 2012). However, our finding is consistent with the previous studies
showing no difference in hepatic GSH level between wild-type and EAAC1–/– mice
(Aoyama et al., 2006) and that Cys in liver is derived from methionine via the
transsulfuration pathway (Lu, 1999, 2013). These results suggest that EAAC1 might play
a minor role in delivering substrates for GSH synthesis in bovine liver, thus highlighting
the relationship of decreased EAAC1 and GS activity in livers of finishing vs. growing
steers.
To test the hypothesis that expression of EAAC1, GS, and GSH content were
inversely proportional to GTRAP3-18 and proportional to ARL6IP1 in LM, immunoblot
analysis was performed to evaluate the expression of GTRAP3-18 and ARL6IP1 protein
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in LM homogenate of finishing vs. growing steers. Concomitant with decreased EAAC1
and GS expression but increased GSH content, GTRAP3-18 and ARL6IP1 content did
not differ in LM of finished vs. growing steers (Table 5.1). These data demonstrate the
negative regulatory relationship between GTRAP3-18 and ARL6IP1 with EAAC1 and
GS expression, that exists in liver, does not exist in LM of fattened cattle, indicating
novel regulators contribute to the differential expression of EAAC1, GS and GSH content
in LM. Overall, additional research is needed for cattle to further investigate pretranslational regulators, including putative microRNAs reported to regulate expression of
EAAC1 and GS, and GSH content in rodents (Kinoshita et al., 2014).
To test whether the expression of EAAC1 and GS, and GSH content were
inversely proportional to GTRAP3-18 and proportional to ARL6IP1 in SF, immunoblot
analysis was performed to evaluate the expression of GTRAP3-18 and ARL6IP1 protein
in SF homogenate of finishing vs. growing steers. Concomitant with decreased GSH
content, both GTRAP3-18 and ARL6IP1 content increased in SF of finished vs. growing
steers (Table 5.2). This finding is consistent with previous studies that GTRAP3-18
negatively regulate cellular GSH content via interaction with EAAC1 in human
embryonic kidney 293 cells (Watabe et al., 2007) and that suppression of GTRAP3-18
increases GSH content in GTRAP3-18–/– mice (Aoyama and Nakaki, 2012). Assuming
increased GTRAP3-18 content leads to decreased EAAC1 transport activity, this finding
suggests that in SF, EAAC1 activity is regulated by GTRAP3-18 and ARL6IP1 to
support GSH synthesis rather than Gln production.
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Mechanisms of How Antioxidant Capacity Is Achieved in LM and SF of Fattening
Steers: Transcriptional Changes of GSH Synthesizing and Metabolizing Proteins in
Tissues of Fattening vs. Growing steers
GSH is the most abundant cellular thiol present in mammalian tissues. GSH
synthesis involves two consecutive ATP-requiring enzymatic reactions: formation of γglutamylcysteine from Glu and cysteine by γ-glutamylcysteine ligase (GCL) and
formation of glutathione from γ-glutamylcysteine and glycine by glutathione synthase.
The rate-limiting enzyme GCL is composed of a catalytic subunit (GCLC) and a modifier
subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC catalyzes γglutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering the Km for
Glu and increasing the Ki for the feedback inhibition of GCL by glutathione (Richman
and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al., 2005).
Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione
synthase (GSS). Although glutathione synthase is usually not considered to be rate
limiting, increased glutathione synthase expression can further promote GSH production
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004).
Several GSH related enzymes guard cells against oxidative injury by scavenging
reactive oxygen species and nitrogen radicals. In the cytosol and mitochondria,
superoxide dismutase (SOD) catalyzes the dismutation of superoxide radical (O2-) into
H2O2, which is subsequently reduced into water and oxygen by catalase in peroxisome
(Salvi et al., 2007). However, in mitochondria and cytosol, GSH is especially important
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in defending against oxidative stress (Fernandez Checa et al., 1997; Garcia Ruiz and
Fernandez Checa, 2006; Lu, 2013). The antioxidant function of GSH is catalyzed by
GSH peroxidase (GPX), which reduces lipid peroxide and hydrogen peroxide into
corresponding alcohols and water to prevent the organism from the oxidative damage.
GSH can also conjugate with xenobiotics via glutathione-S-transferases (GST) for the
purpose of detoxification (Schmidt and Dringen, 2012). At the same time, GSH (reduced
form of glutathione) is oxidized to GSSG (disulfide-oxidized form) that can be
subsequently reduced back into 2 GSH by GSSG reductase (GSR), forming a redox
cycle. In the cell, the ratio of GSH to GSSG mainly determines the intracellular redox
potential (Forman et al., 2009). However, severe oxidative injury may compromise the
ability of the cell to reduce GSSG into 2 GSH molecules, leading to GSSG accumulation
(Lu, 2009). To maintain the redox equilibrium, GSSG is either exported out of the cell or
reacts with a protein sulfhydryl group to form a mixed disulfide (Schmidt and Dringen,
2012; Lu, 2013).
GSH is transported out of the cell by GSH transporters such as the multidrug
resistance protein Mrp family (Schmidt and Dringen, 2012; Bachhawat et al., 2013). The
unique structure of GSH is that cysteine is linked with γ-carboxyl group of Glu instead of
α-carboxyl group, which makes glutathione resistant to intracellular degradation (Lu,
2013). The only enzyme to hydrolyze the γ-carboxyl-amine bond of glutathione is γglutamyltranspeptidase (GGT), expressed on the surface of certain cell types (Meister and
Anderson, 1983). GGT is highly expressed in epithelium of lung, kidney and intestine
(Deneke and Fanburg, 1989). However, importantly, GGT is lowly expressed in
hepatocytes, which is consistent with the role of liver as a net exporter of GSH (see
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below) (Lauterburg et al., 1984). GGT transfers the γ-glutamyl motif to an acceptor
amino acid, forming γ-glutamyl amino acid and cysteinylglycine. The γ-glutamyl amino
acid can be transported back into the cell to release 5-oxoproline, which is finally
converted to Glu as the substrate for GSH synthesis. On the other hand, cysteinylglycine
is broken down by dipeptidase to yield cysteine and glycine, which are also transported
back into the cell to be reincorporated into GSH. Once inside the cell, most of the
cysteine is used for GSH synthesis while the rest is broken down into sulfate and taurine
or is incorporated into new protein. Therefore, the γ-glutamyl cycle is important to
maintain GSH homeostasis by breaking down extracelluar glutathione through GGT and
recycling back into the rate-limiting cysteine for intracellular GSH synthesis (Lu, 2013).
The main site for the GSH production is the liver with amino acid transporters and
glutathione and bile acid synthesizing enzymes localized to pericentral hepatocytes
(Häussinger and Gerok, 1983; Boon et al., 1999; Braeuning et al., 2006). After GSH
synthesized by the liver is exported into blood and bile, the kidney can either directly take
up GSH from the plasma into cells or salvage plasma GSH through the GGT reaction.
Plasma GSH can also be utilized by other organs such as lung and intestinal epithelium
with high levels of GGT activity (Deneke and Fanburg, 1989). The portal vein brings
blood from the intestine to the liver where xenobiotics are neutralized by hepatocytes if
not detoxified in the intestine (Fernandez Checa and Kaplowitz, 2005; Lushchak, 2012).
Because the liver has low GGT activity and is a net exporter of GSH, depletion of liver
GSH under oxidative stress or xenobiotics metabolism may also deplete GSH in other
tissues. Therefore, hepatic GSH production and secretion play a critical role in the whole
animal glutathione homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989;
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Ookhtens and Kaplowitz, 1998).
Liver
For glutathione-synthesizing protein in LV (Table 5.3), real time RT-PCR assays
found less GCLC and GSS mRNA in FINISH vs. GROW steers, whereas GCLM and
GSR expression did not differ. These results suggest a decreased capacity for GSH
synthesis in FINISH vs. GROW steers. For glutathione-metabolizing protein, we found a
decreased GPX1 expression, indicating a decreased capacity to reduce hydrogen peroxide
in the liver as steers develop from growing to finished stages. However, GSTM1
expression was increased in FINISH vs. GROW steers, suggesting that finishing steers
may have a greater capacity for detoxification of xenobiotics, including environmental
toxins and products of oxidative stress, by conjugation with GSH (Schmidt and Dringen,
2012). In parallel with decreased expression of enzymes responsible for GSH synthesis
(GCLC and GSS) in FINISH steers, we also found a decreased expression of genes that
encode for GSH exporters (ABCC1, SLCO2B1 and SLCO1B3), suggesting a decreased
GSH efflux in the liver of FINISH vs. GROW steers in concomitance with reduced GSH
synthesis capacity. Cellular glutathione homeostasis is maintained through substrate
uptake, de novo biosynthesis, and the amount of glutathione that has been utilized and
exported out of the cell. Thus, if the relative abundance in mRNA documented in this
manuscript corresponds to actual changes in metabolic capacities, these transcriptional
changes of GSH-related enzymes and exporters may account the equal GSH content in
the liver of FINISH vs. GROW steers.

LM

99

In LM, our RT-PCR data showed increased GCLC and GCLM mRNA
expression, whereas GSS expression did not differ in FINISH vs. GROW steers (Table
5.4). These results indicate an increased capacity for GSH synthesis in LM of FINISH vs.
GROW steers, and glutathione synthase appears not to be the rate-limiting enzyme for
GSH synthesis in LM as steers develop from growing to finished stage. For GSHmetabolizing protein, our RT-PCR data showed increased GPX1 and GPX3 mRNA
expression, indicating a higher capacity to metabolize hydrogen peroxide and fatty acid
hydroperoxides (Thomas et al., 1990; Esworthy et al., 1991) in LM of FINISH vs.
GROW steers. On the other hand, GPX2 expression was decreased in FINISH vs. GROW
steers, suggesting a reduced reactivity towards organic hydroperoxides (Chu et al., 1993)
in LM of fattening steers. Consistent with increased GSH content in LM, we also found
an increased mRNA expression of GGT1 in LM, suggesting more extra-cellular GSH can
be cleaved by GGT and recycled back to support intracellular GSH synthesis. Thus,
combined with transcriptional changes of GSH-synthesizing and metabolizing enzymes,
and increased GSH content in LM of FINISH vs. GROW steers, these results suggest an
increased antioxidant capacity in the muscle when beef steers compositional gain shifts
from lean to lipid phenotype.

SF
In contrast to LV and LM, the mRNA expression of GCLC, GCLM and GSS
expression did not differ in SF of FINISH vs. GROW steers (Table 5.5). However, we
found decreased GPX4 mRNA expression in SF of FINISH vs. GROW steers, suggesting
a decreased ability to catalyze the reduction of phospholipid hydroperoxide, cholesterol
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hydroperoxide, and linoleic acid hydroperoxide (Maiorino et al., 1990) when steers
develop from growing to finishing stage. Moreover, the mRNA expression of GGT1 in
SF was decreased in concomitance with decreased GSH content, suggesting a decreased
capacity of recycling extracellular GSH to support intracellular GSH synthesis in FINISH
vs. GROW steers. Thus, combined with the above findings, these data indicate decreased
antioxidant capacity in SF, when steers develop from lean to lipid phenotype.

Summary
In summary, our results provide mechanistic knowledge of how the GSHmediated antioxidant capacity may be achieved in liver, LM, and SF of fattened cattle.
Moreover, we identified differential regulatory relationships between GTRAP3-18 and
ARL6IP1 with EAAC1 and GS expression in liver, LM and SF, when beef steers
compositional gain shifts from lean to lipid phenotype.
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Table 5. 1 Densitometric analysis of EAAC1, GTRAP3-18, ARL6IP1, glutamine
synthetase (GS) and glutathione (GSH) content in longissimus dorsi (LM) tissues of
growing vs. finished Angus steers
Growing

Finished

SEM3

P-Value
Protein
EAAC1
10689
7443
972
0.02
GTRAP3-18
2969
3102
363
0.80
ARL6IP1
6755
5821
1285
0.57
GS
8298
5935
700
0.02
2
Metabolites
GSH
0.24
0.34
0.02
<0.01
1
Values (arbitrary densitometric units) are means (n = 8) and SEM of relative EAAC1,
GTRAP3-18, ARL6IP1 and GS content in LM homogenates (Figure 6.1) of growing
(BW = 301 kg) and finished (BW = 576 kg) Angus steers. Densitometric quantification
was of immunoreactive species identified by immunoblot analyses.
2
Values are mg glutathione/g wet tissue.
3
Most conservative error of the mean.
1
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Table 5. 2 Densitometric analysis of EAAC1, GTRAP3-18, ARL6IP1, glutamine
synthetase (GS) and glutathione (GSH) content in subcutaneous adipose (SF) tissues of
growing vs. finished Angus steers
Growing

Finished

SEM3

P-Value
Protein
EAAC1
8774
6117
1317
0.11
GTRAP3-18
4069
9084
1667
0.03
ARL6IP1
19264
27471
2348
0.01
GS
7004
5826
953
0.37
2
Metabolites
GSH
0.13
0.08
0.02
0.04
1
Values (arbitrary densitometric units) are means (n = 8) and SEM of relative EAAC1,
GTRAP3-18, ARL6IP1 and GS content in SF homogenates (Figure 6.2) of growing (BW
= 301 kg) and finished (BW = 576 kg) Angus steers. Densitometric quantification was of
immunoreactive species identified by immunoblot analyses.
2
Values are mg glutathione/g wet tissue.
3
Most conservative error of the mean.
1
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Table 5. 3 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing
and metabolizing protein mRNA by liver from growing vs. finished Angus steers1
Protein2
Growing
Finished
SEM3
P-Value4
Glutathionesynthesizing protein
GCLC
1.07
0.65
0.14
0.024
GCLM
0.95
0.91
0.07
0.683
GSS
1.03
0.73
0.09
0.009
GSR
1.02
0.92
0.08
0.354
Glutathionemetabolizing protein
GPX1
1.01
0.71
0.06
0.001
GSTM1
0.93
1.99
0.20
0.001
mGST3
1.02
1.12
0.07
0.254
GGT1
1.04
1.27
0.10
0.077
GSH/GSSG exporter
protein
ABCC1
1.02
0.62
0.07
0.001
SLCO2B1
1.24
0.48
0.26
0.025
SLCO1B3
0.95
0.65
0.05
0.001
1
The relative mRNA levels of glutathione-synthesizing and metabolizing protein
expressed by liver of growing (n = 8, BW = 301 kg) and finished (n = 8, BW = 576 kg)
steers are presented as normalized to the relative expression level of three reference
genes: TATA-box binding protein (TBP), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and Tyrosine 3-Monooxygenase (YWHAZ).
2
Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γglutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG
reductase); GPX1 (glutathione peroxidase 1); GSTM1 (glutathione-S-transferase M1
subunit); mGST3 (microsomal glutathione-S-transferase 3); GGT1 (γglutamyltranspeptidase 1); ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP),
member 1); SLCO2B1 (solute carrier organic anion transporter family, member 2B1);
SLCO1B3 (solute carrier organic anion transporter family, member 1B3).
3
Most conservative error of the mean.
4
P-values were obtained from ANOVA F-test.
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Table 5. 4 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing
and metabolizing protein mRNA by Longissimus dorsi (LM) from growing vs. finished
Angus steers1
Protein2
Growing
Finished
SEM3
P-Value4
Glutathionesynthesizing protein
GCLC
0.94
1.51
0.12
0.004
GCLM
0.96
1.24
0.05
0.001
GSS
1.01
0.90
0.06
0.146
GSR
1.05
1.09
0.18
0.837
Glutathionemetabolizing protein
GPX1
1.04
1.48
0.12
0.017
GPX2
1.01
0.55
0.06
<0.001
GPX3
1.05
1.81
0.12
0.001
GPX4
1.02
0.83
0.08
0.093
GGT1
1.06
1.65
0.24
0.045
1
The relative mRNA levels of glutathione-synthesizing and metabolizing protein
expressed by Longissimus dorsi (LM) of growing (n = 8, BW = 301 kg) and finished (n =
8, BW = 576 kg) steers are presented as normalized to the relative expression level of
three reference genes: beta-actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and ubiquitin C (UBC).
2
Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γglutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG
reductase); GPX1 (glutathione peroxidase 1); GPX2 (glutathione peroxidase 2); GPX3
(glutathione peroxidase 3); GPX4 (glutathione peroxidase 4); GGT1 (γglutamyltranspeptidase 1).
3
Most conservative error of the mean.
4
P-values were obtained from ANOVA F-test.
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Table 5. 5 Real-time RT-PCR analysis of the relative content of glutathione-synthesizing
and metabolizing protein mRNA by subcutaneous adipose tissues (SF) from growing vs.
finished Angus steers1
Protein2
Growing
Finished
SEM3
P-Value4
Glutathionesynthesizing protein
GCLC
1.10
0.90
0.27
0.599
GCLM
1.01
1.01
0.12
0.991
GSS
1.04
0.72
0.16
0.261
GSR
1.02
1.21
0.14
0.324
Glutathionemetabolizing protein
GPX1
1.00
1.17
0.16
0.319
GPX3
1.04
1.92
0.42
0.101
GPX4
1.02
0.49
0.11
0.013
GGT1
1.02
0.30
0.11
0.001
1
The relative mRNA levels of glutathione-synthesizing and metabolizing protein
expressed by subcutaneous adipose tissues (SF) of growing (n = 4, BW = 301 kg) and
finished (n = 4, BW = 576 kg) steers are presented as normalized to the relative
expression level of three reference genes: beta-actin (ACTB), glyceraldehyde 3phosphate dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA).
2
Gene symbols: GCLC (γ-glutamate-cysteine ligase catalytic subunit); GCLM (γglutamate-cysteine ligase modifier subunit); GSS (glutathione synthetase); GSR (GSSG
reductase); GPX1 (glutathione peroxidase 1); GPX3 (glutathione peroxidase 3); GPX4
(glutathione peroxidase 4); GGT1 (γ-glutamyltranspeptidase 1).
3
Most conservative error of the mean.
4
P-values were obtained from ANOVA F-test.
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Figure 5. 1 Western blot analysis of EAAC1, GTRAP3-18, ARLI6P1, and glutamine
synthetase (GS) in LM homogenates (15µg per lane) of growing (G) and finished (F)
steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower, and
89 kDa for the higher, predominant immunoreactants for EAAC1; 42 for GTRAP3-18;
21 for ARL6IP1; and 43 for GS; respectively. Data are representative of 8 growing and 8
finished steers.
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Figure 5. 2 Western blot analysis of EAAC1, GTRAP3-18, ARLI6P1, and glutamine
synthetase (GS) in SF homogenates (15µg per lane) of growing (G) and finished (F)
steers. The apparent migration weights (kDa) for proteins were 70 kDa for the lower, and
89 kDa for the higher, predominant immunoreactants for EAAC1; 42 for GTRAP3-18;
21 for ARL6IP1; and 43 for GS; respectively. Data are representative of 8 growing and 8
finished steers.

108

Figure 5. 3 The sequences of the real-time RT-PCR products (5’ to 3’ orientation).
Within a sequence, two underlines indicate the forward and reverse primer positions,
respectively.
Gapdh:
ATATCAAGGGGGGTGATGCAGGTGCTGRGTATGTGGTGGAGTCCACTGGGGT
CTTCACTACCATGGAGAAGGCTGGGGCTCACTTGAAGGGTGGCGCCAAGAGG
GTCATCATCTCTGCACCTTCTGCCGATGCCCCCATGTTTGTGATGGGCGTGAA
CCCACGAGAAGTATAACAACACCCTCAAGATTGTCAGCAATGCC
Tbp:
CCGCTGTTTCTGGTGTGCACAAAGATAACCCACAGAGCCGAGCAAGTCGCCA
AGAATAGTGTGCTGGGGATGCTCTAGGAAAAGACTGAATGCTGAGGCAATTT
CCAGTCCAGTAGGTTTTTGATTTGCCAAGAAGGTGAACGTCATGGATCAGAA
CAACAGCCTCCCACCCTATGCCCAGGGCCTGGCCTCCCCTCAGGGTGCCATG
ACTCCTGGAATCCCTATCTTTAGTCCAATGTGCCCTTACGGCA
Ywhaz:
TTGATCCCCAACGCTTCACAAGCAGAGAGCAAAGTCTTCTATTTGAAAATGA
AGGAGACTACTACCGCTACTTGGCTGAGGTTGCAGCTGGTGATGACAAGAAA
GGGATTGTGGACCAGTCACAGCAAGCATACCAAGAAGCTTTGAAATCAGCAA
AAAGGAAATGCAACCAACACATCCTATCAGACTGGGTCTGGCCCTTAACT
GCLC:
TTTGCAAAGGTGGCAACGCCGTGGTGGACGGCTGCGGCAAGGCCGCGGGCA
GGGCGGAGCCAGCGGCGGAGGAGTACGCGCTCATGACCATCGACACCATCA
TCAACGGCAAGGAAGGCGTGTTCCCCGGGCTGATCCCCGTCCTGAACTCCTA
CCTGGAGAGCATGGAGGTGGACGTGGACACCAGGTGCAGCATTCTGAACTAC
CTGAAGCTCATCAAGAAGAGGGCGTCCGGAGAATTAATGACAGTGCCAAATG
GATGAGGGAGTTTATCGCAAAGCATCCCGACTACAAGCAGGACAG
GCLM:
TCCCTGACATTCGAGCACACGAGTGGGTGCCTCTGTGGCTACTGCGGTACTCA
GTCATTGTTAAAAGTAGAGGAATTATCAAATCAAAAGGCTACATCTTACAAG
CTAAAAGAAAGGGTTCGTAACTGCAGCTTAGGATCATAACCTACTGACCTGT
ATTTTCCTTGAATATAAGATAACATGGAGCTGTGTAAAAAACTAATTACTGCC
TGTAAGTGTGTCATGGAGGCAGA
GSS:
GGAGGCCAGNGNNAGGAACGCGGCTGGACGACGGAAGAGTTGGGATGGCCA
CCGGCTGGGGGAGCCTCTTGCAGGATGAACAGCAGCTGGAGGAGCTAGCAA
GGCAGGCTGTGGACCGGGCTCTGGCTGAGGGTGTGTTGCTGAGGACCTCACA
GGCACCCAGCTCCTCTCATGTGGTGAGCTATGCTCCATTCACACTCTTNCCTT
CACCGGT
GSR:
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GTGGAACACTGCTGTCCACTCTGAATTCATGCATGACCACGTTGACTATGGCT
TTCAAAGTTGTGAAAGTAAATTCAATTGGCGGATTATAAAGGAAAAGCGGGA
CGCCTATGTGAGCCGCCTGAACACCATCTATCAAAATAATCTAACCAAGTCC
CACATAGACATCATCCATGGCCATGCAGCATTCACGTGCGATCCTCAGCCCA
CAGTGAGGTCAACGGGAAAAAATACACCGCTCCTCACATCCTGATC
GPX1:
AAACGCCAAGAACGAGGAGATCCTGAATTGCCTGAAGTACGTCCGACCAGG
CGGCGGGTTCGAGCCCAACTTTATGCTCTTCGAAAAGTGCGAGGTGAATGGC
GAGAAGGCGCATCCGCTCTTCGCCTCCTTCGGGAGGTTCTGCCCACGCCAAG
TGACGACGCCACTGCTCTCATGACCGAC
GGT1:
CAATGTGACTGAGGTGGTCCGCAACATGACCTCCGAGTTCTTTGCCGCCAGCT
CTGGGCCCGGATCTCCGACAGCACCACTCACCCAGCCTCCTACTACGAGCCT
GAGTTCTACACGCCAGACGGTGGGGGCACCGCCCACCTGTCGGTGGTCTCGG
AGGACGGCAGCGCTGTGTCGGCCACCAGCACCATCAACCTCTACTTCGGTTC
CAAGGTGCG
GSTM1:
GTAGGAGATGCTCCCGACTATGACAGAAGCCAGTGGCTGAATGAAAAATTCA
AGCTGGGCCTGGACTTCCCCAATCTGCCCTACTTAATCGATGGGACTCACAA
GCTCACCCAGAGCAACGCCATCCTTCGGTACATCGCTCGCAAGCACAACCTG
TGTGGGGAGACAGAGGAGGAGATGATTCGTGTGGACATTTTGGAGAACCAG
GTTATGGATGTCCGCTTGGC
MGST3:
TGGCCGTCCNCTCTAAGGAATATGGTTTCGTGATTCTAACTGGTGCTGCCAGC
TTCTTGATGGTAACTCATCTAGCCATCAATGTTTCTAAGGCCCGCAAGAAGTA
CAAAGTGGAGTATCCTACCATGTACAGCACTGACCCTGAAAACGGGCACATC
TTCAACTGCATTCAGCGAGCTCACCAGAACACGTTGGAAGTGTACCCTCCCTT
CTTATTTTTTCTAGCTGTCGGAGGTGNNATACCA
ABCC1:
GGACCCCGTTTTGTTTTCGGGTTCCCTCCGCATGAACCTGGACCCGTTCAGCC
AGTACTCGGATGAAGAGGTCTGGACGTCCCTGGAGCTCGCCCACCTGAAGGG
CTTCGTGTCGGCCCTTCCCGACAAACTGAACCACGAGTGTGCGGAAGGCGGG
GAGAACCTCAGCGTCGGGCAACGCCAGCTTGTGTGCCTGGCCCGGGCCCTGC
TGAGGAAGACGAAGATCCTCGTGTTGGACGAAGCCACGGCGGCCGTGGACCT
GGAAACGGACGACTCATTCAGTCC
SLCO2B1:
TGACTGTCCCGCACTTCATATCAGAGCCGTACCGCTACGACAGCGCCAGCCC
CGACATGCCACAAGACTTTGAGGCTTCCCTGTGCCTGCCCAGCACCAAGGCC
CTAGCTTCAGCCTCATCCAACAGCAGCTGCTCTAGCTACACAGAGGCTCGGC
ACCTGGCTGTGGTGGGGATCATGTTCACAGCCCASACCCTGCTTGGTGTGGGC
GGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTTCCCACAA
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CAGCAACTCGCCCCTCTACCTCGGTATCCTGTTTGCAGTGACCATGATGGGGC
CGGGCATGGCCTATGGGCTGGGCAGCCTCATGTTGCACCTTTACG
SLCO1B3:
CGTAGAGCAGCAGTATGGCAATTCAGCATCTGAGACGAGCATTTTGCTTGGA
TTCATATCCATACCATCTTTGGCAGCTGGAATGTTTACAGGAGGATTTATTGT
TAAAAAGTTCAAGTTTACCTTGGTTGGAATTGCCAAATTTTCACTTTGTGCCC
ATATGACATCCTTCCTATTTCATCNTAATAAATTTTGCACTAATCTGTGAAAA
CAAATCAGTCGCCGGACTAAACAA
SLC1A1:
GACAGGGANNCCCCCTGAAGTTAGCACAGTGGATGCCATGTTAGACCTGATC
AGGAATATGTTCCCTGAGAACCTTGTCCAAGCCTGTTTTCAGCAGTACAAAAC
CACACGTGAAGAAGTGGAGCTTTCTGAGGAGCCAGGGACAAACAGCACGGA
AGCGACTGTCACAGCCATCATGACAACTGCAATTTCCAAGAACAAAACAAAG
GAATACAAAGTCGTAGGCATGTATTCAGATGGCATAAATGTCCTGGGCTTGA
TCGTCTTTTGCC
SLC1A2:
TTGCCTGCCTAATCTGTGGGAAGATCATTGCAATCAAGGACTTAGAAGTGGTT
GCTAGGCAACTGGGGATGTACATGATTACGGTGATTGTCGGCCTCATCATCC
ATGGGGGGATCTTTCTCCCCTTGATTTACTTTCTAGTGACCAGGAAAAACCCT
TTCTCCTTTTTTGCTGGCATTTTCCAAGCTTGGATCACTGCCCTGGGTACCGCT
TCCAGTGCTGGAACTTTGCCTGTCACCTTCCGCTGCTTGGAAGAAAATCTGGG
GATTGATAAGCGTGTGACTAGATTTGTCCTGCCAGTCGGA
ARL6IP1:
GCAAGGATGGGGAGAAGTGATGCTGATGGCAGATAAAGTCCTCCGATGGGA
AAGAGCCTGGTTTCCACCTGCCATCATGGGTGTGGTTTCTTTGGTGTTTCTGA
CTATCTACTATCTAGATCCATCTGTTCTATCTGGTGTTTCCTGTTTTGTTATGTT
TTTGTGCTTGGCTGACTACCTTGTTCCCATTCTAGCACCTAGAATTTTTGGCTC
CAATAAATGGACCACCGAGCAACAGCAAAGATTCC
ARL6IP5:
GCCGGACTTCAGGGACATTTCCAAATGGAACAACCGTGTGGTGAGCACCTGC
TCTATTACCAGACCAACTACCTAGTGGTGGCTGCCATGATGATTTCCGTTGTG
GGGTTCCTGAGCCCCTTCAACATGATCCTTGGAGGCATTGTGGTGGTGCTGGT
GTTCACAGGCTTCGTGTGGGCAGCCCACAATAAAGACTCCTCCGTCGGATGA
AGAAGCAGTACCCCACAGCGTTTGTCATGGTGG
GLUL:
GAAGAGTTGCCCGAGTGGAATTTTGATGGCTCTAGTACTTTTCAGTCTGAAGG
CTCCAACAGTGACATGTATCTTGTCCCCGCTGCCATGTTTCGGGACCCTTTCC
GCAAGGACCCCAACAAGCTGGTGTTCTGTGAAGTCTTCAAGTACAACCGAAA
GCCTGCAGAGACCAATTTAAGGCACACCTGTAAACGGATAATGGACATGGTG
AGCAACCAGCGCCCCTGGTTTGGAATGGAGCAGGAATATACCCTCATGGGCA
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CTGATGGGCACCCCTTTGGTTGGCCTTCCAATGGCTTTCCTGGGCCCCAAGGT
CCCTACTACTGTGGTGTGGGAGCGGACAAGGCCTACGGCAGGGATATTGTGG
AGG
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Chapter 6. Shifts in hepatic transcriptome profiles of growing vs. finished beef
steers

Abstract
Transcriptome analysis was conducted to gain a greater understanding of hepatic
metabolic shifts associated with the change in whole-body compositional gain of growing
vs. finished beef steers. Weaned Angus steers (BW = 209 ± 29.4 kg) were randomly
assigned (n = 8) to develop through lean (GROW, final BW = 301 kg) or lipid (FINISH,
final BW = 576 kg) growth phases and individually fed enough of a cotton seed hullbased diet to achieve a constant ADG (1.5 kg/d). Marbling score (668, 296) and yield
grade (3.65, 2.13) were greater (P < 0.01), but liver weight (1005, 1341 g/100 kg BW)
less (P < 0.01), for FINISH vs. GROW steers, respectively. Total hepatic RNA was
isolated, subjected to microarray (Bovine Affymetrix Gene 1.0 ST GeneChip) analysis,
and differences in gene expression (false discovery rate < 10%; P < 0.01) between
treatment groups determined by 1-way ANOVA (Partek Genomics Suite). Expression of
405 mRNA was increased (5 to 567%) and 695 (6 to 638%) decreased in FINISH vs.
GROW steers. Bioinformatic (Ingenuity Pathway Analysis) analysis found that the top
functional gene category was cell death and survival (47 genes; P ≤ 0.025) and the top
canonical cell signaling pathway was calcium-induced T lymphocyte apoptosis (13
genes; P ≤ 0.0005). Functional analysis of canonical metabolic pathways found that
FINISH steers had increased (P ≤ 0.009; 17 to 414%) capacities for ammonia (GLS2,
GLUD1, GPT2), Arg (OAT, GOT1, ASS1, ASL), and urea production (ARG2), and
shunting of amino acid carbons into pyruvate (ALT2, SDS, LDHB). For carbohydrate
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metabolism, capacity for glycolysis (PGK1, PKM2) was inhibited (P ≤ 0.003; 19 and
42%), whereas glycogen synthesis (GYG2, GYS2) was greater (P ≤ 0.002; 30 and 31%),
in FINISH steers. For lipid metabolism, FINISH steers showed decreased (P ≤ 0.008; 28
to 163%) capacity for fatty acid activation (ACSL5, ACSF2) and desaturation (SCD,
FADS1, FADS2), but increased (P ≤ 0.009; 26 to 61%) capacity for fatty acid β-oxidation
(ACADL, ACAA1) and lipid storage (LIPA, PLIN3). In addition, redox capacity (GPX1,
GSS, GGT1) and inflammatory responses (NOS2, SOCS2, CCL2, IL6R, TLR3) were
decreased (P ≤ 0.008; 18 to 191%) in FINISH steers. These findings elaborate the shift in
hepatic metabolic capacities as compositional gain shifted from the lean to lipid
phenotype in beef steers.
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Introduction

How to improve efficiency of nutrient use in maturing cattle remains a major
question in beef production. Growing and finishing phases are two important animal
production stages, which differ fundamentally in compositional growth. The growing
stage reflects the acceleration growth phase of greatest lean (protein) to fat deposition. In
contrast, the finishing phase reflects a time of greatest fat to lean deposition ratio with
maximized meat yield and fat cover (U.S market weight). However, the molecular and
cellular mechanisms that contribute to these physiological changes are poorly understood.
Thus, an understanding of potentially altered metabolic pathways and regulatory
mechanisms in tissues of metabolic importance, such as the liver, when beef steers
develop from growing to finished stage, is critical.
The liver is a highly metabolically active tissue and it is the principle site of
amino acid, carbohydrate, and lipid metabolism. For amino acid metabolism, liver plays
important roles in maintaining whole-body Glu and N homeostasis via Glu transporters
and enzymes to produce the Gln-Glu “cycle” (Heitmann and Bergman, 1981a; Wu, 1998;
Burrin and Stoll, 2009). Blood Gln from the peripheral tissues is efficiently absorbed by
periportal hepatocytes and deaminated by glutaminase (liver-type) to release ammonia
and Glu. The released ammonia can be incorporated into carbamoyl phosphate for
ureagenesis, whereas the remaining Glu is available for conversion to α-ketoglutarate (as
an anapleurotic reaction to replenish the citric acid cycle), used for gluconeogenesis, used
for protein synthesis, or transported into the sinusoids (Meijer et al., 1990; Brosnan,
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2000; Watford, 2000). Sinusoidal blood Glu absorbed by pericentral hepatocytes and the
“scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990;
Wagenaar et al., 1994).
For carbohydrate metabolism, because little glucose is absorbed into the hepatic
portal system in ruminants (Baird et al., 1980; Huntington et al., 1981), approximately
85-90% of the glucose is generated by gluconeogenesis for energy production (Nafikov
and Beitz, 2007). In ruminant digestion, the microorganisms in the rumen break down the
feedstuff to produce the volatile fatty acids, acetic acid, propionic acid, and butyric acid,
which are absorbed through the rumen. Liver metabolizes 50–90% of the butyrate and
propionate absorbed by the rumen (Huntington, 1990) and converts them into glucose
through gluconeogenesis pathway (Bergman, 1990). In addition to gluconeogenesis, the
liver is the major site for glycolysis, glycogen synthesis and lysis, which also helps to
regulate blood glucose levels in cattle. For lipid metabolism, fatty acid from the blood
taken up by the liver can either be broken down to provide energy via beta-oxidation, or
be used as a substrate for triglyceride synthesis and lipid storage.
Another important function of the liver is to maintain the whole-body/systemic
redox potential. The liver is the major producer of glutathione (GSH), the most abundant
antioxidant that modulates diverse cellular processes in the body. GSH is involved in
detoxification of xenobiotics and regulates cell proliferation, apoptosis and immunity,
and redox signaling (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et
al., 2009; Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010). GSH synthesized by the
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liver is exported into blood and bile, and subsequently, plasma GSH can be taken up and
utilized by other organs such as kidney, lung and intestine. Depletion of liver GSH under
oxidative stress or xenobiotics metabolism may also deplete GSH in other tissues. Thus,
hepatic GSH production and secretion play a critical role in the whole animal glutathione
homeostasis (Lauterburg et al., 1984; Deneke and Fanburg, 1989; Ookhtens and
Kaplowitz, 1998).
Our previous study has identified hepatic metabolic shift in the efficiency of
nitrogen use associated with the change in whole-body compositional gain of growing vs.
finished beef steers (Chapter 4), using biochemical and targeted-gene and protein
analyses. Because of the pivotal role of the liver in metabolism, the goal of the current
research was to conduct a transcriptome analysis of the same hepatic tissue samples to
gain a greater perspective into other potentially altered hepatic metabolic pathways and
perhaps identify candidate regulatory mechanisms. For convenience, the L-isomer form
of AA is implied unless indicated otherwise. GSH is used to indicate reduced glutathione
and GSSG to indicate oxidized GSH.

MATERIALS AND METHODS
Animal Model
All procedures involving animals were approved by the University of Kentucky
Institutional Animal Care and Use Committee. The steers were raised, and trial
conducted, at the University of Kentucky Research and Education Center in Princeton,
KY.
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Sixteen weaned, predominately Angus, steers of similar shrunk (denied feed and
water for 14 h) body weight (BW = 209 ± 29.4 kg) were randomly assigned (n = 8) to
either growing (GROW, final BW = 301 ± 7.06 kg) or finished (FINISH, final BW = 576
± 36.9 kg) treatment groups. Steers then were randomly assigned to one of 4 feedlot pens
that contained Calan gates in a dry-lot barn. Four steers were assigned per pen. Steers
were individually fed enough of a diet that contained (% as-fed) cracked corn (60),
cottonseed hulls (20), soybean meal (7), soybean hulls (5), dried distiller’s grain (2),
alfalfa meal (2), glycerin (2), limestone (1.5), and urea (0.5) to support 1.51 kg gain/d
(NRC 1996) throughout the trial. Steers had ad libitum access to fresh water and a
vitamin-mineral mix (UK IRM Beef Cattle Vitamin-mineral Mix, Burkmann Mill, Inc.,
Danville, KY). Full BW were determined every 14 d and amount of diet adjusted to
achieve target rate of gain. Steer average daily gain (ADG) was calculated as the
difference between shrunk BW at trial initiation and 1 d before slaughter.

Sample Collection and RNA Extraction
The liver sample from each animal was collected from the mid-lower part of the
right lobe, placed in foil packs, snap-frozen in liquid nitrogen, and stored at –80°C. The
time from killing an animal to freezing of the sample in liquid nitrogen ranged from 35 to
45 min. For each animal, total RNA was extracted from 400 mg of frozen liver tissue
using TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the
manufacturer’s instructions. The purity and concentration of total RNA samples was
analyzed by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies,
Wilmington, DE), which revealed that all samples were of high purity with 260:280 nm
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absorbance ratios of 2.0 to 2.1 and 260:230 nm absorbance ratios ranging from 1.5 to 1.9.
The integrity of total RNA was examined by gel electrophoresis using an Agilent 2100
Bioanalyzer System (Agilent Technologies, Santa Clara, CA) at the University of
Kentucky Microarray Core Facility (Lexington, KY). Visualization of gel images and
electropherograms showed that all RNA samples had high quality with RNA integrity
numbers being greater than 8.5 and 28S: 18S rRNA absorbance ratios greater than 1.8.
Microarray Analysis
The GeneChip Bovine 1.0 ST Array (Affymetrix, Inc., Santa Clara, CA), which
contains 24,341 bovine gene transcripts, was used to investigate the effect of growing vs.
finished growth stage on potential changes of bovine liver gene expression profiles.
Microarray analysis was conducted according to the manufacturer’s standard protocol at
the University of Kentucky Microarray Core Facility. Briefly, 3 μg RNA for each sample
first is reverse transcribed (RT) to cDNA and then from cDNA (double stranded) to
complementary RNA (cRNA; single stranded), which was then labeled with biotin. The
biotinylated cRNA were further fragmented and used as probes to hybridize the gene
chips in the GeneChip Hybridization Oven 640 (Affymetrix), using 1 chip per RNA
sample. After hybridization, the chips were washed and stained on a GeneChip Fluidics
Station 450 (Affymetrix). The reaction image and signals were read with a GeneChip
Scanner (GCS 3000, 7G; Affymetrix) and data were collected using the GeneChip
Operating Software (GCOS; version 1.2; Affymetrix). The raw expression intensity
values from the GCOS (i.e., 19 *.cel les from the raw methylation measurements) were
imported into Partek Genomics Suite (PGS) software (version 6.4; Partek Inc., St. Louis,
MO). For GeneChip background correction, the algorithm of Robust Multichip
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Averaging adjusted with probe length and GC oligo contents was implemented (Irizarry
et al., 2003; Wu et al., 2004). The background-corrected data were further converted into
expression values using quantile normalization across all the chips and median polish
summarization of multiple probes for each probe set (Partek, Inc., 2009).
All the GeneChip transcripts are annotated using NetAffx annotation database for
Exon array on the Bovine GeneChip Array, provided online by the manufacturer
(http://www.affymetrix.com/ analysis/index.affx). Quality control of the microarray
hybridization and data presentation was performed by MA plot on all the gene expression
values and box plot on the control probe sets on the Affymetrix chips (data not shown).
Principal component analysis (PCA) was performed to elucidate the quality of the
microarray hybridization and visualize the general data variation among the chips
(Partek, Inc., 2009). To test the growing vs. finished treatment effects on the relative
expression of the liver gene transcripts, qualified microarray data were subjected to the 1way ANOVA analysis using the same PGS software (Partek, Inc., 2009). To achieve a
higher degree of confidence (i.e., a conservative approach), the transcripts showing
treatment effects at the significance level of P < 0.01 and the controlled false discovery
rate of 10% were defined as being differentially affected. These differentially expressed
genes/gene transcripts (DEG) were subjected to hierarchical clustering and functional,
canonical, and network pathway analyses using the Core Analysis program of Ingenuity
Pathways Analysis online software (8.7-3203; http://www.ingenuity.com [accessed Dec
5, 2016]; Ingenuity Systems, Inc., Redwood City, CA).
All the microarray *.cel files collected by GCOS plus the GC Robust Multichip
Averaging-corrected data processed by PGS software of this manuscript will be deposited
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in the National Center for Biotechnology Information’s Gene Expression Omnibus
(GEO; http:// www.ncbi.nlm.nih.gov/geo/), as minimum information about a microarray
experiment (MIAME) compliant (Brazma et al., 2001).

Real-Time Reverse-Transcribed PCR Analysis
Real-time RT-PCR was performed using RNA samples from liver tissue to
determine the expression of mRNA for EAAC1 regulatory proteins using an Eppendorf
Mastercycler ep realplex2 system (Eppendorf, Hamburg, Germany) with SYBR Green
Supermix (Bio-RAD, Hercules, CA). Briefly, cDNA was synthesized using the
SuperScript III 1st Strand Synthesis System (Invitrogen), with 0.5 μg of RNA used for
each reverse transcription reaction. Real-time RT-PCR was performed with a total
volume of 25 μL per reaction, with each reaction containing 5 μL of cDNA, 1 μL of a 10
μM stock of each primer (forward and reverse), 12.5 μL of 2× SYBR Green PCR Master
Mix, and 5.5 μL of nuclease-free water. The resulting real-time PCR products were
purified using a PureLink Quick Gel Extraction Kit (Invitrogen) and sequenced at
Eurofins Scientific (Eurofins, Louisville, KY). TATA-box binding protein (TBP),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and tyrosine 3-monooxygenase
(YWHAZ) were used as the housekeeping genes. RT-PCR reactions were run in triplicate
and gene expression was analyzed by the 2ΔΔCT method (Livak and Schmittgen, 2001).

Statistical Analysis
To test for GROW vs. FINISH treatment effects on the relative expression of the
liver gene transcripts, microarray hybridization data were subjected to 1-way ANOVA
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analysis using the PGS software as described in the “Microarray Analysis” section above.
The effects of treatment on the relative expression of all other data were subjected to 1way ANOVA analysis using the GLM procedure of SAS (version 9.1; SAS Inst., Inc.,
Cary, NC). For these latter data, significance was declared when P ≤ 0.05 and tendency to
differ was declared when 0.10 ≤ P > 0.05.

RESULTS

Differentially Expressed Genes
Principal component analysis of all microarray data was performed to examine
the correlation and variation among the gene chips, revealing a total variance of 30.5%
(Figure 6.1). The first principal component (PC number 1; x-axis) included genes with a
high degree of variance (13.3%), whereas PC number 2 (y-axis) and PC number 3 (z-axis)
encompassed genes that had median (9.55%) and low (7.71%) ranges of variance.
Overall, PCA demonstrated that the chips within each treatment group were closely
clustered together.
Individual ANOVA was conducted to identify altered expression of RNA
transcripts in the livers of GROW vs. FINISH steers. At the P < 0.05 level, 4,693 gene
transcripts were identified. To refine this analysis, genes with a false discovery rate of
less than 10% and P < 0.01 were considered to be DEG. Of the 1100 DEG, 405 genes
(37%) were upregulated by 5 to 567% and 695 genes (63%) were downregulated by 6 to
638%.
Importantly, hierarchical cluster analysis of the 1100 annotated DEG revealed 2
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treatment clusters associated with each of the growing and finished treatment groups
(Figure 6.2). Relative to growing steers, approximately 40% of the genes in the finished
steers were upregulated and 60% were downregulated.

Canonical Pathway Analysis
To determine the physiological significance of treatment-induced DEG,
bioinformatic analysis of canonical pathways was performed. Canonical cell signaling
pathway analysis of the DEG revealed that the most affected pathways belong to the
cellular immune response category (Table 6.1). The top 7 pathways were calciuminduced T lymphocyte apoptosis (13 genes), protein kinase A signaling (43 genes), netrin
signaling (8 genes), leukocyte extravasation signaling (32 genes), hepatic fibrosis /
hepatic stellate cell activation (28 genes), macropinocytosis signaling (16 genes) and cell
cycle control of chromosomal replication (8 genes).
Canonical metabolic pathway analysis of the 1100 DEG found that the most
affected pathways were related to AA metabolism (Table 6.2). Of the top 7 pathways
identified, arginine biosynthesis (4 genes) and superpathway of citrulline metabolism (6
genes) contained the most DEG.
In addition to Ingenuity Pathway analysis, the microarray data showed that genes
involved in amino acid, carbohydrate, lipid metabolism, antioxidant capacity and
inflammatory responses were differentially expressed (Table 6.3).

Semi-Quantitative Real-time RT-PCR Analysis of Selected mRNA

To corroborate the altered expression of genes known to be responsible for
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EAAC1 regulatory pathways (Table 6.4) identified by our current microarray analyses,
hepatic expression of these genes by finished vs. growing steers was compared by realtime RT-PCR analysis (Table 6.4). Although the fold changes measured by the two
analytical techniques were similar for EAAC1 regulatory pathway genes, the statistical
significance (ANOVA P values) differed between microarray and real-time PCR
analyses. The incongruences between microarray and real-time RT-PCR analyses may be
due to the different regions of DNA sequences used for primer design for RT-PCR.

DISCUSSION

The growing and finishing phases are two important animal production stages that
fundamentally differ in compositional gain. The growing stage reflects the acceleration
growth phase of greatest lean (protein) to fat deposition. In contrast, the finishing phase
reflects a time of greatest fat to lean deposition with maximal meat yield and fat cover
(U.S market weight). Our previous study has identified hepatic metabolic shift in the
efficiency of nitrogen use associated with the change in whole-body compositional gain
of growing vs. finished beef steers (Chapter 4), using biochemical and targeted-gene and
protein analyses. We have demonstrated that the Glu transport and Gln synthesis capacity
was decreased in finished vs. growing steers, concomitant with increased GTRAP3-18
(an inhibitor of Glu transporters) content. Moreover, the mRNA expression of GSHsynthesizing and metabolizing enzymes differed in the liver of finished vs. growing steers
(Chapter 5). Because of the pivotal role of the liver in metabolism, the goal of the current
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research was to conduct a transcriptome analysis of the same hepatic tissues samples to
gain a greater perspective into other potentially altered hepatic metabolic pathways and
perhaps identify candidate regulatory mechanisms.

The Role of Arginine Metabolism in Urea Synthesis and Glu-Gln Cycle
Among the top 7 canonical metabolic pathways (Table 6.2), the arginine
biosynthesis pathway ranked as the most significant pathway by IPA of DEG in our
microarray dataset. Thus, we focused on the arginine biosynthesis pathway to determine
if the capacity for arginine biosynthesis and metabolism changes when beef steers
compositional gain shifts from lean to lipid phenotype.
Arginine synthesis and metabolism are essential to support several metabolic and
physiological functions in the body (Wu and Morris, 1998; Wheatley and Campbell,
2002; Yeh, 2004; Wu et al., 2009). Arg biosynthesis pathway is part of urea cycle
(Morris Jr, 2004). In the urea cycle, the three key enzymes involved in Arg biosynthesis
and metabolisms are arginosuccinate synthetase (ASS), arginosuccinate lyase (ASL) and
arginase (ARG) (Morris, 2002). In the cytoplasm, ASS catalyzes the conversion of
citrulline and aspartate into arginiosuccinate. Subsequently, arginosuccinate is cleaved by
ASL to produce arginine and fumarate. Arginine is then further cleaved by arginase to
produce urea and ornithine. Two isoforms of arginase (ARG1 and ARG2) encoded by
different genes have been identified in mammals (Colleluori et al., 2001; Cederbaum et
al., 2004). ARG1 and ARG2 isoforms have 58% similarity in the amino acid sequences,
with distinct tissue, cellular and subcellular distributions (Choi et al., 2012). ARG1 is
located in the cytosol of periportal hepatocytes (Burke et al., 2009) and is an important
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enzyme in the urea cycle. In contrast, ARG2 is located in the mitochondria of various cell
types (Cederbaum et al., 2004). It is constitutively expressed (Morris, 2002) and plays a
pivotal role in the regulation of hepatic ureagenesis by supplying ornithine for net
synthesis of N-acetylglutamate, citrulline, and aspartate (Nissim et al., 2005). Our
Microarray data showed that the expression of ASS, ASL and ARG2 was increased,
suggesting an increased capacity for Arg synthesis and metabolism, and urea production
in the liver of finished vs. growing steers.
Recognizing that finished steers had a higher capacity for urea production than
growing steers prompted us to ask whether the capacity for ammonia production would
differ between growing and finished steers. A primary function of the mammalian liver is
to coordinate whole-body energy and N metabolism. Hepatic transport and intermediary
metabolism of glutamate are critical to these processes as glutamate is a central substrate
for hepatic ureagenesis, gluconeogenesis, glutathione production, de novo protein
synthesis, and nitrogen shuttling via glutamine (Meijer et al., 1990; Watford, 2000). An
important aspect of glutamate metabolism in the liver is the heterogeneity of Gln/Glu
metabolism. Specifically, Gln, arriving from the peripheral tissues, is efficiently absorbed
by periportal hepatocytes and deaminated by glutaminase (liver-type) to release ammonia
and Glu. Alanine transaminase (glutamic-pyruvic transaminase, GPT), also primarily
expressed by periportal vs. pericentral hepatocytes, supports ammonia production by
transaminating Ala to pyruvate (Welsh, 1972), producing Glu from α-KG. Glutamate, in
turn, can be deaminated by glutamate dehydrogenase to produce ammonia and α-KG.
Ammonia from peripheral Gln and Ala now can be incorporated into carbamoyl
phosphate for ureagenesis. Moreover, aspartate transaminase (GOT) expressed in the

126

periportal hepatocytes (Boon et al., 1999; Braeuning et al., 2006) converts oxaloacetate
and Glu into aspartate and oxoglutarate, that also feed into urea cycle. In the urea cycle,
Arginase (ARG1 and ARG2) cleaves arginine to produce urea. Our microarray data
showed an increased mRNA expression of GPT2, GOT1, and ARG2, suggesting an
increased capacity for ammonia and urea production in finished vs. growing steers.
In contrast to the periportal zone, when released into the sinusoidal blood, Glu is
available for absorption by “down-acinus” pericentral hepatocytes, which express the
high-affinity system X-AG activity (Häussinger and Gerok, 1983; Braeuning et al., 2006;
Brosnan and Brosnan, 2009). If absorbed by pericentral hepatocytes, Glu and the
“scavenged” sinusoidal ammonia that escapes incorporation into urea by periportal
hepatocytes are incorporated into Gln by pericentral hepatocyte-specific GS activity, thus
completing the hepatic Gln-Glu cycle (Moorman et al., 1989; Moorman et al., 1990;
Wagenaar et al., 1994). Besides supporting Gln synthesis by GS, pericentral hepatocytelocalized system X-AG uptake of Glu complements pericentral hepatocyte-specific
synthesis of glutathione synthesis by glutamylcysteine ligase and glutathione synthetase
(Braeuning et al., 2006), as well as supplying Glu as source of gluconeogenic carbons
and for de novo protein synthesis (Watford, 2000).
Two high-affinity (µM), concentrative, Glu transporters (GLT-1 and EAAC1) that
demonstrate system X-AG activity (Na+-dependent L-Glu and L-Aspartate uptake that is
inhibited by D-Aspartate) are expressed by the intestinal epithelia, liver, and kidney of
sheep (Howell et al., 2001; Howell et al., 2003; Xue et al., 2010) and cattle (Howell et al.,
2001; Miles et al., 2015). In mouse neuronal cells, the function of EAAC1 (solute carrier
1A1/SLC1A1) and GLT-1 (SLC1A2) is inhibited by endoplasmic reticulum-localized
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GTRAP3-18 (glutamate transporter-associated protein 3-18; a.k.a. addicsin, ADPribosylation factor-like 6 interacting protein 5/ARL6IP5, PRAF3) (Ruggiero et al., 2008;
Watabe et al., 2008) and that the effect of GTRAP3-18 on EAAC1 activity is
proportional to GTRAP3-18 content (Lin et al., 2001). However, ADP-ribosylation
factor-like 6 interacting protein 1 (ARL6IP1) binds and inhibits GTRAP3-18, and
indirectly promotes EAAC1 activity (Akiduki and Ikemoto, 2008; Aoyama and Nakaki,
2012, 2013). The ARL6IP1/GTRAP3-18/EAAC1 triad is highly expressed in rat liver
(Akiduki and Ikemoto, 2008), whereas cow liver expresses at least EAAC1 and
GTRAP3-18 (Miles et al., 2015).
Our previous studies demonstrated decreased Glu transport capacity and EAAC1
content in concomitance with increased GTRAP3-18 and ARL6IP1 content in the liver of
finished vs. growing steers. To further investigate the regulation of EAAC1, we focused
on the mRNA expression profiles of upstream regulators of EAAC1 in our microarray
dataset, and these upstream regulators were also selected for targeted gene expression
analysis. In mouse neuronal cells, platelet-derived growth factor (PDGF) stimulates
EAAC1 expression and transport activities through the phosphatidylinositol 3-kinase
(PI3K) pathway (Sims et al., 2000). PI3K activates serum- and glucocorticoid- inducible
kinase 1 (SGK1) and protein kinase B (Akt/PKB) through phosphoinositide-dependent
kinase 1(PDK1) activation (Aoyama and Nakaki, 2013). The constitutively active SGK1
and Akt/PKB stimulate glutamate uptake by EAAC1 (Schniepp et al., 2004). Another
upstream regulator of EAAC1 is protein kinase C (PKC). PKCa activation increases the
transport activity and the cell surface expression of EAAC1, whereas PKCe activation
stimulates glutamate transport activity of EAAC1 without changing the protein
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abundance on the plasma membrane (González et al., 2002; Huang et al., 2006). EAAC1
is also up-regulated by the serine/threonine kinase mammalian target of rapamycin
(mTOR) (Almilaji et al., 2012), which plays a critical role in protein synthesis, cell
growth and proliferation (Hay and Sonenberg, 2004). Conversely, EAAC1 activity and
expression were decreased by expression of the constitutively active AMP-activated
protein kinase (AMPK) in Xenopus oocytes (Sopjani et al., 2010).
In contrast to the findings in mouse neuronal models, in cattle liver, our
microarray data showed a reduced mRNA expression of PDGF, PI3K, SGK, Akt and
PKCe in finished vs. growing steers (Table 6.4). Consistent with decreased Glu transport
activity and reduced EAAC1 content when beef steers compositional gain shifts from
lean to lipid phenotype (Chapter 4), our microarray data showed a decreased mRNA
expression of upstream stimulators of EAAC1 in the liver of finished vs. growing beef
steers. However, the mRNA expression of AMPK, the upstream inhibitor of EAAC1, was
also decreased in finished vs. growing steers, suggesting a feedback inhibitory
mechanism of decreased EAAC1 activity and expression in cattle liver hepatocytes.
Paralleling decreased EAAC1 expression and activity, the microarray data
showed an increased expression of ornithine transaminase (OAT) that converts ornithine
into Glu. Because OAT is mainly expressed in the pericentral hepatocytes, these findings
indicate an increased capacity for intracellular Glu production although the ability of
taking up Glu from blood and bile was decreased in the pericentral hepatocytes of
finished steers. Concomitantly, our previous studies showed a decreased GS activity in
finished vs. growing steers. This prompted us to determine the molecular and cellular
mechanisms that contribute to decreased GS activity when beef steers compositional gain
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shifts from lean to lipid phenotype. Our microarray data showed an increased capacity of
incorporating ammonia into urea in the periportal hepatocytes in finished steers, which
may decrease ammonia concentration in the blood, and consequently, less ammonia will
be available for incorporation into Gln in the pericentral hepatocytes, and GS activity is
decreased correspondingly, when beef steers develop from growing to finished stage.

The Role of Arginine Metabolism in Cellular Redox Potential and Immune Response
Arginine can be cleaved by arginase to produce urea, however, it is also the
substrate for nitric oxide synthetase (NOS) that converts arginine into nitric oxide (NO)
and citrulline (Morris, 2004; Mori, 2007). Three distinct isoforms of NOS have been
found as the products of different genes. These isoforms share 50% sequence similarity,
but differ in intracellular localization and enzymatic properties: NOS1 is prevalent in
neuronal tissue; NOS2 is the inducible isoform, which is present in various cells of the
immune system; and NOS3 is mainly found in endothelial cells (Alderton et al., 2001;
Bogdan, 2001). Our microarray data showed upregulation of ARG2 paralleling
downregulation of NOS2, suggesting NOS2 competes with ARG2 for arginine use as a
substrate in the liver, when beef steers develop from growing to finished production
stages. This finding is consistent with previous reports that ARG activation limits the
availability of arginine as a substrate for NOS and consequently, negatively regulates the
enzymatic activity of NOS (Gotoh and Mori, 1999; Munder et al., 1999; Bronte and
Zanovello, 2005). Moreover, some studies showed that upregulation of ARG impeded the
translation of NOS2 mRNA and the stability of NOS2 protein in myeloid cells (El-Gayar
et al., 2003).
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In addition to NOS and ARG, arginine can be cleaved by arginine decarboxylase
(ADC) to produce agmatine that inhibits NOS (Morris Jr, 2004; Satriano, 2004; Halaris
and Plietz, 2007). Consistent with decreased expression of NOS2, we found an increased
mRNA expression of ADC in finished vs. growing steers. Combined, these data suggest a
decreased capacity for NO production when beef steers compositional gain shifts from
lean to lipid phenotype. In addition to ADC, anabolic growth promoters, such as growth
hormone (GH), modulate arginase and NOS activities (Elsasser et al., 2008). Daily
injection of GH decreases arginase activity (Elsasser et al., 1996) and increases the
enzymatic activity of NOS (Elsasser et al., 2007). Although the mRNA expression of GH
did not differ between growing and finished steers, the microarray data showed a
decreased expression of growth hormone receptor (GHR). Thus, combined with increased
mRNA expression of ARG2 and decreased expression of NOS2, these results suggest
that finished steers have a greater capacity of channeling of arginine toward urea
synthesis instead of generation of NO, a pro-inflammatory mediator.
Upregulation of ARG can lead to low arginine concentration in the local cellular
environment. When arginine concentrations are suboptimal, ARG shifts the function of
NOS2 from the production of mostly NO to mostly superoxide (O2-) (Xia and Zweier,
1997; Xia et al., 1998). That is, instead of producing NO, NOS2 transfers electrons to the
co-substrate oxygen (O2) and produces O2–, which reacts with other molecules to
generate reactive nitrogen species and reactive oxygen species (Bronte and Zanovello,
2005). Consequently, these reactive species cause damage to lipids, protein and DNA and
drive cellular dysfunction. Thus, it is critical to maintain an optimal intracellular arginine
concentration to support the normal physiological functions in animal body.
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Induction of ARG expression in the cells is closely linked to upregulation of the
CAT family membrane transporters that augment L-arginine transport (Schwartz et al.,
2002). The cationic amino-acid transporters CATs are integral membrane proteins that
transfer L-arginine, L-lysine and L-ornithine from extracellular to intracellular
compartment (Cunningham and Albritton, 1991). Our microarray data showed the mRNA
expression of CAT-2 (SLC7A2), the main arginine transporter (Elsasser et al., 2008), was
increased in finished vs. growing steers, suggesting a greater capacity of delivering
arginine into the cells to compensate for arginine degradation by intracellular ARG (or
NOS) when beef steers develop from growing to finished stages. As we mentioned
earlier, finished steers have increased capacities for arginine biosynthesis. Combined,
these results suggest finished steers have developed a capacity to compensate for arginine
degradation by increasing the mRNA expression of enzymes (ASS and ASL) responsible
for arginine synthesis and inducing the expression of arginine membrane transporters
(CAT2), to prevent excessive production of reactive species and maintain normal
physiological functions.
Excessive production of reactive species can cause oxidative stress that lead to
suboptimal animal growth. To protect against oxidative damage, glutathione functions as
the most abundant antioxidant to maintain cellular redox potential (Aoyama et al., 2008;
Forman et al., 2009; Schmidt and Dringen, 2012). Glutathione synthesis involves two
consecutive ATP-requiring enzymatic reactions: formation of γ-glutamylcysteine from
glutamate and cysteine by γ-glutamylcysteine ligase (GCLC and GCLM) and formation
of glutathione from γ-glutamylcysteine and glycine by glutathione synthase (GSS). The
rate-limiting enzyme GCL is composed of a catalytic subunit (GCLC) and a modifier
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subunit (GCLM) (Yang et al., 2002; Franklin et al., 2009). GCLC catalyzes γglutamylcysteine synthesis, whereas GCLM modulates GCLC by lowering the Km for
glutamate and increasing the Ki for the feedback inhibition of GCL by glutathione
(Richman and Meister, 1975; Huang et al., 1993a; Huang et al., 1993b; Chen et al.,
2005). Consequently, the holoenzyme GCL more efficiently catalyzes γ-glutamylcysteine
synthesis and is subject to less GSH feedback inhibition compared to GCLC. The second
step of GSH synthesis from γ-glutamylcysteine and glycine is catalyzed by glutathione
synthase (GSS). Although glutathione synthase is usually not considered to be ratelimiting, increased glutathione synthase expression can further promote GSH production
in rat hepatocytes (Huang et al., 2000; Dalton et al., 2004). Our previous RT-PCR data
(Chapter 5) showed a decreased mRNA expression of GCLC and GSS in finished vs.
growing steers, whereas GCLM did not differ. In contrast, the microarray data showed a
decreased mRNA expression of GSS between finished vs. growing steers, although
GSLC and GCLM did not differ. The incongruences between microarray and real-time
RT-PCR analyses may be due to the different regions of DNA sequences used for primer
design for RT-PCR. Combined, this data suggest a decreased capacity for GSH synthesis
when beef steers compositional gain shifts from lean to lipid phenotype.
GSH modulates diverse cellular processes. For example, GSH is involved in
redox signaling, detoxification of xenobiotics and regulates cell proliferation, apoptosis
and immunity (Meister and Anderson, 1983; Suthanthiran et al., 1990; Ballatori et al.,
2009; Lu, 2009; Pallardó et al., 2009; Liu and Pravia, 2010). Glutathione conjugate with
xenobiotics via glutathione-S-transferases (GST) for the purpose of detoxification
(Schmidt and Dringen, 2012). Our microarray data showed an increased mRNA
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expression of GST1, GST2 and MGST3 (microsome GST3) in fininshed vs. growing
steers, indicating a greater capacity of detoxification of blood and waste removal.
Several GSH related enzymes guard cells against oxidative injury by scavenging
reactive oxygen species and nitrogen radicals. In the cytosol and mitochondria,
superoxide dismutase (SOD) catalyzes the dismutation of highly reactive superoxide
radical (O2-) into less reactive hydrogen peroxide (H2O2) (Salvi et al., 2007). H2O2 and
glutathione then can be converted to water and oxidized glutathione (GSSG) catalyzed by
glutathione peroxidases (GPXs) (Fernandez Checa et al., 1997; Garcia Ruiz and
Fernandez Checa, 2006; Lu, 2013). Among the GPXs enzymes, GPX1 is the most
abundant isoform expressed in liver, accounting for more than 90% of total GPX activity
(de Haan et al., 1998; Lei, 2001). Consistent with previous RT-PCR data of decreased
GPX1 in finished vs. growing steers (Chapter 5), our microarray data showed an
increased mRNA expression of SOD3 but decreased expression of GPX1, suggesting
elevated H2O2 production and a decreased capacity of clearance of reactive species in
finished vs. growing steers.
Nitric oxide and superoxide anion are pro-inflammatory mediators. Recognizing
that finished steers have less capacity for NO production but greater potential of
converting highly reactive O2- into less reactive H2O2 prompted us to determine whether
the inflammatory responses change when beef steers compositional gain shifts from lean
to lipid phenotype. Among the top 7 canonical signaling pathways, several
immunological signaling pathways (calcium-induced T lymphocyte apoptosis, leukocyte
extravasation signaling and macropinocytosis signaling, etc.) were inhibited in finished
vs. growing steers. Consistently, the microarray data showed a decreased mRNA
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expression of genes (NOS2, SOCS2, CCL2, IL6R, TLR3) involved in inflammatory
responses and an increased expression of inflammation resolution genes (CRP and SAA3,
SERPINA14) (Suffredini et al., 1999; Foley et al., 2012), indicating a decreased
inflammatory response in finished vs. growing steers. These findings are inconsistent
with the previous reports that increased inflammation was found when non-ruminants
such as mice and human develop from lean to obese phenotype (Zeyda and Stulnig,
2009). However, our findings that finished steers have a reduced expression of hepatic
GPX1 in concomitance with decreased inflammatory response are consistent with recent
studies that hepatic GPX1 knockout mice were protected from inflammation and fibrosis
(Loh et al., 2009; Haas and Staels, 2016; Merry et al., 2016). Because GPX1 acts
primarily to attenuate insulin signaling, loss of hepatic GPX1 is beneficial in the context
of inflammation and insulin resistance (Haas and Staels, 2016).

Carbohydrate Metabolism
Liver is a major organ for glycolysis and glycogen synthesis, which help to
regulate blood glucose level in animal body. For glycolysis, the two critical regulatory
steps are catalyzed by phosphoglycerate kinase (PGK) and pyruvate kinase (PK)
(Newsholme and Gevers, 1967). PGK catalyzes the enzymatic transfer of a phosphate
group from 1,3-bisphosphoglycerate to ADP, forming ATP and 3-phosphoglycerate. The
final step of glycolysis pathway is catalyzed by PK, which converts phosphoenolpyruvate
into a molecule of pyruvate and a molecule of ATP. Our microarray data showed a
decreased mRNA expression of PGK1 and PKM2 in finished vs. growing steers,
suggesting the capacity for glycolysis was inhibited when beef steers compositional gain
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shifts from lean to lipid phenotype.
In the liver, the two key enzymes involved in glycogen synthesis are glycogenin
(GYG) and glycogen synthase (GYS) (Berg, 2012). Glycogen is initially synthesized
from UDP-glucose by glycogenin (GYG) to produce glucosyl-glycogenin. Subsequently,
the enzyme glycogen synthase (GYS) uses UDP-glucose to lengthen the glycogen chain.
Our microarray data showed an increased mRNA expression of GYG2 and GYS2 in
finished vs. growing steers, suggesting the capacity for glycogen synthesis was
stimulated when beef steers compositional gain shifts from lean to lipid phenotype.

Lipid Metabolism
In addition to adipose tissue, the liver is the principle site for lipid metabolism.
Fatty acid from the blood taken up by the liver can either be broken down to provide
energy via beta-oxidation, or be used as a substrate for triglyceride synthesis and lipid
storage. The first step of beta-oxidation of the fatty acid is mediated by acyl-CoA
dehydrogenase (ACAD). After hydration and oxidation by NAD+, the intermediate
product beta-ketoacyl CoA is subsequently cleaved by acetyl-CoA acyltransferase
(ACAA) to produce acetyl-CoA and acyl-CoA (Schulz, 1991). Our microarray data
showed an increased mRNA expression of ACADL (acyl-CoA dehydrogenase, long
chain) and ACAA1, suggesting an increased capacity for beta-oxidation in finished vs.
growing steers.
Growth hormone plays essential roles in mediating hepatic lipid metabolism
(Davidson, 1987; Møller and Jørgensen, 2009; Vijayakumar et al., 2010). Deletion of the
hepatic growth hormone receptor (GHR) gene in mice resulted in enhanced intrahepatic
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triglyceride synthesis and decreased efflux from the liver (Fan et al., 2009). To maintain
the normal lipid metabolism in the liver, lysosomal acid lipase (LIPA) functions to
hydrolyze triglyceride and cholesteryl esters. Deficiency of LIPA leads to massive
storage of triglyceride and cholesteryl esters in the liver of a mouse model (Du et al.,
2001). Our microarray data showed a decreased mRNA expression of GHR and LIPA in
finished vs. growing steers, suggesting increased lipid storage in the liver when beef
steers compositional gain shifts from lean to lipid phenotype.

In summary, the results of this transcriptomic study extended the previous
findings that shifts in hepatic nitrogen metabolism are associated with the change in
whole-body compositional gain of growing vs. finished beef steers (Chapter 4 and 5).
The changes in relative mRNA abundance putatively represent parallel shifts in
functional capacities for (1) arginine synthesis and metabolism, (2) downregulation of
upstream regulators of high-affinity Glu transporters, (3) decreased antioxidant capacity,
(4) altered inflammatory responses, and (5) altered carbohydrate and lipid metabolism.
Although not further evaluated in this manuscript, transcriptomic analysis identified that
calcium induced-T lymphocytes apoptosis pathway was the top canonical signaling
pathway affected when beef steers compositional gain shifts from lean to lipid phenotype.
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32

28

Leukocyte Extravasation
Signaling

Hepatic Fibrosis /
Hepatic Stellate Cell
Activation

Gene
Symbol
CD3E,ITPR2,CD4,CHP1,HDAC1,ATP2A3,CABIN1,CD3G,PRKCD,
HLA-DMB,PRKCE,NFATC2, and PRKCB
TCF4,UBASH3B,CDC23,PTPN12,PRKAG1,NTN1,PTPRF,PTEN,
PTPRC,GNB1,PDE7B,GLI3,TGFB1,NGFR,PRKCE,ATF4,PPP1CA,
CDC16,CDC25A,YWHAG,GNAS,YWHAE,ITPR2,YWHAB,
PDE10A,MAP3K1,PTCH1,CHP1,PTP4A1,GYS2,GNAI2,PDE8A,
ADCY9,PRKCD,RHOA,CREM,ADD1,ANAPC5,NFATC2,ADCY7,
PTPN21,PRKCB, and AKAP1
RAC2,ABLIM3,CHP1,RAC1,NFATC2,ABLIM1,NTN1, and
PRKAG1
RAC2,MMP14,PIK3R1,CTNNA1,CXCL12,RAPGEF4,TXK,CLDN4,
EZR,CYBB,PRKCE,FRS2,ITK,ACTB,RAC1,RDX,MMP2,GNAI2,
ITGB2,WIPF1,ITGAM,ACTA2,GAB1,CDH5,CDC42,PRKCD,
RHOA,FER,PECAM1,CLDN14,CTTN, and PRKCB
CCR5,CTGF,MYH9,CXCR3,CCL5,PDGFC,FAS,COL1A2,TGFB1,
HGF,NGFR,PDGFRA,ECE1,SERPINE1,STAT1,TNFRSF1B,
COL27A1,PDGFRB,COL4A1,IL6R,MMP2,COL1A1,ACTA2,
COL6A3,CSF1,CCL21,and EDNRA,CD14
PIK3R1,RAC1,PDGFC,CSF1R,ITGB2,RAB5A,GAB1,CDC42,CSF1,
PRKCD,HGF,RHOA,CD14,PRKCE,FRS2, and PRKCB
MCM6,RPA3,PRIM1,ORC3,ORC5,POLA2,RPA1, and CDK2
0.26

0.25

0.47

0.24

Ratio2
0.41

3.72 × 10-3

2.45 × 10-3

2.09 × 10-3

1.66 × 10-3

P-value3
5.24 × 10-4

Macropinocytosis
16
0.31
4.07 × 10-3
Signaling
Cell Cycle Control of
8
0.42
4.89 × 10-3
Chromosomal
Replication
1
The number of genes (listed in the “Symbol” column) that are associated with the particular cell signaling pathway.
2
The ratio is calculated as the number of genes in a given pathway that meet cutoff criteria (the ANOVA P-value for the differential
expression between growing and finished steers groups is less than 0.01), divided by total number of genes that make up that pathway.

8

43

Number
13

Netrin Signaling

Cell signaling pathway
Calcium-induced T
Lymphocyte Apoptosis
Protein Kinase A
Signaling

1

Table 6. 1 The top 7 Ingenuity Pathways Analysis–identified canonical cell signaling pathways of genes differentially expressed by
liver tissue of finished vs. growing steers
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The P-value was calculated for the significance of the association with respect to the pathway eligible genes in this experiment data
set and in the reference set of genes in the Ingenuity Knowledge Base (Ingenuity Pathway; Ingenuity Systems, Inc., Redwood City,
CA) using the right-tailed Fisher exact test.

3
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2
2
3
3
3

GDP-mannose Biosynthesis

Glutamine Degradation I

Citrulline Biosynthesis

Citrulline-Nitric Oxide Cycle

Oleate Biosynthesis II (Animals)

SCD,FADS2, and FADS1

ASS1,NOS2, and ASL

GLS,OAT, and GLS2

GLS and GLS2

GPI and PMM2

GLS,ASS1,OAT,NOS2,GLS2, and ASL

Gene
Symbol
ASS1,OAT,GLUD1, and ASL

0.50

0.60

0.60

1.00

1.00

0.55

Ratio2
0.80

5.13 × 10-2

2.88 × 10-2

2.88 × 10-2

2.40 × 10-2

2.40 × 10-2

3.09 × 10-3

P-value3
2.51 × 10-3

2

The number of genes (listed in the “Symbol” column) that are associated with the particular metabolic pathway.
The ratio is calculated as the number of genes in a given pathway that meet cutoff criteria (the ANOVA P-value for the differential
expression between growing and finished steers groups is less than 0.01), divided by total number of genes that make up that pathway.
3
The P-value was calculated for the significance of the association with respect to the pathway eligible genes in this experiment data
set and in the reference set of genes in the Ingenuity Knowledge Base (Ingenuity Pathway; Ingenuity Systems, Inc., Redwood City,
CA) using the right-tailed Fisher exact test.

1

6

Number
4

Superpathway of Citrulline Metabolism

Metabolic pathway
Arginine Biosynthesis IV

1

Table 6. 2 The top 7 Ingenuity Pathways Analysis–identified canonical metabolic pathways of genes differentially expressed by liver
tissue of finished vs. growing steers
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Transcript ID
Amino acid
metabolism
12827732
12754174
12742653
12821398
12861747
12689697
12777203
12821712
12856863
12816513
12780778
12698356
12825466
Carbohydrate
metabolism
12782531
12907457
12861425
12694611
12907613
12893846
12749256
12718657

Gene name

Glutamate dehydrogenase 1
Glutamic pyruvate transaminase (alanine aminotransferase) 2
Serine dehydratase
Glutamic-oxaloacetic transaminase 1
Glutaminase 2 (liver, mitochondrial)
Arginase, type II
Glutaminase
Ornithine aminotransferase
Lactate dehydrogenase B
Argininosuccinate lyase
Arginine decarboxylase
Argininosuccinate synthase 1
Solute carrier family 7 (cationic amino acid transporter)

Pyruvate dehydrogenase kinase, isozyme 1
Glycogenin 2
Glycogen synthase 2 (liver)
Pyruvate kinase, muscle
Phosphoglycerate kinase 1
Aldolase B, fructose-bisphosphate
Glucose-6-phosphate isomerase
Phosphofructokinase, platelet

Gene symbol

GLUD1
GPT2
SDS
GOT1
GLS2
ARG2
GLS
OAT
LDHB
ASL
ADC
ASS1
SLC7A2

PDK1
GYG2
GYS2
PKM2
PGK1
ALDOB
GPI
PFKP

1.60
1.30
1.31
-1.42
-1.19
1.52
-1.15
-1.20

-1.38
1.60
5.14
2.54
1.99
1.97
-1.37
3.52
1.41
1.42
1.15
1.17
3.19

Change1

Table 6. 3 Selected microarray-identified differentially expressed genes in livers of finished vs. growing steers

0.00020839
0.00216259
0.00136703
3.58E-05
0.00264192
8.39E-05
0.00910694
0.00207618

1.41E-05
2.21E-05
3.73E-05
0.000128909
0.000133952
0.00289828
0.00405615
0.00549181
0.00877977
0.00986064
0.0152873
0.000475252
1.22E-05

P-value
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12801151
12889017
12821369
12834425
12882089
12819631
12831035
12784162
12773229
12819574
12798684
12814618
Antioxidant
capacity
12794332
12871557
12720012
12748091
12842911
12847485

Lipase A, lysosomal acid, cholesterol esterase
Diacylglycerol kinase, alpha 80kDa
Lipin 1
ATP-binding cassette, sub-family G (WHITE), member 8
Glycerol kinase
Apolipoprotein E
1-acylglycerol-3-phosphate O-acyltransferase 1
(lysophosphatidic)
Lipoprotein lipase
Stearoyl-CoA desaturase (delta-9-desaturase)
Fatty acid desaturase 1
Perilipin 3
Acyl-CoA synthetase long-chain family member 5
Fatty acid desaturase 2
Acyl-CoA dehydrogenase, long chain
Acyl-CoA synthetase family member 2
Peroxisome proliferator-activated receptor gamma
Acetyl-CoA acyltransferase 1
MLX interacting protein-like /ChREBP

Glutathione peroxidase 1
Superoxide dismutase 3, extracellular
Glutathione synthetase
Gamma-glutamyltransferase 1
Glutathione S-transferase M1
Glutathione S-transferase M2

AGPAT1
LPL
SCD
FADS1
PLIN3
ACSL5
FADS2
ACADL
ACSF2
PPRC1
ACAA1
MLXIPL

GPX1
SOD3
GSS
GGT1
GSTM1
GSTM2

Table 6.3 (continued)
Lipid metabolism
12821141
LIPA
12864719
DGKA
12707198
LPIN1
12699429
ABCG8
12907479
GK
12749283
APOE

-1.28
2.19
-1.27
1.18
1.42
1.55

-1.30
-1.45
-2.05
-2.64
1.30
-1.28
-1.57
1.46
-1.28
1.69
1.26
-1.43

-1.61
-1.42
3.10
-2.49
3.18
1.28

0.00335333
0.00229009
0.00236201
0.00830121
0.0215303
0.00169021

5.06E-06
0.000110604
0.00951053
1.17E-05
0.00968798
0.00669406
0.00577223
0.00186696
0.00803167
0.00606396
0.0068521
6.66E-05

0.000174132
0.000445988
0.00337979
0.00126088
0.000189751
2.74E-05
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Table 6.3 (continued)
12843681
MGST3
Microsomal glutathione S-transferase 3
Inflammatory
response
12767532
NOS2
Nitric oxide synthase 2, inducible
12843689
IL6R
Interleukin 6 receptor
12857394
SOCS2
Suppressor of cytokine signaling 2
12738690
TNFRSF1B
Tumor necrosis factor receptor superfamily, member 1B
12767695
NGFR
Nerve growth factor receptor
12767023
CCL2
Chemokine (C-C motif) ligand 2
12823479
TLR3
Toll-like receptor 3
12883076
CD14
CD14 molecule
12819033
FAS
Fas (TNF receptor superfamily, member 6)
12832640
SAA3
Serum amyloid A 3
12839334
CRP
C-reactive protein, pentraxin-related
1
Data are expressed as fold change in finished vs. growing steers.

0.00928388

0.00601685
1.99E-07
5.22E-05
5.25E-05
0.000230669
0.00414764
0.00307493
0.00686066
0.00981881
0.000906157
0.0013692

1.19

-1.18
-1.45
-2.91
-1.39
-1.36
-1.63
-1.60
-1.29
-1.22
2.15
1.25
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protein kinase C, delta
protein kinase C, epsilon
mammalian target of rapamycin
(serine/threonine kinase)
protein kinase, AMP-activated, alpha 1
catalytic subunit

PRKCD
PRKCE
mTOR

PRKAA1

PRKCA

SGK1
SLC1A1

AKT3

JAK2
PDPK1

PIK3R1

PIK3CG

PDGFRB

Gene Name
platelet-derived growth factor receptor, alpha
polypeptide
platelet-derived growth factor receptor, beta
polypeptide
phosphoinositide-3-kinase, catalytic, gamma
polypeptide
phosphoinositide-3-kinase, regulatory
subunit 1 (alpha)
Janus kinase 2
3-phosphoinositide dependent protein kinase1
v-akt murine thymoma viral oncogene
homolog 3 (protein kinase B)
serum/glucocorticoid regulated kinase 1
Solute Carrier Family 1 (Neuronal/Epithelial
High Affinity Glutamate Transporter, System
Xag), Member 1
protein kinase C, alpha

Gene
PDGFRA

-1.19

-1.29
-1.22
1.11

-1.08

1.07
-1.30

-1.22

-1.12
1.12

-1.18

-1.42

-1.26

0.005

0.009
0.002
0.012

0.312

0.716
0.178

0.001

0.145
0.018

0.006

0.001

0.001

Microarray1
Change
P-value
-1.38
6.67E-05

1.03

0.89

1.03

1.14
0.90

0.88

1.06
1.01

1.02

1.06

1.05

0.79

0.83

0.94

1.42
0.83

0.84

0.75
1.40

0.92

0.69

1.28

0.070

0.769

0.517

0.495
0.769

0.597

0.067
0.001

0.368

0.037

0.199

Real-time RT-PCR
Finished2
Growing
P-value
0.94
0.85
0.204
2

Table 6. 4 Comparison of microarray and real-time RT-PCR identification of EAAC1 regulators in livers of finished vs. growing
steers1
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Table 6.4 (continued)
PRKAG1
protein kinase, AMP-activated, gamma 1
1.23
0.005
1.04
1.63
0.005
non-catalytic subunit
PRKAR2B
protein kinase, cAMP-dependent, regulatory,
-1.28
0.008
1.03
0.84
0.072
type II, beta polypeptide
1
Data are expressed as fold change in finished relative to growing steers.
2
The relative mRNA levels of glutathione-synthesizing and metabolizing protein expressed by liver of growing (n = 8, BW = 301 kg)
and finished (n = 8, BW = 576 kg) steers are presented as normalized to the relative expression level of three reference genes: TATAbox binding protein (TBP), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Tyrosine 3-Monooxygenase (YWHAZ).

Figure 6. 1 Principle component (PC) analysis of microarray transcriptome analysis of 16
liver samples from growing (lean, n = 8, red dots) and finished (lipid, n = 8, blue dots)
Angus steers. The red and blue dots represent linear combinations of the relative
expression data, including expression values and variances, of the 26,773 gene transcripts
in each Bovine GeneChip. The center dot (centroid) for each treatment groups represents
the overall treatment expression pattern. The relative relationship of genes with either a
high (13.3%, PC #1, x-axis), median (9.55%, PC#2, y-axis), and low (7.71%, PC#3, zaxis) range of variance are mapped.
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Figure 6. 2 Hierarchical cluster analysis of the 1100 genes selected as being differentially
expressed (ANOVA P values of < 0.01 and false discovery rates of < 10%) by the liver of
finished (lipid, n = 8) vs. growing (lean, n = 8) steers. The expression level for each gene
transcript was standardized to mean of 0 and scale to SD of 1, which is the default setting
of the Partek Genomics Suite software. As indicated by the legend color box, gray color
in the middle represents the mean value, 0, red color represents gene expression levels
above the mean expression whereas blue color denotes expression below the mean. The
intensity of the color reflects the relative intensity of the fold change.
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Figure 6. 3 The sequences of the real-time RT-PCR products (5’ to 3’ orientation).
Within a sequence, two underlines indicate the forward and reverse primer positions,
respectively.
Akt3: NM_001191309.1
TGGGTTCAGAAGAGGGGAGAATATATAAAAAACTGGAGGCCAAGATATTTCCTTTTG
AAGACAGATGGCTCATTCATAGGATATAAAGAGAAACCCCAAGATGTGGATTTACCT
TATCCCCTCAACAACTTTTCAGTAGCAAAATGCCAGTTAATGAAAACAGAACGACCA
AAGCCAAACANA
Jak2: XM_015464498.1
TGCCGGTATGACCCTCTACAAGACAATACTGGGGAGGTGGTGGCTGTGAAAAAGCTCCAGCA
CAGTACTGAAGAGCACCTCAGAGACTTCGAAAGAGAAATTGAAATCCTTAAATCCTTGCAGC
ATGACAACATTGTAAAATACAAAGGAGTCTGCTACAGTGCTGGCCGGCATAATCTAAGATTA
ATTATGGAGTATTTACCATATGGAAGTTTACGAGACTATCTCCAAAAACATAAAGAACGGATA
GATCATAAAAAACTTCTGCAATACACATCTCAGATATGCAAGGGGATGGAATATCTTGGTACA
AAAAGATATATCCACAGGGATCTGGNAANAACAAGG

Mtor: XM_015466778.1
CGGCAACTTGACCATCCTCTGCCAACGGTTCACCCCCAGGTGACCTACGCCTACATG
AAAAATATGTGGAAGAGCGCCCGCAAGATTGATGCCTTCCAGCACATGCAGCACTTT
GTTCAGACCATGCAGCAGCAAGCCCAGCATGCCATCGCCACCGAGGACCAGCAGCA
CAAGCAGGAGCTGCACAAGCTCATGGCCCGATGTTTCCTGAAACTCGGGGAGTGGCA
GCTGAACCTACAGGGCATCAACGAGAGCACGATCCC
Pdgfra: NM_001192345.2
GTGGAACACTGCTGTCCACTCTGAATTCATGCATGACCACGTTGACTATGGCTTTCAA
AGTTGTGAAAGTAAATTCAATTGGCGGATTATAAAGGAAAAGCGGGACGCCTATGT
GAGCCGCCTGAACACCATCTATCAAAATAATCTAACCAAGTCCCACATAGACATCAT
CCATGGCCATGCAGCATTCACGTGCGATCCTCAGCCCACAGTGAGGTCAACGGGAAA
AAATACACCGCTCCTCACATCCTGATC
Pdgfrb: NM_001075896.2
AGGCATCAGCAGCAAGGATACCATGTGGCTTCCGAGCGCCATGCAAGCTGTTGTCCT
CAAAGGCCGGGTGCTATTGCTGCCCCTGCTGTTTCTGCTGGGACCACAGGCCTCCTG
GGGCCTGGCCATCATACCCCCGGGGCCAGAACTTGTCCTCAACCTCTCCAGCACCTTT
GTCCTGACCTGCTCGGGCCCAGCTCCAGTGGTGTGGGAACGGATGTCCCAGAAACCC
CCCCAGGAAATGACCGAGACCCAGG
Pdpk1: XM_015469224.1
CAATGTGACTGAGGTGGTCCGCAACATGACCTCCGAGTTCTTTGCCGCCAGCTCTGG
GCCCGGATCTCCGACAGCACCACTCACCCAGCCTCCTACTACGAGCCTGAGTTCTAC
ACGCCAGACGGTGGGGGCACCGCCCACCTGTCGGTGGTCTCGGAGGACGGCAGCGC
TGTGTCGGCCACCAGCACCATCAACCTCTACTTCGGTTCCAAGGTGCG
Pik3cg: NM_001102125.2
CTGCGCCTAGACATGCTTATTCTACAGATTCTACGAATTATGGAGTCCATTTGGGAGA
CTGAATCTTTGGATCTGTGCCTCCTGCCATATGGTTGCATTTCAACTGGTGACAAAAT
AGGAAACCACCAGCACGAACCTGGAAAATAACCTTCTGGTTGAGAAAGCTCTCTACC
CTCCACTGAACAAAGACACAGCCATTCCTCCTCTGGGTCCGGTGCTTGGTTCCAGTTC
ACA

148

Pik3r1: NM_174575.1
AGAGGACATTGACTTGCACCTGGGGGACATATTGACTGTGAACAAAGGGTCCTTAGT
CGCTCTTGGATTCAGTGAGGACAGGAAGCCAAGCCTGAAGAAATTGGCTGGTTAAAT
GGTATAACGAGACGACAGGGGAGAG
Prkaa1: NM_001109802.2
TTTGCGTGTTCGGAGGAAGAATCCTGTGACAAGTACATACTCCAAAATGAGTCTGCA
GTTATACCAAGTGGATAGTAGAACGTATTTACTGGATTTCCGAAGTATTGATGATGA
AATTACTGAAGCCAAATCAGGGACTGCTACGCCACAGAGATCGGGCTCAGTTAGCA
ACTATCGAGCTTGCCA
Prkag1: NM_174586.2
GATGAGAAAGGGCGTGTGGTGGACATCTACTCCAAGTTTGATGTTATCAACCTGGCA
GCAGAAAAGACCTACAACAACCTAGATGTGTCAGTGACCAAAGCCCTGCAACATCG
ATCACATTACTTTGAGGGTGTTCTCAAGTGCTACCTGCATGAGACTCTGGAAACCATC
ATCAATAGGCTGGTAGAAGCAGAGGTTCACCGACTT
Prkar2b: NM_174649.2
GATGAGAAAGGGCGTGTGGTGGACATCTACTCCAAGTTTGATGTTATCAACCTGGCA
GCAGAAAAGACCTACAACAACCTAGATGTGTCAGTGACCAAAGCCCTGCAACATCG
ATCACATTACTTTGAGGGTGTTCTCAAGTGCTACCTGCATGAGACTCTGGAAACCATC
ATCAATAGGCTGGTAGAAGCAGAGGTTCACCGACTT
Prkca: NM_174435.1
CGGATGAANAGCTGCACGTCACAGTACGAGACGCGAAAAACCTAATCCCTATGGAT
CCAAATGGGCTTTCAGATCCTTACGTGAAGCTGAAGCTTATTCCTGACCCCAAGAAC
GAGAGCAAACAGAAAACCAAGACCATCCGCTCGACGCTGAACCCCCGGTGGGACGA
GTCCTTCACGTTCAAATTAAAACCTTCTGATAAAGACCGGCGACTGTCCGTGGAAAT
CTGGGACTGGGATCGAACCACACGGAACGACTTCATGGGGTCCCTTTCCTTTGGGGT
CTCGGAGCTGATGAAGATGCC
Prkce: NM_001111120.2
CAGACTTTCCCTTCGACCCCTACATCGCCCTCAACGTGGACGACTCGCGCATCGGCC
AAACGGCCACCAAGCAGAAGACCAACAGCCCGGCCTGGCACGACGAGTTCGTCACT
GATGTGTGCAACGGGCGCAAGATCGAGTTGGCTGTCTTCCACGATGCCCCCATCGGC
TACGATGACTTCGTGGCCAACTGCACCATCCAGTTTGAGGAGCTGCTGCAGAACGGG
AGCCGTCACTTCGAGGACTGGATTGATCTGGAGCCAGAAGGAAGAGTGTATGTGATC
ATTGATCTCTCGGGGTCGTCAGGTAAAGCCCCTAA
Sgk1: NM_001102033.1
CTCCAGAATGAGAGGCATGGTAGCAATTCTCATCGCTTTTATGAAACAGAGAAGGAT
GGGCCTGAATGACTTTATTCAGAAGATTGCCAATAACTCCTATGCATGCAAACACCC
TGAAGTTCAGTCCATTTGAAATCTCCCCACCTCAGGAACCTGAGCTTATGAATGCCA
ACCCTTCTCCTCCACCAAG
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CHAPTER 7. Summary and Conclusions

Improvement of feeding regimens for production animals has been hindered by a
lack of fundamental knowledge about how the capacity to regulate nutrient absorption
across cell membranes affects the function of nutrient metabolizing enzymes. The overall
objective of this dissertation was to determine how Glu transport capacity is regulated to
support peripheral tissue metabolism, and to identify the metabolic shift when beef steers
compositional gain shifts from lean to lipid phenotype.
In chapter 4, this study aimed to determine if hepatic activities and protein content
of system X-AG transporter (EAAC1, GLT-1) and system X-AG regulatory proteins
(GTRAP3-18, ARL6IP1), and glutamine synthetase (GS) activity and content, differed as
beef steers transitioned from predominantly-lean (growing) to –lipid (finished) tissue
accretion phases. There are three salient observations from this study. To our knowledge,
this is the first report to describe a decrease in glutamate transport capacity in the liver as
cattle develop from lean to finished phenotypes. Second, the decreased content of
EAAC1 and system X-AG activity in hepatic apical membranes was concomitant with
decreased hepatic GS activity. Both of these findings appear incongruent with accepted
understandings for nonruminants. That is, for nonruminants, it has been argued that Na+dependent Glu uptake does not limit pericentral hepatocyte GS activity and that GS
activity is relatively insensitive to change in various metabolic states (as reviewed by
Watford, 2000). Thus, our findings may represent another difference in hepatic Gln
metabolism between ruminants and nonruminats. Third, a negative functional
relationship of system X-AG activity and transporter content to GTRAP3-18 and ARP6IP1
content outside of brain tissue/cultured cells, was first identified in finished vs. growing
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steers. In summary, these results indicate the metabolic shift in nitrogen metabolism
when beef steers compositional gain shifts from lean to lipid phenotype. Moreover, future
research is warranted to measure the ammonia concentration in the blood of growing and
finished steers, and to investigate the mechanisms of how GTRAP3-18 regulates blood
ammonia concentrations when steers develop from growing to finished production stage.
In addition to liver, skeletal muscle and adipose tissues play important roles in
maintaining whole-body Glu and N homeostasis via Glu transporters and Glu-utilizing
enzymes. The goal of Chapter 5 was to determine if the content of high affinity Glu
transporter EAAC1, GTRAP3-18 (an inhibitor of EAAC1), ARL6IP1 (an inhibitor of
GTRAP3-18), glutamine synthase (GS) and glutathione (GSH) changes in longissimus
dorsi (LM) and subcutaneous adipose tissue (SF), as it does in the liver, when steers
develop from predominately lean to lipid growth phases. There are two major findings in
Chapter 4. First, the negative regulatory relationship between GTRAP3-18 and ARL6IP1
with EAAC1 and GS expression, which exists in liver, does not exist in LM and SF of
fattened cattle. Thus, novel regulators may contribute to the differential expression of
EAAC1, GS and GSH content in LM and SF. Second, the antioxidant capacity in LM and
SF changes and differs as steer compositional gain shifts from lean to lipid phenotype.
These findings provide mechanistic knowledge of how the antioxidant capacity is
achieved in tissues of economic and metabolic importance to fattened cattle. Given the
potentially large economic benefits associated with optimized tissue accretion, future
research is needed to determine if activities of glutamate transport, GS and antioxidant
enzymes change in LM and SF when beef steers develop from growing to finished
production stage.
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To further explore the upstream regulatory machinery of EAAC1, transcriptome
analysis (Chapter 6) was conducted to gain a greater understanding of hepatic metabolic
shifts associated with the change in whole-body compositional gain of growing vs.
finished beef steers. The expression of upstream regulators of EAAC1 was decreased in a
manner consistent with the decreased EAAC1 activity in Experiment 1. Thus, the results
of this transcriptomic study extended the previous findings that shifts in hepatic nitrogen
metabolism are associated with the change in whole-body compositional gain of growing
vs. finished beef steers. In addition to nitrogen metabolism, the changes in relative
mRNA abundance putatively represent parallel shifts in functional capacities for (1)
arginine synthesis and metabolism, (2) decreased antioxidant capacity, (3) altered
inflammatory responses, and (4) altered carbohydrate and lipid metabolism. Although not
further evaluated in Chapter 6, transcriptomic analysis identified that calcium induced-T
lymphocytes apoptosis pathway was the top canonical signaling pathway affected when
beef steers compositional gain shifts from lean to lipid phenotype.
In conclusion, these studies describe novel regulatory relationships of system XAG

in liver and peripheral tissues, and the metabolic mechanisms that control nutrient use

efficiency, as beef steers develop from lean to lipid phenotypes. By understanding the
molecular and cellular mechanisms associated with different phases of growth, this
dissertation provides mechanistic knowledge that can be applied to optimize tissue
protein accretion, resulting in improved carcass quality and diminished animal waste.
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Appendix 1. Examples of SAS Analysis and Outputs

Analysis of mRNA expression of GPX1 in the liver of finished vs. growing steers
(Chapter 4)

1. Representative of SAS editor programming language using Proc glm (mRNA
expression of GPX1 in the liver of finished vs. growing steers) (Chapter 4)
/* Import data */
PROC IMPORT OUT= WORK.liver
DATAFILE= "C:\Users\as_gen\Desktop\SAS\liver.csv"
DBMS=csv REPLACE;
GETNAMES=YES;
DATAROW=2;
RUN;
PROC PRINT DATA=liver;
RUN;
proc means n mean stddev stderr min max print;
by trt;
run;
proc glm DATA=liver plots=diagnostics;
class trt;
model GPX1=trt;
LSMEANS trt/STDERR PDIFF;
run;quit;

2. SAS output
The SAS System
The GLM Procedure

Class Level Information
Class Levels Values
trt

2 LEAN LIPID

Number of Observations Read 16
Number of Observations Used 16
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The SAS System
The GLM Procedure
Dependent Variable: GPX1

Source

DF Sum of Squares Mean Square F Value Pr > F

Model

1

0.35479819

0.35479819

Error

14

0.30090523

0.02149323

Corrected Total 15

0.65570342

16.51 0.0012

R-Square Coeff Var Root MSE GPX1 Mean
0.541096 16.97259
Source DF
trt

0.146606

0.863779

Type I SS Mean Square F Value Pr > F

1 0.35479819

0.35479819

16.51 0.0012

Source DF Type III SS Mean Square F Value Pr > F
trt

1 0.35479819

0.35479819
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16.51 0.0012
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The SAS System
The GLM Procedure
Least Squares Means

trt

GPX1
LSMEAN

Standard H0:LSMEAN=0 H0:LSMean1=LSMean2
Error
Pr > |t|
Pr > |t|

LEAN

1.01269133

0.05183294

<.0001

LIPID

0.71486664

0.05183294

<.0001
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0.0012

158

References

Abd, E. M., K. Okada, M. Goryo, S. Kobayashi, A. Oishi, and J. Yasuda. 2008. Total
glutathione and glutathione reductase in bovine erythrocytes and liver biopsy. The
Journal of veterinary medical science/the Japanese Society of Veterinary Science
70: 861-864.
Adjeitey, C. N.-K., R. J. Mailloux, and M.-E. Harper. 2013. Mitochondrial uncoupling in
skeletal muscle by UCP1 augments energy expenditure and glutathione content
while mitigating ROS production. American Journal of PhysiologyEndocrinology and Metabolism 305: E405-E415.
Akiduki, S., and M. J. Ikemoto. 2008. Modulation of the neural glutamate transporter
EAAC1 by the addicsin-interacting protein ARL6IP1. J. Biol. Chem. 283: 3132331332.
Alderton, W. K., C. E. Cooper, and R. G. Knowles. 2001. Nitric oxide synthases:
structure, function and inhibition. Biochem. J. 357: 593-615.
Ali, N., R. Aligue, and W. H. Evans. 1990. Highly purified bile-canalicular vesicles and
lateral plasma membranes isolated from rat liver on Nycodenz gradients.
Biochemical and immunolocalization studies. Biochem. J. 271: 185-192.
Almilaji, A., T. Pakladok, A. Guo, C. Munoz, M. Föller, and F. Lang. 2012. Regulation
of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR.
Biochem. Biophys. Res. Commun. 421: 159-163.
Anderson, M. E. 1985. Determination of glutathione and glutathione disulfide in
biological samples. Methods Enzymol. 113: 548-555.
Aoyama, K., and T. Nakaki. 2012. Inhibition of GTRAP3-18 may increase
neuroprotective glutathione (GSH) synthesis. Int. J. Mol. Sci. 13: 12017-12035.
Aoyama, K., and T. Nakaki. 2013. Neuroprotective properties of the excitatory amino
acid carrier 1 (EAAC1). Amino Acids 45: 133-142.
Aoyama, K., S. W. Suh, A. M. Hamby, J. Liu, W. Y. Chan, Y. Chen, and R. A. Swanson.
2005. Neuronal glutathione deficiency and age-dependent neurodegeneration in
the EAAC1 deficient mouse. Nat. Neurosci. 9: 119-126.
Aoyama, K., S. W. Suh, A. M. Hamby, J. Liu, W. Y. Chan, Y. Chen, and R. A. Swanson.
2006. Neuronal glutathione deficiency and age-dependent neurodegeneration in
the EAAC1 deficient mouse. Nat. Neurosci. 9: 119-126.
Aoyama, K., F. Wang, N. Matsumura, H. Kiyonari, G. Shioi, K. Tanaka, C. Kinoshita, K.
Kikuchi-Utsumi, M. Watabe, and T. Nakaki. 2012. Increased neuronal glutathione
and neuroprotection in GTRAP3-18-deficient mice. Neurobiol. Dis. 45: 973-982.
Aoyama, K., M. Watabe, and T. Nakaki. 2008. Regulation of neuronal glutathione
synthesis. J. Pharmacol. Sci. 108: 227-238.
Arriza, J., M. P. Kavanaugh, W. A. Fairman, Y.-N. Wu, G. H. Murdoch, R. A. North, and
S. G. Amara. 1993. Cloning and expression of a human neutral amino acid
transporter with structural similarity to the glutamate transporter gene family. J.
Biol. Chem. 268: 15329-15332.

159

Arriza, J. L., S. Eliasof, M. P. Kavanaugh, and S. G. Amara. 1997. Excitatory amino acid
transporter 5, a retinal glutamate transporter coupled to a chloride conductance.
Proceedings of the National Academy of Sciences 94: 4155-4160.
Avissar, N. E., C. K. Ryan, V. Ganapathy, and H. C. Sax. 2001. Na+-dependent neutral
amino acid transporter ATB0 is a rabbit epithelial cell brush-border protein.
American Journal of Physiology-Cell Physiology 281: C963-C971.
Bachhawat, A. K., A. Thakur, J. Kaur, and M. Zulkifli. 2013. Glutathione transporters.
Biochimica et Biophysica Acta (BBA)-General Subjects 1830: 3154-3164.
Bagchi, D., M. Bagchi, E. Hassoun, and S. Stohs. 1996. Cadmium-induced excretion of
urinary lipid metabolites, DNA damage, glutathione depletion, and hepatic lipid
peroxidation in Sprague-Dawley rats. Biol. Trace Elem. Res. 52: 143-154.
Baird, G. D., M. A. Lomax, H. W. Symonds, and S. R. Shaw. 1980. Net hepatic and
splanchnic metabolism of lactate, pyruvate and propionate in dairy cows in vivo
in relation to lactation and nutrient supply. Biochem. J. 186: 47-57.
Baldwin, R. t., K. McLeod, J. McNamara, T. Elsasser, and R. Baumann. 2007. Influence
of abomasal carbohydrates on subcutaneous, omental, and mesenteric adipose
lipogenic and lipolytic rates in growing beef steers. J. Anim. Sci. 85: 2271-2282.
Ballatori, N., S. M. Krance, S. Notenboom, S. Shi, K. Tieu, and C. L. Hammond. 2009.
Glutathione dysregulation and the etiology and progression of human diseases.
Biol. Chem. 390: 191-214.
Ballatori, N., R. Moseley, and J. Boyer. 1986. Sodium gradient-dependent L-glutamate
transport is localized to the canalicular domain of liver plasma membranes.
Studies in rat liver sinusoidal and canalicular membrane vesicles. J. Biol. Chem.
261: 6216-6221.
Bannai, S., and E. Kitamura. 1980. Transport interaction of L-cystine and L-glutamate in
human diploid fibroblasts in culture. J. Biol. Chem. 255: 2372-2376.
Bannai, S., and N. Tateishi. 1986. Role of membrane transport in metabolism and
function of glutathione in mammals. J. Membr. Biol. 89: 1-8.
Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell
116: 281-297.
Bassi, M., E. Gasol, M. Manzoni, M. Pineda, M. Riboni, R. Martín, A. Zorzano, G.
Borsani, and M. Palacín. 2001. Identification and characterisation of human xCT
that co-expresses, with 4F2 heavy chain, the amino acid transport activity system
x-c. Pflügers Archiv 442: 286-296.
Beart, P., and R. O'shea. 2007. Transporters for L‐ glutamate: An update on their
molecular pharmacology and pathological involvement. Br. J. Pharmacol. 150: 517.
Benkoël, L., A. Benoliel, J. Brisse, B. Sastre, P. Bongrand, and A. Chamlian. 1995.
Immunocytochemical study of Na+ K+-ATPase alpha 1 and beta 1 subunits in
human and rat normal hepatocytes using confocal microscopy. Cell. Mol. Biol.
(Noisy-le-grand) 41: 499-504.
Berg, T. 2012. Biochemistry (7th, International ed.). W. H. Freeman. p. 650.
Berger, U., and M. Hediger. 1998. Comparative analysis of glutamate transporter
expression in rat brain using differential double in situ hybridization. Anat.
Embryol. (Berl.) 198: 13-30.

160

Bergman, E. 1990. Energy contributions of volatile fatty acids from the gastrointestinal
tract in various species. Physiol. Rev. 70: 567-590.
Biolo, G., X.-J. Zhang, and R. R. Wolfe. 1995. Role of membrane transport in interorgan
amino acid flow between muscle and small intestine. Metabolism 44: 719-724.
Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916.
Boon, L., W. J. Geerts, A. Jonker, W. H. Lamers, and C. J. Van Noorden. 1999. High
protein diet induces pericentral glutamate dehydrogenase and ornithine
aminotransferase to provide sufficient glutamate for pericentral detoxification of
ammonia in rat liver lobules. Histochem. Cell Biol. 111: 445-452.
Bouligand, J., A. Deroussent, A. Paci, J. Morizet, and G. Vassal. 2006. Liquid
chromatography–tandem mass spectrometry assay of reduced and oxidized
glutathione and main precursors in mice liver. Journal of Chromatography B 832:
67-74.
Boyer, J. L. 1980. New concepts of mechanisms of hepatocyte bile formation. Physiol.
Rev. 60: 303-326.
Boyer, J. L., R. M. Allen, and O. C. Ng. 1983. Biochemical separation of Na+, K+ATPase from a “purified” light density,“canalicular”-enriched plasma membrane
fraction from rat liver. Hepatology 3: 18-28.
Braeuning, A., C. Ittrich, C. Köhle, S. Hailfinger, M. Bonin, A. Buchmann, and M.
Schwarz. 2006. Differential gene expression in periportal and perivenous mouse
hepatocytes. FEBS J 273: 5051-5061.
Brazma, A., P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J.
Aach, W. Ansorge, C. A. Ball, and H. C. Causton. 2001. Minimum information
about a microarray experiment (MIAME)—toward standards for microarray data.
Nat. Genet. 29: 365-371.
Bröer, A., K. Klingel, S. Kowalczuk, J. E. Rasko, J. Cavanaugh, and S. Bröer. 2004.
Molecular cloning of mouse amino acid transport system B0, a neutral amino acid
transporter related to Hartnup disorder. J. Biol. Chem. 279: 24467-24476.
Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-arginine
metabolism. Nature reviews. Immunology 5: 641.
Brosnan, J. T. 2000. Glutamate, at the interface between amino acid and carbohydrate
metabolism. J. Nutr. 130: 988S-990S.
Brosnan, M. E., and J. T. Brosnan. 2009. Hepatic glutamate metabolism: a tale of 2
hepatocytes. Am. J. Clin. Nutr. 90: 857S-861S.
Brown, K., G. Anderson, K. Son, G. Rentfrow, L. Bush, J. Klotz, J. Strickland, J. Boling,
and J. Matthews. 2009. Growing steers grazing high versus low endophyte
(Neotyphodium coenophialum)-infected tall fescue have reduced serum enzymes,
increased hepatic glucogenic enzymes, and reduced liver and carcass mass. J.
Anim. Sci. 87: 748-760.
Burke, Z. D., K. R. Reed, T. J. Phesse, O. J. Sansom, A. R. Clarke, and D. Tosh. 2009.
Liver zonation occurs through a β-catenin–dependent, c-Myc–independent
mechanism. Gastroenterology 136: 2316-2324. e2313.
Burrin, D. G., and B. Stoll. 2009. Metabolic fate and function of dietary glutamate in the
gut. Am. J. Clin. Nutr. 90: 850S-856S.
Cadenas, S., C. Rojas, R. Perez-Campo, M. Lopez-Torres, and G. Barja. 1995. Vitamin E
protects guinea pig liver from lipid peroxidation without depressing levels of

161

antioxidants. The international journal of biochemistry & cell biology 27: 11751181.
Cariappa, R., and M. S. Kilberg. 2006. Plasma membrane domain localization and
transcytosis of the glucagon-induced hepatic system A carrier. American Journal
of Physiology-Endocrinology and Metabolism 263: E1021-E1028.
Carrion, Y., V. Fernandez, and L. A. Videla. 1993. Influence of thyroid hormone
administration on hepatic glutathione content and basolateral γglutamyltransferase ectoactivity in the isolated perfused rat liver. Biochem.
Pharmacol. 45: 2527-2535.
Cederbaum, S. D., H. Yu, W. W. Grody, R. M. Kern, P. Yoo, and R. K. Iyer. 2004.
Arginases I and II: do their functions overlap? Mol. Genet. Metab. 81: 38-44.
Chattopadhyay, M., V. K. Khemka, G. Chatterjee, A. Ganguly, S. Mukhopadhyay, and S.
Chakrabarti. 2015. Enhanced ROS production and oxidative damage in
subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes
subjects. Mol. Cell. Biochem. 399: 95-103.
Chen, Y., H. G. Shertzer, S. N. Schneider, D. W. Nebert, and T. P. Dalton. 2005.
Glutamate Cysteine ligase catalysis dependence on ATP and modifier subunit for
regulation of tissue glutathione levels. J. Biol. Chem. 280: 33766-33774.
Choi, S., C. Park, M. Ahn, J. H. Lee, and T. Shin. 2012. Immunohistochemical study of
arginase 1 and 2 in various tissues of rats. Acta Histochem. 114: 487-494.
Chu, F.-F., J. Doroshow, and, and R. Esworthy. 1993. Expression, characterization, and
tissue distribution of a new cellular selenium-dependent glutathione peroxidase,
GSHPx-GI. J. Biol. Chem. 268: 2571-2576.
Colleluori, D. M., S. M. Morris, and D. E. Ash. 2001. Expression, purification, and
characterization of human type II arginase. Arch. Biochem. Biophys. 389: 135143.
Conde-Aguilera, J. A., L. Lefaucheur, S. Tesseraud, Y. Mercier, N. Le Floc’h, and J. van
Milgen. 2015. Skeletal muscles respond differently when piglets are offered a diet
30% deficient in total sulfur amino acid for 10 days. Eur. J. Nutr.: 1-10.
Cruzat, V. F., L. C. Pantaleão, J. Donato, P. I. H. de Bittencourt, and J. Tirapegui. 2014.
Oral supplementations with free and dipeptide forms of L-glutamine in
endotoxemic mice: effects on muscle glutamine-glutathione axis and heat shock
proteins. J. Nutr. Biochem. 25: 345-352.
Cunningham, J. M., and L. M. Albritton. 1991. Transport of cationic amino acids by the
mouse ecotropic retrovirus receptor. Nature 352: 725.
Dalton, T. P., Y. Chen, S. N. Schneider, D. W. Nebert, and H. G. Shertzer. 2004.
Genetically altered mice to evaluate glutathione homeostasis in health and
disease. Free Radic. Biol. Med. 37: 1511-1526.
Dam, A. D., A. S. Mitchell, J. W. Rush, and J. Quadrilatero. 2012. Elevated skeletal
muscle apoptotic signaling following glutathione depletion. Apoptosis 17: 48-60.
Danbolt, N. C. 2001. Glutamate uptake. Prog. Neurobiol. 65: 1-105.
Davidson, M. B. 1987. Effect of growth hormone on carbohydrate and lipid metabolism.
Endocr. Rev. 8: 115-131.
de Haan, J. B., C. Bladier, P. Griffiths, M. Kelner, R. D. O’Shea, N. S. Cheung, R.
Bronson, M. J. Silvestro, S. Wild, and S. S. Zheng. 1998. Mice with a
homozygous null mutation for the most abundant glutathione peroxidase, Gpx1,

162

show increased susceptibility to the oxidative stress-inducing agents paraquat and
hydrogen peroxide. J. Biol. Chem. 273: 22528-22536.
Decaens, C., M. Durand, B. Grosse, and D. Cassio. 2008. Which in vitro models could be
best used to study hepatocyte polarity? Biol. Cell. 100: 387-398.
Deneke, S. M., and B. L. Fanburg. 1989. Regulation of cellular glutathione. Am. J.
Physiol. Lung Cell Mol. Physiol. 257: L163-L173.
Descalzo, A. M., L. Rossetti, G. Grigioni, M. Irurueta, A. M. Sancho, J. Carrete, and N.
A. Pensel. 2007. Antioxidant status and odour profile in fresh beef from pasture or
grain-fed cattle. Meat Science 75: 299-307.
Du, H., M. Heur, M. Duanmu, G. A. Grabowski, D. Y. Hui, D. P. Witte, and J. Mishra.
2001. Lysosomal acid lipase-deficient mice: depletion of white and brown fat,
severe hepatosplenomegaly, and shortened life span. J. Lipid Res. 42: 489-500.
Dunning, S., A. ur Rehman, M. H. Tiebosch, R. A. Hannivoort, F. W. Haijer, J.
Woudenberg, F. A. van den Heuvel, M. Buist-Homan, K. N. Faber, and H.
Moshage. 2013. Glutathione and antioxidant enzymes serve complementary roles
in protecting activated hepatic stellate cells against hydrogen peroxide-induced
cell death. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
1832: 2027-2034.
Eguinoa, P., S. Brocklehurst, A. Arana, J. Mendizabal, R. Vernon, and A. Purroy. 2003.
Lipogenic enzyme activities in different adipose depots of Pirenaican and
Holstein bulls and heifers taking into account adipocyte size. J. Anim. Sci. 81:
432-440.
El-Gayar, S., H. Thüring-Nahler, J. Pfeilschifter, M. Röllinghoff, and C. Bogdan. 2003.
Translational control of inducible nitric oxide synthase by IL-13 and arginine
availability in inflammatory macrophages. The Journal of Immunology 171:
4561-4568.
Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77.
Elsasser, T., T. Caperna, C. Li, S. Kahl, and J. Sartin. 2008. Critical control points in the
impact of the proinflammatory immune response on growth and metabolism. J.
Anim. Sci. 86: E105-E125.
Elsasser, T., R. Rosebrough, T. Rumsey, and W. Moseley. 1996. Hormonal and
nutritional modulation of hepatic arginase activity in growing cattle. Domest.
Anim. Endocrinol. 13: 219-228.
Elsasser, T. H., C.-J. Li, T. J. Caperna, S. Kahl, and W. F. Schmidt. 2007. Growth
hormone (GH)-associated nitration of Janus kinase-2 at the 1007Y-1008Y epitope
impedes phosphorylation at this site: mechanism for and impact of a GH, AKT,
and nitric oxide synthase axis on GH signal transduction. Endocrinology 148:
3792-3802.
Ercal, N., P. Yang, and N. Aykin. 2001. Determination of biological thiols by highperformance liquid chromatography following derivatization by ThioGlo
maleimide reagents. Journal of Chromatography B: Biomedical Sciences and
Applications 753: 287-292.
Eriksson, S., J. R. Prigge, E. A. Talago, E. S. Arnér, and E. E. Schmidt. 2015. Dietary
methionine can sustain cytosolic redox homeostasis in the mouse liver. Nature
communications 6: 6479.

163

Esworthy, R. S., F.-F. Chu, S. Akman, J. H. Doroshow, and R. J. Paxton. 1991.
Characterization and partial amino acid sequence of human plasma glutathione
peroxidase. Arch. Biochem. Biophys. 286: 330-336.
Evans, W. H. 1980. A biochemical dissection of the functional polarity of the plasma
membrane of the hepatocyte. Biochimica et Biophysica Acta (BBA)Biomembranes 604: 27-64.
Fairman, W., R. Vandenberg, J. Arriza, M. Kavanaugh, and S. Amara. 1995a. An
excitatory amino-acid transporter with properties of a ligand-gated chloride
channel. Nature 375: 599.
Fairman, W., R. Vandenberg, J. Arriza, M. Kavanaught, and S. Amara. 1995b. An
excitatory amino-acid transporter with properties of a ligand-gated chloride
channel.
Fan, M. Z., J. C. Matthews, N. M. Etienne, B. Stoll, D. Lackeyram, and D. G. Burrin.
2004. Expression of apical membrane L-glutamate transporters in neonatal
porcine epithelial cells along the small intestinal crypt-villus axis. Am. J. Physiol.
Gastrointest. Liver Physiol. 287: G385-G398.
Fan, Y., R. K. Menon, P. Cohen, D. Hwang, T. Clemens, D. J. DiGirolamo, J. J.
Kopchick, D. Le Roith, M. Trucco, and M. A. Sperling. 2009. Liver-specific
deletion of the growth hormone receptor reveals essential role of growth hormone
signaling in hepatic lipid metabolism. J. Biol. Chem. 284: 19937-19944.
Fernandez Checa, J. C., and N. Kaplowitz. 2005. Hepatic mitochondrial glutathione:
transport and role in disease and toxicity. Toxicol. Appl. Pharmacol. 204: 263273.
Fernandez Checa, J. C., N. Kaplowitz, C. Garcia-Ruiz, A. Colell, M. Miranda, M. MARi,
E. Ardite, and A. Morales. 1997. GSH transport in mitochondria: defense against
TNF-induced oxidative stress and alcohol-induced defect. American Journal of
Physiology-Gastrointestinal and Liver Physiology 273: G7-G17.
Findeisen, H. M., K. J. Pearson, F. Gizard, Y. Zhao, H. Qing, K. L. Jones, D. Cohn, E. B.
Heywood, R. de Cabo, and D. Bruemmer. 2011. Oxidative stress accumulates in
adipose tissue during aging and inhibits adipogenesis. PLoS One 6: e18532.
Flaring, U., O. Rooyackers, J. Wernerman, and F. Hammarqvist. 2003. Glutamine
attenuates post-traumatic glutathione depletion in human muscle. Clin. Sci. 104:
275-282.
Foley, C., A. Chapwanya, C. J. Creevey, F. Narciandi, D. Morris, E. M. Kenny, P.
Cormican, J. J. Callanan, C. O’Farrelly, and K. G. Meade. 2012. Global
endometrial transcriptomic profiling: transient immune activation precedes tissue
proliferation and repair in healthy beef cows. BMC Genomics 13: 489.
Forman, H. J., H. Zhang, and A. Rinna. 2009. Glutathione: overview of its protective
roles, measurement, and biosynthesis. Mol. Aspects Med. 30: 1-12.
Franklin, C. C., D. S. Backos, I. Mohar, C. C. White, H. J. Forman, and T. J. Kavanagh.
2009. Structure, function, and post-translational regulation of the catalytic and
modifier subunits of glutamate cysteine ligase. Mol. Aspects Med. 30: 86-98.
Frayn, K., K. Khan, S. Coppack, and M. Elia. 1991. Amino acid metabolism in human
subcutaneous adipose tissue in vivo. Clin. Sci. (Lond.) 80: 471-474.

164

Galinier, A., A. Carrière, Y. Fernandez, C. Carpéné, M. André, S. Caspar-Bauguil, J.-P.
Thouvenot, B. Périquet, L. Pénicaud, and L. Casteilla. 2006. Adipose tissue
proadipogenic redox changes in obesity. J. Biol. Chem. 281: 12682-12687.
Ganapathy, V., M. Brandsch, and F. Leibach. 1994. Intestinal transport of amino acids
and peptides. Physiology of the gastrointestinal tract 2: 1773-1820.
Garcia Ruiz, C., and J. C. Fernandez Checa. 2006. Mitochondrial glutathione:
hepatocellular survival–death switch. J. Gastroenterol. Hepatol. 21: S3-S6.
Gegelashvili, G., M. B. Robinson, D. Trotti, and T. Rauen. 2003. Regulation of glutamate
transporters in health and disease. Glial Cell Function 132: 267.
Gegelashvili, G., and A. Schousboe. 1997. High affinity glutamate transporters:
regulation of expression and activity. Mol. Pharmacol. 52: 6-15.
González, M. I., M. G. Kazanietz, and M. B. Robinson. 2002. Regulation of the neuronal
glutamate transporter excitatory amino acid carrier-1 (EAAC1) by different
protein kinase C subtypes. Mol. Pharmacol. 62: 901-910.
Gotoh, T., and M. Mori. 1999. Arginase II downregulates nitric oxide (NO) production
and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7
cells. The Journal of cell biology 144: 427-434.
Griffith, O. W. 1999. Biologic and pharmacologic regulation of mammalian glutathione
synthesis. Free Radic. Biol. Med. 27: 922-935.
Guidotti, G. G., and G. C. Gazzola. 1992. Amino acid transporters: systematic approach
and principles of control. In: M. S. Kilberg and D. Haussinger (ed.) Mammalian
amino acid transport. p 3-29. Springer.
Haas, J. T., and B. Staels. 2016. An oxidative stress paradox: time for a conceptual
change? Diabetologia 59: 2514-2517.
Hack, V., O. Stütz, R. Kinscherf, M. Schykowski, M. Kellerer, E. Holm, and W. Dröge.
1996. Elevated venous glutamate levels in (pre) catabolic conditions result at least
partly from a decreased glutamate transport activity. J. Mol. Med. 74: 337-343.
Halaris, A., and J. Plietz. 2007. Agmatine. CNS drugs 21: 885-900.
Ham, D. J., K. T. Murphy, A. Chee, G. S. Lynch, and R. Koopman. 2014. Glycine
administration attenuates skeletal muscle wasting in a mouse model of cancer
cachexia. Clin. Nutr. 33: 448-458.
Häussinger, D., and W. Gerok. 1983. Hepatocyte heterogeneity in glutamate uptake by
isolated perfused rat liver. Eur. J. Biochem. 136: 421-425.
Häussinger, D., B. Stoll, T. Stehle, and W. Gerok. 1989. Hepatocyte heterogeneity in
glutamate metabolism and bidirectional transport in perfused rat liver. Eur. J.
Biochem. 185: 189-195.
Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:
1926-1945.
Hediger, M., and T. Welbourne. 1999a. Introduction: glutamate transport, metabolism,
and physiological responses. American Journal of Physiology-Renal Physiology
277: F477-F480.
Hediger, M., and T. Welbourne. 1999b. Introduction: glutamate transport, metabolism,
and physiological responses. Am. J. Physiol. Renal Physiol. 277: F477-F480.
Heitmann, R., and E. Bergman. 1980. Integration of amino acid metabolism in sheep:
effects of fasting and acidosis. Am. J. Physiol. 239: E248-E254.

165

Heitmann, R., and E. Bergman. 1981a. Glutamate interconversions and glucogenicity in
the sheep. Am. J. Physiol. Endocrinol. Metab. 241: E465-E472.
Heitmann, R., and E. Bergman. 1981b. Glutamate interconversions and glucogenicity in
the sheep. American Journal of Physiology-Endocrinology and Metabolism 241:
E465-E472.
Hellsten, Y., M. Svensson, B. Sjödin, S. Smith, A. Christensen, E. A. Richter, and J.
Bangsbo. 2001. Allantoin formation and urate and glutathione exchange in human
muscle during submaximal exercise. Free Radic. Biol. Med. 31: 1313-1322.
Hofmann, K., M. Düker, T. Fink, P. Lichter, and W. Stoffel. 1994. Human neutral amino
acid transporter ASCT1: structure of the gene (SLC1A4) and localization to
chromosome 2p13-p15. Genomics 24: 20-26.
Howell, J., A. Matthews, K. Swanson, D. Harmon, and J. Matthews. 2001. Molecular
identification of high-affinity glutamate transporters in sheep and cattle
forestomach, intestine, liver, kidney, and pancreas. J. Anim. Sci. 79: 1329-1336.
Howell, J., A. Matthews, T. Welbourne, and J. Matthews. 2003. Content of ileal EAAC1
and hepatic GLT-1 high-affinity glutamate transporters is increased in growing
vs. nongrowing lambs, paralleling increased tissue D-and L-glutamate, plasma
glutamine, and alanine concentrations. J. Anim. Sci. 81: 1030-1039.
Huang, C.-S., M. E. Anderson, and A. Meister. 1993a. Amino acid sequence and function
of the light subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol.
Chem. 268: 20578-20583.
Huang, C.-S., L.-S. Chang, M. E. Anderson, and A. Meister. 1993b. Catalytic and
regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine
synthetase. J. Biol. Chem. 268: 19675-19680.
Huang, Y., X. Feng, J. J. Sando, and Z. Zuo. 2006. Critical role of serine 465 in
isoflurane-induced increase of cell-surface redistribution and activity of glutamate
transporter type 3. J. Biol. Chem. 281: 38133-38138.
Huang, Z.-Z., C. Chen, Z. Zeng, H. Yang, J. Oh, L. Chen, and S. C. Lu. 2001.
Mechanism and significance of increased glutathione level in human
hepatocellular carcinoma and liver regeneration. The FASEB Journal 15: 19-21.
Huang, Z.-Z., H. Yang, C. Chen, Z. Zeng, and S. C. Lu. 2000. Inducers of γglutamylcysteine synthetase and their effects on glutathione synthetase
expression. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression
1493: 48-55.
Hundal, H. S., and P. M. Taylor. 2009. Amino acid transceptors: gate keepers of nutrient
exchange and regulators of nutrient signaling. Am. J. Physiol. Endocrinol. Metab.
296: E603-E613.
Huntington, G. 1990. Energy metabolism in the digestive tract and liver of cattle:
influence of physiological state and nutrition. Reproduction Nutrition
Development 30: 35-47.
Huntington, G. B., R. L. Prior, and R. A. Britton. 1981. Glucose and lactate absorption
and metabolic interrelationships in steers changed from low to high concentrate
diets. The Journal of nutrition 111: 1164-1172.
Hwang, C., A. J. Sinskey, and H. F. Lodish. 1992. Oxidized redox state of glutathione in
the endoplasmic reticulum. Science 257: 1496-1502.

166

Inoue, M., R. Kinne, T. Tran, L. Biempica, and I. Arias. 1983. Rat liver canalicular
membrane vesicles. Isolation and topological characterization. J. Biol. Chem. 258:
5183-5188.
Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer‐ Barclay, K. J. Antonellis, U. Scherf,
and T. P. Speed. 2003. Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics 4: 249-264.
James, L., P. Lunn, and M. Elia. 1998. Glutamine metabolism in the gastrointestinal tract
of the rat assessed by the relative activities of glutaminase (EC 3.5. 1.2) and
glutamine synthetase (EC 6.3. 1.2). British Journal of Nutrition 79: 365-372.
Jeong, D.-w., T. S. Kim, Y. W. Chung, B. J. Lee, and I. Y. Kim. 2002. Selenoprotein W
is a glutathione‐ dependent antioxidant in vivo. FEBS Lett. 517: 225-228.
Ji, L. L., and R. Fu. 1992. Responses of glutathione system and antioxidant enzymes to
exhaustive exercise and hydroperoxide. J. Appl. Physiol. 72: 549-554.
Kanai, Y., and M. A. Hediger. 1992. Primary structure and functional characterization of
a high-affinity glutamate transporter. Nature 360: 467-471.
Kanai, Y., and M. A. Hediger. 2003. The glutamate and neutral amino acid transporter
family: physiological and pharmacological implications. Eur. J. Pharmacol. 479:
237-247.
Kannan, R., J. C. Fernández-Checa, C. García-Ruiz, J. B. Mackic, and B. V. Zlokovic.
1997. Liver and lens glutathione and cysteine regulation in galactose-fed guinea
pigs. Curr. Eye Res. 16: 365-371.
Kekuda, R., P. D. Prasad, Y.-J. Fei, V. Torres-Zamorano, S. Sinha, T. L. Yang-Feng, F.
H. Leibach, and V. Ganapathy. 1996. Cloning of the sodium-dependent, broadscope, neutral amino acid transporter B0 from a human placental choriocarcinoma
cell line. J. Biol. Chem. 271: 18657-18661.
Kekuda, R., V. Torres-Zamorano, Y. J. Fei, P. D. Prasad, H. W. Li, L. D. Mader, F. H.
Leibach, and V. Ganapathy. 1997. Molecular and functional characterization of
intestinal Na+-dependent neutral amino acid transporter B0. American Journal of
Physiology-Gastrointestinal and Liver Physiology 272: G1463-G1472.
Kilberg, M. S. 1982. Amino acid transport in isolated rat hepatocytes. J. Membr. Biol. 69:
1-12.
Kilberg, M. S. 1989. Measurement of amino acid transport by hepatocytes in suspension
or monolayer culture. Methods Enzymol. 173: 564-575.
Kinoshita, C., K. Aoyama, N. Matsumura, K. Kikuchi-Utsumi, M. Watabe, and T.
Nakaki. 2014. Rhythmic oscillations of the microRNA miR-96-5p play a
neuroprotective role by indirectly regulating glutathione levels. Nat Commun
5:3823.
Kobayashi, H., M. Matsuda, A. Fukuhara, R. Komuro, and I. Shimomura. 2009.
Dysregulated glutathione metabolism links to impaired insulin action in
adipocytes. American Journal of Physiology-Endocrinology and Metabolism 296:
E1326-E1334.
Kowalski, T. J., and M. Watford. 1994. Production of glutamine and utilization of
glutamate by rat subcutaneous adipose tissue in vivo. American Journal of
Physiology-Endocrinology And Metabolism 266: E151-E154.

167

Kowalski, T. J., G. Wu, and M. Watford. 1997. Rat adipose tissue amino acid metabolism
in vivo as assessed by microdialysis and arteriovenous techniques. American
Journal of Physiology-Endocrinology And Metabolism 273: E613.
Kuhn, K. S., K. Schuhmann, P. Stehle, D. Darmaun, and P. Fürst. 1999. Determination of
glutamine in muscle protein facilitates accurate assessment of proteolysis and de
novo synthesis–derived endogenous glutamine production. The American journal
of clinical nutrition 70: 484-489.
Lacroix, M., C. Gaudichon, A. Martin, C. Morens, V. Mathé, D. Tomé, and J.-F. Huneau.
2004. A long-term high-protein diet markedly reduces adipose tissue without
major side effects in Wistar male rats. American Journal of PhysiologyRegulatory, Integrative and Comparative Physiology 287: R934-R942.
Lanca, A. J., and Y. Israel. 1991. Histochemical demonstration of sinusoidal γ‐
glutamyltransferase activity by substrate protection fixation: Comparative studies
in rat and guinea pig liver. Hepatology 14: 857-863.
Lauterburg, B. H., J. D. Adams, and J. R. Mitchell. 1984. Hepatic glutathione
homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology 4:
586-590.
Lee, Y. S., A. Y. Kim, J. W. Choi, M. Kim, S. Yasue, H. J. Son, H. Masuzaki, K. S. Park,
and J. B. Kim. 2008. Dysregulation of adipose glutathione peroxidase 3 in obesity
contributes to local and systemic oxidative stress. Mol. Endocrinol. 22: 21762189.
Leeuwenburgh, C., R. Fiebig, R. Chandwaney, and L. Ji. 1994. Aging and exercise
training in skeletal muscle: responses of glutathione and antioxidant enzyme
systems. American Journal of Physiology-Regulatory, Integrative and
Comparative Physiology 267: R439-R445.
Leffert, H. L., D. B. Schenk, J. J. Hubert, H. Skelly, M. Schumacher, R. Ariyasu, M.
Ellisman, K. S. Koch, and G. A. Keller. 1985. Hepatic (Na+, K+)‐ ATPase: A
current view of its structure, function and localization in rat liver as revealed by
studies with monoclonal antibodies. Hepatology 5: 501-507.
Lei, X. G. 2001. Differential regulation and function of glutathione peroxidases and other
selenoproteins. Nutrient-Gene Interactions in Health and Disease Modern
Nutrition Series 38: 425-448.
Lew, H., S. Pyke, and A. Quintanilha. 1985. Changes in the glutathione status of plasma,
liver and muscle following exhaustive exercise in rats. FEBS Lett. 185: 262-266.
Li, Y., L. Li, J. Li, L. Zhang, F. Gao, and G. Zhou. 2015. Effects of dietary
supplementation with ferulic acid or vitamin E individually or in combination on
meat quality and antioxidant capacity of finishing Pigs. Asian-Australasian
journal of animal sciences 28: 374.
Liao, K., and M. D. Lane. 1995. Expression of a novel insulin-activated amino acid
transporter gene during differentiation of 3T3-L1 preadipocytes into adipocytes.
Biochem. Biophys. Res. Commun. 208: 1008-1015.
Lin, C.-l. G., I. Orlov, A. M. Ruggiero, M. Dykes-Hoberg, A. Lee, M. Jackson, and J. D.
Rothstein. 2001. Modulation of the neuronal glutamate transporter EAAC1 by the
interacting protein GTRAP3-18. Nature 410: 84-88.
Liu, R.-M., and K. G. Pravia. 2010. Oxidative stress and glutathione in TGF-β-mediated
fibrogenesis. Free Radic. Biol. Med. 48: 1-15.

168

Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using
real-time quantitative PCR and the 2− ΔΔCT method. Methods 25: 402-408.
Lobley, G. E., S. O. Hoskin, and C. J. McNeil. 2001. Glutamine in animal science and
production. J. Nutr. 131: 2525S-2531S.
Loh, K., H. Deng, A. Fukushima, X. Cai, B. Boivin, S. Galic, C. Bruce, B. J. Shields, B.
Skiba, and L. M. Ooms. 2009. Reactive oxygen species enhance insulin
sensitivity. Cell Metab. 10: 260-272.
Low, S., M. Rennie, and P. Taylor. 1994. Sodium-dependent glutamate transport in
cultured rat myotubes increases after glutamine deprivation. FASEB J. 8: 127131.
Low, S., P. M. Taylor, H. S. Hundal, C. I. Pogson, and M. J. Rennie. 1992. Transport of
L-glutamine and L-glutamate across sinusoidal membranes of rat liver. Effects of
starvation, diabetes and corticosteroid treatment. Biochem. J. 284: 333-340.
Lu, S. C. 1999. Regulation of hepatic glutathione synthesis: current concepts and
controversies. The FASEB Journal 13: 1169-1183.
Lu, S. C. 2009. Regulation of glutathione synthesis. Mol. Aspects Med. 30: 42-59.
Lu, S. C. 2013. Glutathione synthesis. BBA-Gen Subjects 1830: 3143-3153.
Lushchak, V. I. 2012. Glutathione homeostasis and functions: potential targets for
medical interventions. Journal of amino acids 2012.
Lutz, M. S., and R. D. Burk. 2006. Primary cilium formation requires von hippel-lindau
gene function in renal-derived cells. Cancer Res. 66: 6903-6907.
Lynch, A. M., and J. D. McGivan. 1987. Evidence for a single common Na+-dependent
transport system for alanine, glutamine, leucine and phenylalanine in brushborder membrane vesicles from bovine kidney. Biochimica et Biophysica Acta
(BBA)-Biomembranes 899: 176-184.
Maiorino, M., C. Gregolin, and F. Ursini. 1990. Phospholipid hydroperoxide glutathione
peroxidase. Methods Enzymol. 186: 448-457.
Matthews, J., J. Huang, and G. Rentfrow. 2016. High-affinity glutamate transporter and
glutamine synthetase content in longissimus dorsi and adipose tissues of growing
Angus steers differs among suckling, weanling, backgrounding, and finishing
production stages. J. Anim. Sci. 94: 1267-1275.
Matthews, J. C. 2005. Expression of non-organelle glutamate transporters to support
peripheral tissue function. Glutamate Receptors in Peripheral Tissue: Excitatory
Transmission Outside the CNS. p 47-75. Springer.
Matthews, J. C., M. J. Beveridge, M. S. Malandro, J. D. Rothstein, M. CampbellThompson, J. W. Verlander, M. S. Kilberg, and D. A. Novak. 1998. Activity and
protein localization of multiple glutamate transporters in gestation day 14 vs. day
20 rat placenta. American Journal of Physiology-Cell Physiology 274: C603C614.
Matthews, J. C., Z. Zhang, J. D. Patterson, P. J. Bridges, A. J. Stromberg, and J. Boling.
2014. Hepatic transcriptome profiles differ among maturing beef heifers
supplemented with inorganic, organic, or mixed (50% Inorganic: 50% Organic)
forms of dietary selenium. Biol. Trace Elem. Res. 160: 321-339.
Meier, P. J., and J. L. Boyer. 1990. Preparation of basolateral (sinusoidal) and canalicular
plasma membrane vesicles for the study of hepatic transport processes. Methods
Enzymol. 192: 534-545.

169

Meier, P. J., E. S. Sztul, A. Reuben, and J. L. Boyer. 1984. Structural and functional
polarity of canalicular and basolateral plasma membrane vesicles isolated in high
yield from rat liver. J. Cell Biol. 98: 991-1000.
Meijer, A. J., W. H. Lamers, and R. Chamuleau. 1990. Nitrogen metabolism and
ornithine cycle function. Physiol. Rev. 70: 701-748.
Meister, A., and M. E. Anderson. 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
Meister, A., Tate, S. S., and Griffith, O. W. 1981. γ-Glutamyl transpeptidase. Methods
Enzymol. 77: 237-253.
Meredith, M. J., and D. Reed. 1982. Status of the mitochondrial pool of glutathione in the
isolated hepatocyte. J. Biol. Chem. 257: 3747-3753.
Merry, T. L., M. Tran, G. T. Dodd, S. P. Mangiafico, F. Wiede, S. Kaur, C. L. McLean,
S. Andrikopoulos, and T. Tiganis. 2016. Hepatocyte glutathione peroxidase-1
deficiency improves hepatic glucose metabolism and decreases steatohepatitis in
mice. Diabetologia 59: 2632-2644.
Messarah, M., F. Klibet, A. Boumendjel, C. Abdennour, N. Bouzerna, M. S. Boulakoud,
and A. El Feki. 2012. Hepatoprotective role and antioxidant capacity of selenium
on arsenic-induced liver injury in rats. Exp. Toxicol. Pathol. 64: 167-174.
Miles, E., B. McBride, Y. Jia, S. Liao, J. Boling, P. Bridges, and J. Matthews. 2015.
Glutamine synthetase and alanine transaminase expression are decreased in livers
of aged vs. young beef cows and GS can be upregulated by 17β-estradiol
implants. J. Anim. Sci. 93: 4500-4509.
Miles, E. D., B. McBride, P. J. Bridges, and J. C. Matthews. 2016. Effect of 17β-estradiol
administration on hepatic expression of glutamine synthetase, β-catenin, and
GPR30 in young and aged beef cows. Can J Anim Sci. doi: 10.1139/CJAS-20160002.
Møller, N., and J. O. L. Jørgensen. 2009. Effects of growth hormone on glucose, lipid,
and protein metabolism in human subjects. Endocr. Rev. 30: 152-177.
Moorman, A., P. De Boer, A. Das, W. T. Labruyère, R. Charles, and W. Lamers. 1990.
Expression patterns of mRNAs for ammonia metabolizing enzymes in the
developing rat: the ontogenesis of hepatocyte heterogeneity. Histochem. J. 22:
457-468.
Moorman, A. F., J. L. Vermeulen, R. Charles, and W. H. Lamers. 1989. Localization of
ammonia‐ metabolizing enzymes in human liver: Ontogenesis of heterogeneity.
Hepatology 9: 367-372.
Mori, M. 2007. Regulation of nitric oxide synthesis and apoptosis by arginase and
arginine recycling. The Journal of nutrition 137: 1616S-1620S.
Moron, M. S., J. W. Depierre, and B. Mannervik. 1979. Levels of glutathione, glutathione
reductase and glutathione S-transferase activities in rat lung and liver. Biochimica
et Biophysica Acta (BBA)-General Subjects 582: 67-78.
Morris Jr, S. M. 2004. Recent advances in arginine metabolism. Curr. Opin. Clin. Nutr.
Metab. Care 7: 45-51.
Morris, S. M. 2002. Regulation of enzymes of the urea cycle and arginine metabolism.
Annu. Rev. Nutr. 22: 87-105.
Morris, S. M. 2004. Enzymes of arginine metabolism. The Journal of nutrition 134:
2743S-2747S.

170

Mosoni, L., D. Breuillé, C. Buffière, C. Obled, and P. P. Mirand. 2004. Age-related
changes in glutathione availability and skeletal muscle carbonyl content in healthy
rats. Exp. Gerontol. 39: 203-210.
Mourtzakis, M., and T. E. Graham. 2002. Glutamate ingestion and its effects at rest and
during exercise in humans. J. Appl. Physiol. 93: 1251-1259.
Munder, M., K. Eichmann, J. M. Morán, F. Centeno, G. Soler, and M. Modolell. 1999.
Th1/Th2-regulated expression of arginase isoforms in murine macrophages and
dendritic cells. The Journal of Immunology 163: 3771-3777.
Nafikov, R. A., and D. C. Beitz. 2007. Carbohydrate and lipid metabolism in farm
animals. The Journal of nutrition 137: 702-705.
Nagao, S., S. Kwak, and I. Kanazawa. 1997. EAAT4, a glutamate transporter with
properties of a chloride channel, is predominantly localized in Purkinje cell
dendrites, and forms parasagittal compartments in rat cerebellum. Neuroscience
78: 929-933.
Nakayama, T., H. Kawakami, K. Tanaka, and S. Nakamura. 1996. Expression of three
glutamate transporter subtype mRNAs in human brain regions and peripheral
tissues. Molecular brain research 36: 189-192.
Netto, A. S., M. A. Zanetti, G. R. Del Claro, M. P. de Melo, F. G. Vilela, and L. B.
Correa. 2014. Effects of copper and selenium supplementation on performance
and lipid metabolism in confined brangus bulls. Asian-Australasian journal of
animal sciences 27: 488.
Newsholme, E., and W. Gevers. 1967. Control of glycolysis and gluconeogenesis in liver
and kidney cortex. Vitam. Horm. 25: 1-87.
Newsholme, E., and M. Parry-Billings. 1990. Properties of glutamine release from
muscle and its importance for the immune system. Journal of Parenteral and
Enteral Nutrition 14: 63S-67S.
Nissim, I. 1999. Newer aspects of glutamine/glutamate metabolism: the role of acute pH
changes. Am. J. Physiol. Renal Physiol. 277: F493-F497.
Nissim, I., B. Luhovyy, O. Horyn, Y. Daikhin, I. Nissim, and M. Yudkoff. 2005. The role
of mitochondrially bound arginase in the regulation of urea synthesis. J. Biol.
Chem. 280: 17715-17724.
NRC. 1996. Nutrient requirements of beef cattle. National Academy Press, Washington,
DC.
Ookhtens, M., and N. Kaplowitz. 1998. Role of the liver in interorgan homeostasis of
glutathione and cyst (e) ine. In: Seminars in liver disease. p 313-329.
Osorio, J., E. Trevisi, P. Ji, J. Drackley, D. Luchini, G. Bertoni, and J. Loor. 2014.
Biomarkers of inflammation, metabolism, and oxidative stress in blood, liver, and
milk reveal a better immunometabolic status in peripartal cows supplemented
with Smartamine M or MetaSmart. J. Dairy Sci. 97: 7437-7450.
Palacín, M., R. Estévez, J. Bertran, and A. Zorzano. 1998. Molecular biology of
mammalian plasma membrane amino acid transporters. Physiol. Rev. 78: 9691054.
Pallardó, F. V., J. Markovic, J. L. García, and J. Viña. 2009. Role of nuclear glutathione
as a key regulator of cell proliferation. Mol. Aspects Med. 30: 77-85.
Patterson, B. W., J. F. Horowitz, G. Wu, M. Watford, S. W. Coppack, and S. Klein. 2002.
Regional muscle and adipose tissue amino acid metabolism in lean and obese

171

women. American Journal of Physiology-Endocrinology and Metabolism 282:
E931-E936.
Perez, M. J., R. I. Macias, C. Duran, M. J. Monte, J. M. Gonzalez-Buitrago, and J. J.
Marin. 2005. Oxidative stress and apoptosis in fetal rat liver induced by maternal
cholestasis. Protective effect of ursodeoxycholic acid. J. Hepatol. 43: 324-332.
Picklo, M. J., J. P. Idso, and M. I. Jackson. 2013. S‐ Glutathionylation of hepatic and
visceral adipose proteins decreases in obese rats. Obesity 21: 297-305.
Pines, G., N. C. Danbolt, M. Bjørås, Y. Zhang, A. Bendahan, L. Eide, H. Koepsell, J.
Storm-Mathisen, E. Seeberg, and B. I. Kanner. 1992. Cloning and expression of a
rat brain L-glutamate transporter.
Plakidou-Dymock, S., and J. D. McGivan. 1993. Regulation of the glutamate transporter
by amino acid deprivation and associated effects on the level of EAAC1 mRNA
in the renal epithelial cell line NBL-I. Biochem. J. 295: 749-755.
Podszun, M. C., N. Grebenstein, A. Spruss, T. Schlueter, C. Kremoser, I. Bergheim, and
J. Frank. 2014. Dietary α-tocopherol and atorvastatin reduce high-fat-induced
lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs. J.
Nutr. Biochem. 25: 573-579.
Pollard, M., D. Meredith, and J. D. McGivan. 2002. Characterisation and cloning of a
Na+-dependent broad-specificity neutral amino acid transporter from NBL-1 cells:
a novel member of the ASC/B0 transporter family. Biochimica et Biophysica Acta
(BBA)-Biomembranes 1561: 202-208.
Poupon, R. E., and W. H. Evans. 1979. Biochemical evidence that Na+, K+-ATPase is
located at the lateral region of the hepatocyte surface membrane. FEBS Lett. 108:
374-378.
Rakowska, R., A. Sadowska, and B. Waszkiewicz-Robak. 2017. Influence of pre-and
post-slaughter factors on the reduced glutathione content of beef muscles. Meat
science 124: 48-53.
Reichen, J., and G. Paumgartner. 1977. Relationship between bile flow and Na+, K+adenosinetriphosphatase in liver plasma membranes enriched in bile canaliculi. J.
Clin. Invest. 60: 429.
Richman, P., and A. Meister. 1975. Regulation of gamma-glutamyl-cysteine synthetase
by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 250: 14221426.
Riehle, K. J., J. Haque, R. S. McMahan, T. J. Kavanagh, N. Fausto, and J. S. Campbell.
2013. Sustained glutathione deficiency interferes with the liver response to TNF-α
and liver regeneration after partial hepatectomy in mice. Journal of liver: disease
& transplantation 1.
Ritchie, J. W., F. E. Baird, G. R. Christie, A. Stewart, S. Y. Low, H. S. Hundal, and P. M.
Taylor. 2001. Mechanisms of glutamine transport in rat adipocytes and acute
regulation by cell swelling. Cell. Physiol. Biochem. 11: 259-270.
Ruggiero, A. M., Y. Liu, S. Vidensky, S. Maier, E. Jung, H. Farhan, M. B. Robinson, H.
H. Sitte, and J. D. Rothstein. 2008. The endoplasmic reticulum exit of glutamate
transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein.
J. Biol. Chem. 283: 6175-6183.

172

Sadi, G., D. Bozan, and H. B. Yildiz. 2014. Redox regulation of antioxidant enzymes:
post-translational modulation of catalase and glutathione peroxidase activity by
resveratrol in diabetic rat liver. Mol. Cell. Biochem. 393: 111-122.
Salvi, M., V. Battaglia, A. M. Brunati, N. La Rocca, E. Tibaldi, P. Pietrangeli, L.
Marcocci, B. Mondovì, C. A. Rossi, and A. Toninello. 2007. Catalase takes part
in rat liver mitochondria oxidative stress defense. J. Biol. Chem. 282: 2440724415.
Sato, H., A. Shiiya, M. Kimata, K. Maebara, M. Tamba, Y. Sakakura, N. Makino, F.
Sugiyama, K.-i. Yagami, and T. Moriguchi. 2005. Redox imbalance in
cystine/glutamate transporter-deficient mice. J. Biol. Chem. 280: 37423-37429.
Sato, H., M. Tamba, T. Ishii, and S. Bannai. 1999. Cloning and expression of a plasma
membrane cystine/glutamate exchange transporter composed of two distinct
proteins. J. Biol. Chem. 274: 11455-11458.
Satriano, J. 2004. Arginine pathways and the inflammatory response: interregulation of
nitric oxide and polyamines. Amino Acids 26: 321-329.
Schenk, D. B., and H. L. Leffert. 1983. Monoclonal antibodies to rat Na+, K+-ATPase
block enzymatic activity. Proc Natl Acad Sci USA 80: 5281-5285.
Schmidt, M. M., and R. Dringen. 2012. Glutathione (GSH) synthesis and metabolism.
Neural Metabolism In Vivo. p 1029-1050. Springer.
Schniepp, R., K. Kohler, T. Ladewig, E. Guenther, G. Henke, M. Palmada, C. Boehmer,
J. D. Rothstein, S. Bröer, and F. Lang. 2004. Retinal colocalization and in vitro
interaction of the glutamate receptor EAAT3 and the serum-and glucocorticoidinducible kinase SGK1. Invest. Ophthalmol. Vis. Sci. 45: 1442-1449.
Schulz, H. 1991. Beta oxidation of fatty acids. Biochimica et Biophysica Acta (BBA)Lipids and Lipid Metabolism 1081: 109-120.
Schwartz, I. F., D. Schwartz, M. Traskonov, T. Chernichovsky, Y. Wollman, E. Gnessin,
I. Topilsky, Y. Levo, and A. Iaina. 2002. L-Arginine transport is augmented
through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in
rats. Kidney Int. 62: 1700-1706.
Sen, C. K., E. Marin, M. Kretzschmar, and O. Hanninen. 1992. Skeletal muscle and liver
glutathione homeostasis in response to training, exercise, and immobilization. J.
Appl. Physiol. 73: 1265-1272.
Shaik, I. H., and R. Mehvar. 2006. Rapid determination of reduced and oxidized
glutathione levels using a new thiol-masking reagent and the enzymatic recycling
method: application to the rat liver and bile samples. Anal. Bioanal. Chem. 385:
105-113.
Simon, F. R., E. Sutherland, and L. Accatino. 1977. Stimulation of hepatic sodium and
potassium-activated adenosine triphosphatase activity by phenobarbital. Its
possible role in regulation of bile flow. J. Clin. Invest. 59: 849.
Sims, K. D., D. J. Straff, and M. B. Robinson. 2000. Platelet-derived growth factor
rapidly increases activity and cell surface expression of the EAAC1 subtype of
glutamate transporter through activation of phosphatidylinositol 3-kinase. J. Biol.
Chem. 275: 5228-5237.
Smith, S. B. 1995. Substrate utilization in ruminant adipose tissues. The biology of fat in
meat animals. Champaign, IL: American Society of Animal Science: 166-188.

173

Smith, S. B., and R. L. Prior. 1982. The effect of 3-mercaptopicolinic acid and substrate
interactions on the incorporation of lipogenic precursors into glyceride-glycerol,
glyceride-fatty acids and nonesterified fatty acids in bovine adipose tissue.
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 712: 365373.
Sopjani, M., I. Alesutan, M. Dërmaku‐ Sopjani, S. Fraser, B. E. Kemp, M. Föller, and F.
Lang. 2010. Down‐ regulation of Na+‐ coupled glutamate transporter EAAT3 and
EAAT4 by AMP‐ activated protein kinase. J. Neurochem. 113: 1426-1435.
Stevens, B. R., H. J. Ross, and E. M. Wright. 1982. Multiple transport pathways for
neutral amino acids in rabbit jejunal brush border vesicles. The Journal of
membrane biology 66: 213-225.
Storck, T., S. Schulte, K. Hofmann, and W. Stoffel. 1992. Structure, expression, and
functional analysis of a Na+-dependent glutamate/aspartate transporter from rat
brain. Proceedings of the National Academy of Sciences 89: 10955-10959.
Suffredini, A. F., G. Fantuzzi, R. Badolato, J. J. Oppenheim, and N. P. O'grady. 1999.
New insights into the biology of the acute phase response. J. Clin. Immunol. 19:
203-214.
Suthanthiran, M., M. E. Anderson, V. K. Sharma, and A. Meister. 1990. Glutathione
regulates activation-dependent DNA synthesis in highly purified normal human T
lymphocytes stimulated via the CD2 and CD3 antigens. Proceedings of the
National Academy of Sciences 87: 3343-3347.
Sutherland, E., B. Dixon, H. Leffert, H. Skally, L. Zaccaro, and F. Simon. 1988.
Biochemical localization of hepatic surface-membrane Na+, K+-ATPase activity
depends on membrane lipid fluidity. Proc Natl Acad Sci USA 85: 8673-8677.
Swanson, K., J. Matthews, A. Matthews, J. Howell, C. Richards, and D. Harmon. 2000.
Dietary carbohydrate source and energy intake influence the expression of
pancreatic α-amylase in lambs. J. Nutr. 130: 2157-2165.
Takada, A., and S. Bannai. 1984. Transport of cystine in isolated rat hepatocytes in
primary culture. J. Biol. Chem. 259: 2441-2445.
Tapiero, H., G. Mathe, P. Couvreur, and K. Tew. 2002. II. Glutamine and glutamate.
Biomed. Pharmacother. 56: 446-457.
Thomas, J., M. Maiorino, F. Ursini, and A. Girotti. 1990. Protective action of
phospholipid hydroperoxide glutathione peroxidase against membrane-damaging
lipid peroxidation. In situ reduction of phospholipid and cholesterol
hydroperoxides. J. Biol. Chem. 265: 454-461.
Tietze, F. 1969. Enzymic method for quantitative determination of nanogram amounts of
total and oxidized glutathione: applications to mammalian blood and other tissues.
Anal. Biochem. 27: 502-522.
Toda, G., H. Oka, T. Oda, and Y. Ikeda. 1975. Subfractionation of rat liver plasma
membrane: uneven distribution of plasma membrane-bound enzymes on the liver
cell surface. BBA-Biomembranes 413: 52-64.
Torp, R., N. Danbolt, E. Babaie, M. Bjørås, E. Seeberg, J. Storm‐ Mathisen, and O.
Ottersen. 1994. Differential expression of two glial glutamate transporters in the
rat brain: an in situ hybridization study. Eur. J. Neurosci. 6: 936-942.
Torp, R., F. Hoover, N. Danbolt, J. Storm-Mathisen, and O. Ottersen. 1997. Differential
distribution of the glutamate transporters GLT1 and rEAAC1 in rat cerebral

174

cortex and thalamus: an in situ hybridization analysis. Anat. Embryol. (Berl.) 195:
317-326.
USDA. 1997. United States standards for beef carcasses. Livest. Seed Program, Agric.
Market. Serv., Des Moines, IA.
Ushmorov, A., V. Hack, and W. Dröge. 1999. Differential reconstitution of
mitochondrial respiratory chain activity and plasma redox state by cysteine and
ornithine in a model of cancer cachexia. Cancer Res. 59: 3527-3534.
Utsunomiya Tate, N., H. Endou, and Y. Kanai. 1996. Cloning and functional
characterization of a system ASC-like Na+-dependent neutral amino acid
transporter. J. Biol. Chem. 271: 14883-14890.
Vandenberg, R. J., and R. M. Ryan. 2013. Mechanisms of glutamate transport. Physiol.
Rev. 93: 1621-1657.
Vendemiale, G., I. Grattagliano, A. Signorile, and E. Altomare. 1998. Ethanol-induced
changes of intracellular thiol compartmentation and protein redox status in the rat
liver: effect of tauroursodeoxycholate. J. Hepatol. 28: 46-53.
Vesali, R., M. Klaude, O. Rooyackers, I. Tjäder, H. Barle, and J. Wernerman. 2002.
Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay
intensive care unit patients. Clin. Nutr. 21: 505-514.
Videla, L. A., and V. Fernández. 1995. Effect of thyroid hormone administration on the
depletion of circulating glutathione in the isolated perfused rat liver and its
relationship to basolateral γ‐ glutamyltransferase activity. J. Biochem. Toxicol.
10: 69-77.
Vijayakumar, A., R. Novosyadlyy, Y. Wu, S. Yakar, and D. LeRoith. 2010. Biological
effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm.
IGF Res. 20: 1-7.
Vogel, C., and E. M. Marcotte. 2012. Insights into the regulation of protein abundance
from proteomic and transcriptomic analyses. Nature reviews. Genetics 13: 227.
Volterra, A., D. Trotti, and G. Racagni. 1994. Glutamate uptake is inhibited by
arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
Mol. Pharmacol. 46: 986-992.
Wagenaar, G. T., W. J. Geerts, R. A. Chamuleau, N. E. Deutz, and W. H. Lamers. 1994.
Lobular patterns of expression and enzyme activities of glutamine synthase,
carbamoylphosphate synthase and glutamate dehydrogenase during postnatal
development of the porcine liver. BBA-Gen Subjects 1200: 265-270.
Wannagat, F., R. Adler, and R. Ockner. 1978. Bile acid-induced increase in bile acidindependent flow and plasma membrane Na+K+-ATPase activity in rat liver. J.
Clin. Invest. 61: 297.
Watabe, M., K. Aoyama, and T. Nakaki. 2007. Regulation of glutathione synthesis via
interaction between glutamate transport-associated protein 3-18 (GTRAP3-18)
and excitatory amino acid carrier-1 (EAAC1) at plasma membrane. Mol.
Pharmacol. 72: 1103-1110.
Watabe, M., K. Aoyama, and T. Nakaki. 2008. A dominant role of GTRAP3-18 in
neuronal glutathione synthesis. J. Neurosci. 28: 9404-9413.
Watford, M. 2000. Glutamine and glutamate metabolism across the liver sinusoid. J Nutr
130: 983S-987S.

175

Weiss, M. D., S. Derazi, M. S. Kilberg, and K. J. Anderson. 2001. Ontogeny and
localization of the neutral amino acid transporter ASCT1 in rat brain.
Developmental Brain Research 130: 183-190.
Welsh, F. A. 1972. Changes in distribution of enzymes within the liver lobule during
adaptive increases. J. Histochem. Cytochem. 20: 107-111.
Wheatley, D. N., and E. Campbell. 2002. Arginine catabolism, liver extracts and cancer.
Pathology & Oncology Research 8: 18-25.
Wheeler, H. O. 1972. Secretion of bile acids by the liver and their role in the formation of
hepatic bile. Arch. Intern. Med. 130: 533-541.
Wu, G. 1998. Intestinal mucosal amino acid catabolism. J. Nutr. 128: 1249-1252.
Wu, G., F. W. Bazer, T. A. Davis, S. W. Kim, P. Li, J. M. Rhoads, M. C. Satterfield, S.
B. Smith, T. E. Spencer, and Y. Yin. 2009. Arginine metabolism and nutrition in
growth, health and disease. Amino Acids 37: 153-168.
Wu, G., and S. M. Morris. 1998. Arginine metabolism: nitric oxide and beyond.
Biochem. J. 336: 1-17.
Wu, Z., R. A. Irizarry, R. Gentleman, F. Martinez-Murillo, and F. Spencer. 2004. A
model-based background adjustment for oligonucleotide expression arrays.
Journal of the American statistical Association 99: 909-917.
Xia, Y., L. J. Roman, B. S. S. Masters, and J. L. Zweier. 1998. Inducible nitric-oxide
synthase generates superoxide from the reductase domain. J. Biol. Chem. 273:
22635-22639.
Xia, Y., and J. L. Zweier. 1997. Superoxide and peroxynitrite generation from inducible
nitric oxide synthase in macrophages. Proceedings of the National Academy of
Sciences 94: 6954-6958.
Xue, Y., S. Liao, K. Son, S. Greenwood, B. McBride, J. Boling, and J. Matthews. 2010.
Metabolic acidosis in sheep alters expression of renal and skeletal muscle amino
acid enzymes and transporters. J. Anim. Sci. 88: 707-717.
Xue, Y., S. Liao, J. Strickland, J. Boling, and J. Matthews. 2011. Bovine neuronal
vesicular glutamate transporter activity is inhibited by ergovaline and other
ergopeptines. J. Dairy Sci. 94: 3331-3341.
Yang, Y., M. Z. Dieter, Y. Chen, H. G. Shertzer, D. W. Nebert, and T. P. Dalton. 2002.
Initial characterization of the glutamate-cysteine ligase modifier subunit gclm(−/−)
knockout mouse novel model system for a severely compromised oxidative stress
response. J. Biol. Chem. 277: 49446-49452.
Yeh, C. L. 2004. Specific nutrient: role of arginine in sepsis. Nutrition 20: 581.
Yuan, L., and N. Kaplowitz. 2009. Glutathione in liver diseases and hepatotoxicity. Mol.
Aspects Med. 30: 29-41.
Zeyda, M., and T. M. Stulnig. 2009. Obesity, inflammation, and insulin resistance–a
mini-review. Gerontology 55: 379-386.
Zhang, H. J., L. Xu, V. J. Drake, L. Xie, L. W. Oberley, and K. C. Kregel. 2003. Heatinduced liver injury in old rats is associated with exaggerated oxidative stress and
altered transcription factor activation. The FASEB journal 17: 2293-2295.
Zhao, H., K. Li, J. Y. Tang, J. C. Zhou, K. N. Wang, X. J. Xia, and X. G. Lei. 2015.
Expression of selenoprotein genes is affected by obesity of pigs fed a high-fat
diet. J. Nutr. 145: 1394-1401.

176

Vita

Jing Huang entered the College of Agriculture, ShanDong Agricultural University
in 2004 and earned separate B.S. degrees in Agronomy and in English Literature in 2008.
She earned a M.S. degree in Ecology from the Chinese Academy of Sciences in 2012.
Ms. Huang began her Ph.D. program in Animal and Food Sciences with Dr. Matthews in
2014.

177

